UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or Section 15(d) of
the Securities Exchange Act of 1934
Date of Report (Date of earliest event
reported): July 4, 2023
MedTech Acquisition Corporation
(Exact name of registrant as specified in its charter)
Delaware |
|
001-39813 |
|
85-3009869 |
(State or other jurisdiction of
incorporation) |
|
(Commission File Number) |
|
(I.R.S. Employer Identification No.) |
48
Maple Avenue,
Greenwich, CT |
|
06830 |
(Address of principal executive offices) |
|
(Zip Code) |
Registrant’s telephone number, including
area code: (908) 391-1288
Not Applicable
(Former name or former
address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation to the registrant under
any of the following provisions:
x |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|
|
¨ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
|
|
¨ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
|
|
¨ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b)
of the Act:
Title of each class |
|
Trading
Symbol(s) |
|
Name
of each
exchange on which registered |
Units, each consisting of one share of Class A common stock and one-third of one Redeemable Warrant |
|
MTACU |
|
The Nasdaq Stock Market LLC |
Class A common stock, par value $0.0001 per share |
|
MTAC |
|
The Nasdaq Stock Market LLC |
Warrants, each whole warrant exercisable for one share of Class A common stock, each at an exercise price of $11.50 per share |
|
MTACW |
|
The Nasdaq Stock Market LLC |
Indicate by check mark whether the registrant is an emerging growth
company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange
Act of 1934 (§240.12b-2 of this chapter).
Emerging growth
company x
If an emerging
growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any
new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨
Item 1.01 |
Entry into a Material Definitive Agreement. |
On November 11, 2022, MedTech Acquisition
Corporation, a Delaware corporation (the “Company”), entered into an Agreement and Plan of Merger, as amended by that
certain First Amendment to the Agreement and Plan of Merger, dated April 4, 2023 and that certain Second Amendment to the Agreement
and Plan of Merger, dated May 13, 2023 (as amended, the “Merger Agreement”), with MTAC Merger Sub, Inc.,
a Delaware corporation and wholly owned subsidiary of the Company (“Merger Sub”), and TriSalus Life Sciences, Inc.,
a Delaware corporation (“TriSalus”), pursuant to which, subject to the satisfaction or waiver of certain conditions
set forth therein, Merger Sub will merge with and into TriSalus (the “Merger”), with TriSalus surviving the Merger
as a wholly owned subsidiary of the Company, and with TriSalus’ equity holders receiving shares of Company common stock, par value
$0.0001 per share (the “Common Stock” and the transactions contemplated by the Merger Agreement and the related ancillary
agreements, the “Business Combination”). Upon consummation of the Business Combination, the Company will be renamed
“TriSalus Life Sciences, Inc.”
Third Amendment to Agreement and Plan of Merger
On July 5, 2023, MTAC, Merger Sub, and TriSalus
further amended the Merger Agreement (the “Amendment”) to update the form of Amended and Restated Bylaws, attached
as Appendix A to the Amendment, that will become effective immediately prior to the consummation of the Business Combination. The foregoing
description of the Amendment is a summary only and is qualified in its entirety by the full text of the Amendment, a copy of which is
attached hereto as Exhibit 10.1 and incorporated herein by reference.
Additional Subscription Agreements
On June 7, 2023, the Company and certain investors
(collectively, the “Initial Subscribers”) entered into subscription agreements (the “Initial Subscription
Agreements”), pursuant to, and subject to the conditions of which, the Initial Subscribers collectively subscribed for and agreed
to purchase from the Company 1,785,502 shares of a to-be-authorized class of preferred stock, par value $0.0001 per share that will be
designated as Series A Convertible Preferred Stock (the “Series A Convertible Preferred Stock”), at a purchase
price of $10.00 per share, resulting in an aggregate purchase price of $17,855,020. Upon issuance, each share of Series A Convertible
Preferred Stock will be initially convertible into one share of Common Stock.
On July 4, 2023, the Company and certain investors
(collectively, the “Additional Subscribers”, and collectively with the Initial Subscribers, the “Subscribers”)
entered into subscription agreements (the “Additional Subscription Agreements”, and collectively with the Initial Subscription
Agreements, the “Subscription Agreements”), pursuant to, and subject to the conditions of which, the Additional Subscribers
collectively subscribed for and agreed to purchase from the Company 2,229,500 shares of Series A Convertible Preferred Stock, at
a purchase price of $10.00 per share, resulting in an aggregate purchase price of $22,295,000 (in addition to the $17,855,020 subscribed
for by the Initial Subscribers). Other than updating the representations as to the Company’s issued and outstanding shares of Class A
Common Stock and Class B Common Stock due to (i) the redemption of shares of Class A Common Stock in connection with the
Company’s special meeting of stockholders held on June 12, 2023 (the results of which were disclosed in the Current Report
on Form 8-K filed by the Company on June 15, 2023) and (ii) the conversion of 6,249,999 shares of Class B Common Stock
held by MedTech Acquisition Sponsor LLC (the “Sponsor”) into 6,249,999 shares of Class A Common Stock on June 26,
2023 (as was disclosed in the Current Report on Form 8-K filed by the Company on June 30, 2023), the terms of the Initial Subscription
Agreements and Additional Subscription Agreements are substantially the same.
The closing of the purchase and sale of the Series A
Convertible Preferred Stock (the “Closing”) pursuant to the Subscription Agreements will occur concurrently with the
closing of the Business Combination and is subject to the conditions in the Subscription Agreements, including the filing of the Certificate
of Designations, Preferences and Rights of Series A Convertible Preferred Stock specifying the terms of the Series A Convertible
Preferred Stock (the form of which was disclosed in the Current Report on Form 8-K filed by the Company on June 8, 2023) with
the Secretary of State of the State of Delaware. The Subscription Agreements contain customary representations, warranties, and covenants
of the Company and the respective Subscribers.
The Subscription Agreements provide for certain
registration rights with respect to the Common Stock issuable upon conversion of the Series A Convertible Preferred Stock as well
as any shares of Common Stock issued as payment of any annual dividends declared and paid by the Company to the holders of the Series A
Convertible Preferred Stock (the “Annual Dividends”). In particular, the Company is required to file a registration
statement (the “Registration Statement”) within 30 calendar days of the date of the Closing registering the resale
of the number of shares of Common Stock issuable upon the conversion of the Series A Convertible Preferred Stock or issuable as payments
of any Annual Dividends (the “Conversion Shares”), and the Company shall use its commercially reasonable efforts to
have the Registration Statement declared effective as soon as practicable after the filing thereof, but in any event no later than 90
calendar days after the Closing (the “Effectiveness Deadline”); provided that the Effectiveness Deadline shall be extended
to 120 calendar days after the Closing if the Registration Statement is reviewed by, and comments thereto are provided from, the Securities
and Exchange Commission (the “SEC”). The Company must use commercially reasonable efforts to keep the Registration Statement
effective with respect to each Subscriber until the earliest to occur of (i) two years from the effective date of the Registration
Statement, (ii) the date on which such Subscriber ceases to hold any Series A Convertible Preferred Stock or Conversion Shares
issued pursuant to the Subscription Agreement and covered by the Registration Statement and (iii) the first date on which such Subscriber
can sell all of its Conversion Shares issued pursuant to the Subscription Agreement and covered by the Registration Statement under Rule 144
of the Securities Act of 1933, as amended (the “Securities Act”), without limitation as to the manner of sale or the
amount of such securities that may be sold and without the requirement for the Company to be in compliance with the current public information
required under Rule 144(c)(1) (or Rule 144(i)(2), if applicable).
The foregoing description of the Additional Subscription
Agreements is a summary only and is qualified in its entirety by the full text of the form of Additional Subscription Agreement, a copy
of which is attached hereto as Exhibit 10.2 and incorporated herein by reference.
Item 1.02 |
Termination of a Material Definitive Agreement. |
As previously disclosed, on June 7, 2023,
the Company entered into a Backstop Letter Agreement with the Sponsor, pursuant to which the Sponsor agreed that, to the extent that the
Sponsor’s members, or their respective affiliates, related parties or designees, did not collectively purchase an aggregate of $2,000,000
worth of Series A Convertible Preferred Stock from the Company (any such shortfall, the “Sponsor Commitment Amount”),
the Sponsor would execute and deliver to the Company a Subscription Agreement providing for a subscription by the Sponsor in an amount
equal to the Sponsor Commitment Amount to purchase shares of Series A Convertible Preferred Stock on the same terms and conditions
as the other Subscribers who have executed Subscription Agreements to date.
On July 4, 2023,
the Company and the Sponsor formalized the termination of the Backstop Letter Agreement in a letter agreement (the “Letter Agreement”)
to confirm that the Backstop Letter Agreement terminated in accordance with its terms as an additional $2 million of Series A Convertible
Preferred Stock were collectively subscribed for by Sponsor’s members and their respectively affiliates, related parties and designees
pursuant to the Additional Subscription Agreements executed on such date. The foregoing description of the Letter Agreement is
a summary only and is qualified in its entirety by the full text of the Letter Agreement, a copy of which is attached hereto as Exhibit 10.3
and incorporated herein by reference.
Item 3.02 |
Unregistered Sales of Equity Securities. |
The disclosure set forth
above in Item 1.01 of this Current Report on Form 8-K is incorporated by reference herein. The Series A Convertible Preferred
Stock and the Conversion Shares to be issued in connection with the Additional Subscription Agreements will not be registered under the
Securities Act, in reliance on the exemption from registration provided by Section 4(a)(2) of the Securities Act and/or Regulation
D promulgated thereunder.
Changes and Additional Information in Connection with SEC Filing
In connection with the Merger Agreement and the
proposed Business Combination, the Company filed with the SEC a registration statement on Form S-4 (File No. 333-269138) (as
amended, the “Registration Statement”), which includes a proxy statement/prospectus of the Company that will be both
the proxy statement to be distributed to holders of the Common Stock in connection with its solicitation of proxies for the vote by the
Company’s stockholders with respect to the Business Combination and other matters as may be described in the Registration Statement,
as well as the prospectus relating to the offer and sale of the securities to be issued in the Business Combination. The Registration
Statement is not yet effective. The Registration Statement, including the proxy statement/prospectus contained therein, when it is declared
effective by the SEC, will contain important information about the Business Combination and the other matters to be voted upon at a meeting
of the Company’s stockholders to be held to approve the Business Combination and other matters (the “Special Meeting”).
The Company may also file other documents with the SEC regarding the Business Combination. The Company’s stockholders and other
interested persons are advised to read, when available, the Registration Statement, including the proxy statement/prospectus contained
therein, as well as any amendments or supplements thereto, because they will contain important information about the Business Combination.
When available, the definitive proxy statement/prospectus will be mailed to the Company’s stockholders as of a record date to be
established for voting on the Business Combination and the other matters to be voted upon at the Special Meeting.
Participation in Solicitation
The Company and TriSalus and their respective directors
and executive officers, under SEC rules, may be deemed to be participants in the solicitation of proxies of the Company’s stockholders
in connection with the Business Combination. Investors and security holders may obtain more detailed information regarding the names and
interests in the Business Combination of the Company’s directors and officers in the Company’s filings with the SEC, including
the Company’s registration statement on Form S-1, which was originally filed with the SEC on November 30, 2020, as amended,
the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2022, filed with the SEC on March 22,
2023, and the Registration Statement. To the extent that holdings of the Company’s securities have changed from the amounts reported
in the Registration Statement, such changes have been or will be reflected on Statements of Change in Ownership on Form 4 filed with
the SEC. Information regarding the persons who may, under SEC rules, be deemed participants in the solicitation of proxies from the Company’s
stockholders in connection with the Business Combination are included in the Registration Statement and will be set forth in the definitive
proxy statement/prospectus forming a part of the Registration Statement. Investors and security holders of the Company and TriSalus are
urged to carefully read in their entirety the proxy statement/prospectus and other relevant documents that will be filed with the SEC,
when they become available, because they will contain important information about the Business Combination.
Investors and security holders will be able to
obtain free copies of the proxy statement/prospectus and other documents containing important information about the Company and TriSalus
through the website maintained by the SEC at www.sec.gov. Copies of the documents filed with the SEC by the Company can be obtained free
of charge by directing a written request to MedTech Acquisition Corporation at 48 Maple Avenue, Greenwich, CT 06830.
INVESTMENT IN ANY SECURITIES DESCRIBED HEREIN HAS
NOT BEEN APPROVED OR DISAPPROVED BY THE SEC OR ANY OTHER REGULATORY AUTHORITY NOR HAS ANY AUTHORITY PASSED UPON OR ENDORSED THE MERITS
OF THE OFFERING THEREOF OR THE ACCURACY OR ADEQUACY OF THE INFORMATION CONTAINED HEREIN. ANY REPRESENTATION TO THE CONTRARY IS A CRIMINAL
OFFENSE.
Forward-Looking Statements
This Current Report
on Form 8-K contains certain “forward-looking statements” within the meaning of the United States federal securities
laws regarding the Company’s or TriSalus’ expectations, hopes, beliefs, assumptions, intentions or strategies regarding the
future including, without limitation, statements regarding raising additional financing in connection with the Business Combination. These
forward-looking statements generally are identified by words such as “intend,” “may,” “plan,” “will”
and similar expressions or the negative or other variations of such statements. These statements are predictions, projections and other
statements about future events that are based on various assumptions, whether or not identified in this Current Report on Form 8-K
and on the current expectations of the Company’s and TriSalus’ respective managements and are not predictions of actual performance
and, as a result, are subject to risks and uncertainties.
Many factors could cause
actual results or developments to differ materially from those expressed or implied by such forward-looking statements, including but
not limited to: (i) the risk that the Business Combination may not be completed in a timely manner or at all, which may adversely
affect the price of the Company’s securities; (ii) the risk that the Business Combination may not be completed by the Company’s
business combination deadline; (iii) the failure to satisfy the conditions to the consummation of the Business Combination, including
the approval of the Merger Agreement by the stockholders of the Company, the satisfaction of the minimum cash amount following any redemptions
by the Company’s public stockholders, and the receipt of certain governmental and regulatory approvals; (iv) the lack of a
third-party valuation in determining whether or not to pursue the Business Combination on the terms set forth in the Merger Agreement;
(v) the failure to satisfy the conditions to the consummation of the Subscription Agreements and the resulting impact on the amount
of capital available to the Company at the potential closing of the Business Combination; (vi) the occurrence of any event, change
or other circumstance that could give rise to the termination of the Merger Agreement; (vii) the receipt of an unsolicited offer
from another party for an alternative transaction that could interfere with the Business Combination; (viii) the effect of the announcement
or pendency of the Business Combination on TriSalus’ business relationships, operating results and business generally; (ix) the
risk that the Business Combination disrupts current plans and operations of TriSalus; (x) the outcome of any legal proceedings that
may be instituted against TriSalus or the Company related to the Merger Agreement or the Business Combination; (xi) the ability to
maintain the listing of the Company’s securities on the Nasdaq; (xii) changes in business, market, financial, political and
legal conditions; (xiii) unfavorable changes in the reimbursement environment for TriSalus’ products; (xiv) the ability
of the Company or the combined company to raise additional financing in connection with the Business Combination or to finance its operations
in the future; (xv) the ability to implement business plans, forecasts and other expectations after the completion of the Business
Combination, and identify and realize additional opportunities; (xvi) costs related to the Business Combination; (xvii) the
failure to realize the anticipated benefits of the Business Combination or to realize estimated pro forma results and the underlying assumptions,
including with respect to estimated stockholder redemptions; and (xviii) other risks and uncertainties indicated from time to time
in the Registration Statement, including those under the “Risk Factors” section therein and in the Company’s other filings
with the SEC. The foregoing list of factors is not exclusive.
The Company’s
other SEC filings identify and address other important risks and uncertainties that could cause actual events and results to differ materially
from those expressed or implied in the forward-looking statements. Forward-looking statements speak only as of the date they are made.
Readers are cautioned not to put undue reliance on forward-looking statements, and none of the Company, TriSalus, or any of their respective
representatives assume any obligation and do not intend to update or revise these forward-looking statements, whether as a result of new
information, future events, or otherwise. None of the Company, TriSalus, or any of their respective representatives gives any assurance
that either the Company or TriSalus will achieve its expectations.
No Offer or Solicitation
This Current Report on Form 8-K shall not
constitute an offer to sell, a solicitation of an offer to buy or a recommendation to purchase any securities, or the solicitation of
any proxy, vote, consent or approval in any jurisdiction in connection with the Business Combination, nor shall there be any offer, solicitation
or sale of securities in any jurisdiction in which the offer, solicitation or sale would be unlawful prior to the registration or qualification
under the securities laws of such jurisdictions. This communication is restricted by law; it is not intended for distribution to, or use
by any person in, any jurisdiction where such distribution or use would be contrary to local law or regulation. No offering of securities
shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act.
Item 9.01 |
Financial Statements and Exhibits. |
(d) Exhibits
Exhibit No. |
|
Description |
10.1 |
|
Third Amendment to Agreement and Plan of Merger, dated as of July 5, 2023, by and among MedTech Acquisition Corporation, MTAC Merger Sub, Inc., and TriSalus Life Sciences, Inc. |
10.2 |
|
Form of Subscription Agreement. |
10.3 |
|
Letter Agreement, dated as of July 4, 2023, by and between MedTech Acquisition Corporation and MedTech Acquisition Sponsor LLC. |
104 |
|
Cover Page Interactive Data File (embedded within the Inline XBRL document). |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
MedTech Acquisition Corporation |
|
|
Dated: July 6, 2023 |
By: |
/s/ Christopher C. Dewey |
|
|
Name: |
Christopher C. Dewey |
|
|
Title: |
Chief Executive Officer |
Exhibit 10.1
THIRD Amendment
To Agreement AND PLAN OF MERGER
THIS THIRD AMENDMENT TO AGREEMENT AND PLAN OF MERGER
(this “Third Amendment”), dated as of July 5, 2023, is made and entered into by and among MedTech Acquisition Corporation,
a Delaware corporation (“Acquiror”), MTAC Merger Sub, Inc., a Delaware corporation and direct, wholly owned subsidiary
of Acquiror (“Merger Sub”), and TriSalus Life Sciences, Inc., a Delaware corporation (the “Company”).
Capitalized terms used but not otherwise defined herein shall have the meanings ascribed to them in the Merger Agreement (as defined below).
RECITALS
A. WHEREAS, Acquiror, Merger Sub and the Company are parties to that certain Agreement and Plan of Merger, dated as of November
11, 2022, as amended pursuant to that certain (i) First Amendment to Agreement and Plan of Merger, dated as of April 4, 2023 and (ii)
Second Amendment to Agreement and Plan of Merger, dated as of May 13, 2023 (as amended, the “Merger Agreement”);
B. WHEREAS, Section 12.10 of the Merger Agreement provides that the Merger Agreement may be amended or modified in whole
or in part, only by a duly authorized agreement in writing executed in the same manner as the Merger Agreement and which makes reference
to the Merger Agreement; and
C. WHEREAS, Acquiror, Merger Sub and the Company desire to amend the Merger Agreement pursuant to Section 12.10 thereof
as set forth in this Amendment.
AGREEMENT
NOW,
THEREFORE, in consideration of the mutual agreements, covenants and other promises set forth herein, the mutual benefits to
be gained by the performance thereof, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged
and accepted, Acquiror, Merger Sub and the Company hereby agree as follows:
1. AMENDMENT TO EXHIBIT D. The form of Acquiror Bylaws attached to the Merger Agreement as Exhibit D is hereby deleted
in its entirety and is replaced with the new form of Acquiror Bylaws attached as Appendix A to this Third Amendment.
2. NO FURTHER AMENDMENT; EFFECT OF AMENDMENT. This Amendment shall be deemed incorporated into, and form a part of, the Merger
Agreement and have the same legal validity and effect as the Merger Agreement. Except as expressly and specifically amended hereby, the
Merger Agreement is not otherwise being amended, modified or supplemented and all terms and provisions of the Merger Agreement are and
shall remain in full force and effect in accordance with its terms, and all references to the Merger Agreement in this Amendment and in
any ancillary agreements or documents delivered in connection with the Merger Agreement shall hereafter refer to the Merger Agreement
as amended by this Amendment, and as it may hereafter be further amended or restated.
3. REFERENCES TO THE MERGER AGREEMENT. Once this Amendment becomes effective, each reference in the Merger Agreement to “this
Agreement,” “herein,” “hereof,” “hereunder” or words of similar import shall hereafter be deemed
to refer to the Merger Agreement as amended hereby (except that references in the Merger Agreement to “as of the date hereof”
or “as of the date of this Agreement” or words of similar import shall continue to mean November 11, 2022).
4. OTHER CHANGES. The Merger Agreement is hereby amended, mutatis mutandis, in any additional way as may be necessary
to further the intent set forth in this Amendment.
5. COUNTERPARTS. This Amendment may be executed in several counterparts, each of which shall be deemed an original and all
of which shall constitute one and the same instrument. This Amendment may be executed by electronic transmission, each of which shall
be deemed an original.
6. HEADINGS. The bold-faced headings contained in this Amendment are for convenience of reference only, shall not be deemed
to be a part of this Amendment and shall not be referred to in connection with the construction or interpretation of this Amendment.
7. GOVERNING LAW. This Amendment, and all claims or causes of action based upon, arising out of, or related to this Amendment,
shall be governed by, and construed in accordance with, the Laws of the State of Delaware, without giving effect to principles or rules
of conflict of Laws to the extent such principles or rules would require or permit the application of Laws of another jurisdiction.
[Signature page follows]
IN WITNESS WHEREOF, the parties
listed below, by their duly authorized representatives, have executed this Amendment as of the date first written above.
|
MEDTECH ACQUISITION CORPORATION |
|
|
|
By: |
/s/ Christopher Dewey |
|
Name: Christopher Dewey |
|
Title: Chief Executive Officer |
|
|
|
|
|
MTAC MERGER SUB, INC. |
|
|
|
By: |
/s/ Christopher Dewey |
|
Name: Christopher Dewey |
|
Title: Chief Executive Officer |
|
|
|
|
|
TRISALUS LIFE SCIENCES, INC. |
|
|
|
By: |
/s/ Mary Szela |
|
Name: Mary Szela |
|
Title: CEO and President |
(Signature Page
to Third Amendment to Agreement and Plan of Merger)
Appendix A
Form of Acquiror Bylaws
AMENDED AND RESTATED
BYLAWS
OF
Trisalus life sciences,
inc.
__________________________________________________
(A DELAWARE CORPORATION)
[●], 2023
ARTICLE
I
Offices
Section 1. Registered Office. The registered office of TriSalus Life Sciences, Inc. (the “corporation”) in the State
of Delaware and the name of the corporation’s registered agent at such address shall be as set forth in the Amended and Restated
Certificate of Incorporation of the corporation (as the same may be amended and/or restated from time to time, the “Certificate
of Incorporation”).
Section 2. Other Offices. The corporation may also have and maintain an office or principal place of business at such place as may be fixed by
the Board of Directors of the corporation (the “Board of Directors”), and may also have offices at such other
places, both within and without the State of Delaware as the Board of Directors may from time to time determine or the business of the
corporation may require.
ARTICLE
II
Corporate Seal
Section 3. Corporate Seal. The Board of Directors may adopt a corporate seal. Said seal may be used by causing it or a facsimile thereof to be
impressed, affixed or reproduced or otherwise.
ARTICLE
III
Stockholders’ Meetings
Section 4. Place of Meetings. Meetings of the stockholders of the corporation may be held at such place, if any, either within or without the
State of Delaware, as may be determined from time to time by the Board of Directors. The Board of Directors may, in its sole discretion,
determine that the meeting shall not be held at any place, but may instead be held solely by means of remote communication as provided
under the General Corporation Law of the State of Delaware (“DGCL”) and Section 14 below.
Section 5. Annual Meetings.
(a) The annual meeting of the stockholders of the corporation, for the purpose of election of directors and for such other business as
may properly come before it, shall be held on such date, time and place, if any, as may be determined from time to time by the Board of
Directors. Subject to applicable law, the Board of Directors, or any director or officer of the corporation to whom the Board of Directors
delegated such authority, may postpone, reschedule or cancel any annual meeting of stockholders previously scheduled by the Board of Directors
at any time before or after notice of such meeting has been given to stockholders. Nominations of persons for election to the Board of
Directors and proposals of other business to be considered by the stockholders may be made at an annual meeting of stockholders: (i) pursuant
to the corporation’s notice of meeting of stockholders (or any supplement thereto); (ii) by or at the direction of the Board of
Directors or a duly authorized committee thereof; (iii) as may be provided in the certificate of designation for any class or series of
preferred stock; or (iv) by any stockholder of the corporation who was a stockholder of record at the time of giving the stockholder’s
notice provided for in Section 5(b) of these amended and restated bylaws (as may be amended and/or restated from time to time, the “Bylaws”)
and who is a stockholder of record at the time of the annual meeting of stockholders, who is entitled to vote at the meeting and who complied
with the notice procedures set forth in this Section 5. For the avoidance of doubt, clause (iv) above shall be the exclusive means for
a stockholder to make nominations and submit other business (other than matters properly included in the corporation’s notice of
meeting of stockholders and proxy statement under Rule 14a-8 under the Securities Exchange Act of 1934, as amended, and the rules and
regulations thereunder (the “1934 Act”)) before an annual meeting of stockholders.
(b) At an annual meeting of the stockholders, only such business shall be conducted as is a proper matter for stockholder action under
the DGCL, the Certificate of Incorporation, the Bylaws, and only such nominations shall be made and such business shall be conducted as
shall have been properly brought before the meeting in accordance with the procedures below.
(i)
For nominations for the election to the Board of Directors to be properly brought before an annual meeting by a stockholder pursuant
to clause (iv) of Section 5(a), the stockholder must deliver written notice to the Secretary at the principal executive offices of
the corporation on a timely basis as set forth in Section 5(b)(iii) and must update and supplement the information contained in such written
notice on a timely basis as set forth in Section 5(c). Such stockholder’s notice shall include: (A) as to each nominee such stockholder
proposes to nominate at the meeting: (1) the name, age, business address and residence address of such nominee, (2) the principal occupation
or employment of such nominee, (3) the class or series and number of shares of each class or series of capital stock of the corporation
that are owned of record and beneficially by such nominee and a list of any pledges of or encumbrances on such shares, (4) the date or
dates on which such shares were acquired and the investment intent of such acquisition, (5) the questionnaire, representation and agreement
required by Section 5(e), completed and signed by such nominee; and (6) all other information concerning such nominee as would be required
to be disclosed or provided to the corporation in a proxy statement soliciting proxies for the election of such nominee as a director
in an election contest (even if an election contest is not involved and whether or not proxies are being or will be solicited), or that
is otherwise required to be disclosed pursuant to applicable requirements of state and federal law, including Section 14 of the 1934 Act
and the rules and regulations promulgated thereunder, the Certificate of Incorporation, and these Bylaws (including such person’s
written consent to being named in the corporation’s proxy statement and associated proxy card and other filings as a nominee of
the stockholder and to serving as a director if elected); and (B) all of the information required by Section 5(b)(iv). The corporation
may require any proposed nominee to furnish such other information as it may reasonably require to determine the eligibility of such proposed
nominee to serve as a director of the corporation and to determine the independence (as such term is used in any applicable stock exchange
listing requirements or applicable law) of such proposed nominee or to determine the eligibility of such proposed nominee to serve on
any committee or sub-committee of the Board of Directors under any applicable stock exchange listing requirements or applicable law, or
that the Board of Directors determines, in its sole discretion, could be material to a reasonable stockholder’s understanding of
the background, qualifications, experience, independence, or lack thereof, of such proposed nominee. The number of nominees a stockholder
may nominate for election at the annual meeting of stockholders (or in the case of a stockholder giving the notice on behalf of a beneficial
owner, the number of nominees a stockholder may nominate for election at the annual meeting of stockholders on behalf of such beneficial
owner) shall not exceed the number of directors to be elected at such annual meeting. A stockholder may not designate any substitute nominees
unless the stockholder provides timely notice of such substitute nominee(s) in accordance with this Section 5, in the case of an annual
meeting, or Section 6, in the case of a special meeting (and such notice contains all of the information, representations, questionnaires
and certifications with respect to such substitute nominee(s) that are required by the Bylaws with respect to nominees for director).
(ii)
For business other than nominations for the election to the Board of Directors to be properly brought before an annual meeting by
a stockholder pursuant to clause (iv) of Section 5(a), the Proposing Person must deliver written notice to the Secretary at the principal
executive offices of the corporation on a timely basis as set forth in Section 5(b)(iii), and must update and supplement such written
notice on a timely basis as set forth in Section 5(c). The Proposing Person’s notice shall set forth: (A) as to each matter the
Proposing Person proposes to bring before the meeting, a brief description of the business desired to be brought before the meeting, the
text of the proposal or business (including the text of any resolutions proposed for consideration and in the event that such business
includes a proposal to amend the Bylaws, the language of the proposed amendment), the reasons for conducting such business at the meeting,
and any material interest (including any anticipated benefit of such business to any Proposing Person (as defined below) other than solely
as a result of its ownership of the corporation’s capital stock, that is material to any Proposing Person individually, or to the
Proposing Persons in the aggregate) in such business of any Proposing Person; and (B) the information required by Section 5(b)(iv).
(iii)
To be timely, the written notice required by Section 5(b)(i) or 5(b)(ii) must be received by the Secretary at the principal executive
offices of the corporation not later than the close of business on the 90th day, nor earlier than the close of business on
the 120th day, prior to the first anniversary of the date (as stated in the corporation’s proxy materials) the definitive
proxy statement was first sent to stockholders in connection with the preceding year’s annual meeting of stockholders (for purposes
of notice required for action to be taken at the corporation’s annual meeting of stockholders for the 2024 calendar year, the date
of the 2023 annual meeting shall be deemed to have occurred on [ ], 2023); provided, however, that, subject to the last sentence
of this Section 5(b)(iii), in the event that the date of the annual meeting is advanced more than 30 days prior to or delayed by more
than 70 days after the anniversary of the preceding year’s annual meeting, or if no annual meeting was held (or deemed to have been
held), notice by the stockholder to be timely must be so received not earlier than the close of business on the 120th day prior
to such annual meeting and not later than the close of business on the later of the 90th day prior to such annual meeting or,
if later than the 90th day prior to such annual meeting, the tenth day following the day on which public announcement of the
date of such meeting is first made by the corporation. In no event shall an adjournment or postponement of an annual meeting (or the public
announcement thereof) for which notice has been given, or for which a public announcement of the date of the meeting has been made by
the corporation, commence a new time period (or extend any time period) for the giving of a stockholder’s notice as described above.
(iv)
The written notice required by Sections 5(b)(i) or 5(b)(ii) shall also set forth, as of the date of the notice and as to the Proposing
Person: (A) the name and address of each Proposing Person, including, if applicable, such name and address as they appear on the corporation’s
books and records; (B) the class, series and number of shares of each class or series of the capital stock of the corporation that are,
directly or indirectly, owned of record or beneficially (within the meaning of Rule 13d-3 under the 1934 Act) by each Proposing Person
(provided, that for purposes of this Section 5(b)(iv), such Proposing Person shall in all events be deemed to beneficially own all shares
of any class or series of capital stock of the corporation as to which such Proposing Person or any of its affiliates or associates has
a right to acquire beneficial ownership at any time in the future); (C) a description of any agreement, arrangement or understanding (whether
oral or in writing) with respect to such nomination or proposal (and/or the voting of shares of any class or series of capital stock of
the corporation) between or among any Proposing Person and any of its affiliates or associates, and/or any other persons (including their
names), including without limitation, any agreements, arrangements or understandings required to be disclosed pursuant to Item 5 or Item
6 of Schedule 13D under the 1934 Act, regardless of whether the requirement to file a Schedule 13D is applicable; (D) a representation
that the Proposing Persons are holders of record or beneficial owners, as the case may be, of shares of the corporation at the time of
giving notice, will be entitled to vote at the meeting, and that such stockholder (or a qualified representative thereof) intends to appear
in person or by proxy at the meeting to nominate the person or persons specified in the notice (with respect to a notice under Section
5(b)(i)) or to propose the business that is specified in the notice (with respect to a notice under Section 5(b)(ii)); (E) a representation
as to whether the Proposing Persons or any other participant (as defined in Item 4 of Schedule 14A under the 1934 Act) intend to solicit
proxies from the required number of the corporation’s voting shares in support of any proposed nominee, as promulgated under Rule
14a-19 of the 1934 Act (with respect to a notice under Section 5(b)(i)), and, if so, the name of each participant in such solicitation
and the amount of the cost of solicitation that has been and will be borne, directly or indirectly, by each participant in such solicitation,
and a representation as to whether the Proposing Persons intend or are part of a group which intends to (x) deliver, or make available,
a proxy statement and/or form of proxy to holders of at least such percentage of the corporation’s voting shares that would be required
to approve or adopt the proposal or elect the nominee or (y) otherwise solicit proxies or votes from stockholders in support of such proposal
(with respect to a notice under Section 5(b)(ii)); (F) to the extent known by any Proposing Person, the name and address of any other
stockholder supporting the proposal on the date of such stockholder’s notice; (G) a description of all Derivative Transactions (as
defined below) by each Proposing Person during the previous 12 month period, including the date of the transactions and the class, series
and number of securities involved in, and the material economic or voting terms of, such Derivative Transactions; (H) a certification
regarding whether each Proposing Person has complied with all applicable federal, state and other legal requirements in connection with
such Proposing Person’s acquisition of shares of capital stock or other securities of the corporation and/or such Proposing Person’s
acts or omissions as a stockholder or beneficial owner of the corporation; and (I) any other information relating to each Proposing Person
required to be disclosed in a proxy statement or other filings required to be made in connection with solicitations of proxies for, as
applicable, the proposal and/or for the election of directors in an election contest pursuant to and in accordance with Section 14 of
the 1934 Act and the rules and regulations promulgated thereunder.
(c) A Proposing Person providing the written notice required by Section 5(b)(i) or (ii) shall update and supplement such notice in writing,
if necessary, so that the information (other than the representations required by Section 5(b)(iv)(E)) provided or required to be provided
in such notice is true and correct in all material respects as of (i) the record date for the determination of stockholders entitled to
notice of the meeting and (ii) the date that is five Business Days (as defined below) prior to the meeting and, in the event of any adjournment
or postponement thereof, five Business Days prior to such adjourned or postponed meeting; provided, that no such update or supplement
shall cure or affect the accuracy (or inaccuracy) of any representations made by any Proposing Person, any of its affiliates or associates
or a nominee, or the validity (or invalidity) of any nomination or proposal that failed to comply with this Section 5 or is rendered invalid
as a result of any inaccuracy therein. In the case of an update and supplement pursuant to clause (i) of this Section 5(c), such update
and supplement shall be received by the Secretary at the principal executive offices of the corporation not later than five Business Days
after the public announcement of the record date for the determination of stockholders entitled to notice of the meeting. In the case
of an update and supplement pursuant to clause (ii) of this Section 5(c), such update and supplement shall be received by the Secretary
at the principal executive offices of the corporation not later than two Business Days prior to the date for the meeting, and, in the
event of any adjournment or postponement thereof, two Business Days prior to such adjourned or postponed meeting.
(d) Notwithstanding anything in Section 5(b)(iii) to the contrary, in the event that the number of directors to be elected to the Board
of Directors at the next annual meeting is increased effective after the time period for which nominations would otherwise be due under
Section 5(b)(iii) and there is no public announcement by the corporation naming all of the nominees for the new positions created by such
increase at least 100 days before the first anniversary of the preceding year’s annual meeting, a Proposing Person’s notice
required by this Section 5 and that complies with the requirements in Section 5(b)(i), other than the timing requirements in Section
5(b)(iii), shall also be considered timely, but only with respect to nominees for the new positions created by such increase, if it shall
be received by the Secretary at the principal executive offices of the corporation not later than the close of business on the tenth day
following the day on which such public announcement is first made by the corporation.
(e) To
be eligible to be a nominee for election or re-election as a director of the corporation pursuant to a nomination under Section 5 or
Section 6, each Proposing Person must deliver (in accordance with the time periods prescribed for delivery of notice under Section 5(b)(iii)
to the Secretary at the principal executive offices of the corporation a written questionnaire with respect to the background, qualifications,
stock ownership and independence of such proposed nominee and the background of any other person or entity on whose behalf the nomination
is being made (in the form provided by the Secretary within 10 days following a written request therefor by a stockholder of record)
and a written representation and agreement (in the form provided by the Secretary within 10 days following written request therefor by
a stockholder of record) that such person (i) is not and will not become a party to (A) any agreement, arrangement or understanding (whether
oral or in writing) with, and has not given any commitment or assurance to, any person or entity as to how such person, if elected as
a director of the corporation, will act or vote on any issue or question (a “Voting Commitment”) that has not
been disclosed to the corporation in the questionnaire or (B) any Voting Commitment that could limit or interfere with such person’s
ability to comply, if elected as a director of the corporation, with such person’s fiduciary duties under applicable law; (ii)
is not and will not become a party to any agreement, arrangement or understanding (whether oral or in writing) with any person or entity
other than the corporation with respect to any direct or indirect compensation, reimbursement or indemnification in connection with service
or action as a director of the corporation or a nominee that has not been disclosed in such questionnaire; (iii) would be in compliance,
if elected as a director of the corporation, and will comply with, all applicable publicly disclosed corporate governance, conflict of
interest, confidentiality and stock ownership and trading policies and guidelines of the corporation; and (iv) if elected as a director
of the corporation, intends to serve the entire term until the next meeting at which such candidate would face re-election.
(f) A person shall not be eligible for election or re-election as a director at an annual meeting, unless the person is nominated, in
the case of an annual meeting, in accordance with either clause (ii), (iii) or (iv) of Section 5(a) and in accordance with the procedures
set forth in Section 5(b), Section 5(c), Section 5(d) and Section 5(e), as applicable, or in the case of a special meeting, in accordance
with Section 6(c). Only such business shall be conducted at any annual meeting of the stockholders of the corporation as shall have been
brought before the meeting in accordance with clauses (i), (ii), (iii) or (iv) of Section 5(a) and in accordance with the procedures set
forth in Section 5(b), Section 5(c), Section 5(d) and Section 5(e), as applicable. Notwithstanding anything to the contrary in the Bylaws,
unless otherwise required by applicable law, if any Proposing Person (i) provides notice pursuant to Rule 14a-19(b) promulgated under
the 1934 Act with respect to any proposed nominee and (ii) subsequently (x) fails to comply with the requirements of Rule 14a-19 promulgated
under the 1934 Act (or fails to timely provide reasonable evidence sufficient to satisfy the corporation that such Proposing Person has
met the requirements of Rule 14a-19(a)(3) promulgated under the 1934 Act in accordance with the following sentence) or (y) fails to inform
the corporation that they no longer plan to solicit proxies in accordance with the requirements of Rule 14a-19 under the 1934 Act by delivering
a written notice to the Secretary at the principal executive offices of the corporation within two Business Days after the occurrence
of such change, then the nomination of each such proposed nominee shall be disregarded (and such nominee disqualified from standing for
election or re-election), notwithstanding that the nominee is included (as applicable) as a nominee in the corporation’s proxy statement,
notice of meeting or other proxy materials for any stockholder meeting (or any supplement thereto) and notwithstanding that proxies or
votes in respect of the election of such proposed nominees may have been received by the corporation (which proxies and votes shall be
disregarded). Upon request by the corporation, if any Proposing Person provides notice pursuant to Rule 14a-19(b) promulgated under the
1934 Act, such Proposing Person shall deliver to the corporation, no later than five Business Days prior to the applicable meeting, reasonable
evidence that it has met the requirements of Rule 14a-19(a)(3) promulgated under the 1934 Act. Notwithstanding anything to the contrary
set forth herein, and for the avoidance of doubt, the nomination of any person whose name is included (as applicable) as a nominee in
the corporation’s proxy statement, notice of meeting or other proxy materials for any stockholder meeting (or any supplement thereto)
as a result of any notice provided by any Proposing Person pursuant to Rule 14a-19(b) promulgated under the Exchange Act with respect
to such proposed nominee and whose nomination is not made by or at the direction of the Board of Directors or any authorized committee
thereof shall not be deemed (for purposes of clause (i) of Section 5(a) or otherwise) to have been made pursuant to the corporation’s
notice of meeting (or any supplement thereto) and any such nominee may only be nominated by a Proposing Person pursuant to clause (b)
of Section 5 and, in the case of a special meeting of stockholders, pursuant to and to the extent permitted under Section 6(c) of these
Bylaws. Except as otherwise required by applicable law, the chairperson of the meeting shall have the power and duty to determine whether
a nomination or any business proposed to be brought before the meeting was made, or proposed, as the case may be, in accordance with the
procedures and requirements set forth in the Bylaws (including, without limitation, compliance with Rule 14a-19 promulgated under the
1934 Act) and, if any proposed nomination or business is not in compliance with the Bylaws, or the Proposing Person does not act in accordance
with the representations in Sections 5(b)(iv)(D), 5(b)(iv)(E) and 5(e), to declare that such proposal or nomination shall not be presented
for stockholder action at the meeting and shall be disregarded (and such nominee disqualified from standing for election or re-election),
or that such business shall not be transacted, notwithstanding such proposal or nomination is set forth in (as applicable) the corporation’s
proxy statement, notice of meeting or other proxy materials and notwithstanding that proxies or votes in respect of such nomination or
such business may have been solicited or received. Notwithstanding the foregoing provisions of this Section 5(f), unless otherwise required
by applicable law, if the stockholder (or a qualified representative of the stockholder) does not appear at the annual meeting of stockholders
of the corporation to present a nomination or proposed business, such nomination shall be disregarded (and such nominee disqualified from
standing for election or re-election) and such proposed business shall not be transacted, notwithstanding such nomination or proposed
business is set forth in (as applicable) the corporation’s proxy statement, notice of meeting or other proxy materials and notwithstanding
that proxies in respect of such vote may have been received by the corporation. For purposes of this Section 5(f), to be considered a
qualified representative of the stockholder, a person must be a duly authorized officer, manager or partner of such stockholder or must
be authorized by a writing executed by such stockholder or an electronic transmission delivered by such stockholder to act for such stockholder
as proxy at the meeting of stockholders and such person must produce such writing or electronic transmission, or a reliable reproduction
of the writing or electronic transmission, at the meeting of stockholders.
(g) For purposes of Sections 5 and 6,
(i)
“affiliates” and “associates” shall have the meanings set forth in Rule 405 under
the Securities Act of 1933, as amended (the “1933 Act”);
(ii)
“Business Day” means any day other than Saturday, Sunday or a day on which banks are closed in New York
City, New York;
(iii)
“close of business” means 6:00 p.m. local time at the principal executive offices of the corporation on
any calendar day, whether or not the day is a Business Day;
(iv)
“Derivative Transaction” means any agreement, arrangement, interest or understanding entered into by, or
on behalf or for the benefit of, any Proposing Person or any of its affiliates or associates, whether record or beneficial:
(A) the value of which
is derived in whole or in part from the value of any class or series of shares or other securities of the corporation;
(B) that otherwise provides
any direct or indirect opportunity to gain or share in any gain derived from a change in the value of securities of the corporation;
(C) the effect or intent
of which is to mitigate loss, manage risk or benefit from changes in value or price with respect to any securities of the corporation;
or
(D) that provides the
right to vote or increase or decrease the voting power of, such Proposing Person, or any of its affiliates or associates, directly or
indirectly, with respect to any securities of the corporation,
which agreement, arrangement, interest
or understanding may include, without limitation, any option, warrant, debt position, note, bond, convertible security, swap, stock appreciation
or similar right, short position, profit interest, hedge, right to dividends, voting agreement, performance-related fee or arrangement
to borrow or lend shares (whether or not subject to payment, settlement, exercise or conversion in any such class or series), and any
proportionate interest of such Proposing Person in the securities of the corporation held by any general or limited partnership, or any
limited liability company, of which such Proposing Person is, directly or indirectly, a general partner or managing member; and
(v) “Proposing Person” includes each of the stockholders giving the notice, the beneficial owner or beneficial
owners, if different, on whose behalf the nomination or proposal for other business subject to Section 5 of Article III is made, any of
their respective affiliates or associates (including, if such stockholder or beneficial owner is an entity, each director, executive,
managing member or control person of such entity), and any others acting in concert.
(vi) “public announcement” shall mean disclosure in a press release reported by the Dow Jones News Service, Associated
Press or comparable national news service or in a document publicly filed by the corporation with the Securities and Exchange Commission
pursuant to Section 13, 14 or 15(d) of the 1934 Act or by such other means reasonably designed to inform the public or security holders
in general of such information, including, without limitation, posting on the corporation’s investor relations website.
Section 6. Special Meetings.
(a) Special meetings of the stockholders of the corporation may be called, for any purpose as is a proper matter for stockholder action
under Delaware law, by (i) the Chairperson of the Board of Directors, (ii) the Chief Executive Officer, or (iii) the Board
of Directors pursuant to a resolution adopted by the Board of Directors.
(b) The Board of Directors shall determine the date, time and place, if any, of such special meeting. Upon determination of the date,
time and place, if any, of the meeting, the Secretary shall cause a notice of meeting to be given to the stockholders entitled to vote,
in accordance with the provisions of Section 7. No business may be transacted at such special meeting otherwise than specified in
the notice of meeting.
(c) Only such business (including the election of specific individuals to fill vacancies or newly created directorships on the Board of
Directors) shall be conducted at a special meeting of stockholders as shall have been brought before the meeting pursuant to the corporation’s
notice of meeting. Nominations of persons for election to the Board of Directors may be made at a special meeting of stockholders at which
directors are to be elected (i) by or at the direction of the Board of Directors or a duly authorized committee thereof or (ii) by any
stockholder of the corporation who is a stockholder of record (and, with respect to any beneficial owner, if different, on whose behalf
such nomination or nominations are made, only if such beneficial owner was the beneficial owner of shares of the corporation) at the time
of giving notice provided for in this paragraph and who is a stockholder of record at the time of the special meeting, who is entitled
to vote at the meeting and who delivers written notice to the Secretary of the corporation setting forth the information required by Sections
5(b)(i), 5(b)(iv) and 5(e). The number of nominees a stockholder may nominate for election at a special meeting on its own behalf (or
in the case of a stockholder giving the notice on behalf of a beneficial owner, the number of nominees a stockholder may nominate for
election at the special meeting on behalf of such beneficial owner) shall not exceed the number of directors to be elected at such special
meeting. In the event the corporation calls a special meeting of stockholders for the purpose of electing one or more directors to the
Board of Directors, any such stockholder of record may nominate a person or persons (as the case may be), for election to such position(s)
as specified in the corporation’s notice of meeting, if written notice setting forth the information required by Sections 5(b)(i),
5(b)(iv) and 5(e) shall be received by the Secretary at the principal executive offices of the corporation not earlier than 120 days prior
to such special meeting and not later than the close of business on the later of the 90th day prior to such meeting or the
tenth day following the day on which the corporation first makes a public announcement of the date of the special meeting and of the nominees
proposed by the Board of Directors to be elected at such meeting. The stockholder shall also update and supplement such information as
required under Section 5(c). In no event shall an adjournment or a postponement of a special meeting for which notice has been given,
or the public announcement thereof has been made, commence a new time period (or extend any time period) for the giving of a stockholder’s
notice as described above.
(d) A person shall not be eligible for election or re-election as a director at the special meeting unless the person is nominated either
in accordance with clause (i) or clause (ii) of Section 6(c). Except as otherwise required by applicable law, the chairperson of the meeting
shall have the power and duty to determine whether a nomination was made in accordance with the procedures and requirements set forth
in the Bylaws and, if any proposed nomination or business is not in compliance with the Bylaws (including, without limitation, compliance
with Rule 14a-19 under the 1934 Act), or if the Proposing Person does not act in accordance with the representations in Sections 5(b)(iv)(D),
5(b)(iv)(E) and 5(e), to declare that such nomination shall not be presented for stockholder action at the meeting and shall be disregarded
(and such nominee disqualified from standing for election or re-election), notwithstanding that such nomination is set forth in (as applicable)
the corporation’s proxy statement, notice of meeting or other proxy materials and notwithstanding that proxies in respect of such
nomination may have been solicited or received. Notwithstanding the foregoing provisions of this Section 6(d), unless otherwise required
by applicable law, if the stockholder or a qualified representative of the stockholder does not appear at the special meeting of stockholders
of the corporation to present a nomination, such nomination shall be disregarded (and such nominee disqualified from standing for election
or re-election), notwithstanding that the nomination is set forth (as applicable) in the corporation’s proxy statement, notice of
meeting or other proxy materials and notwithstanding that proxies or votes in respect of such nomination may have been solicited or received
by the corporation.
(e) Notwithstanding the foregoing provisions of Sections 5 and 6, a stockholder must also comply with all applicable requirements
of the 1934 Act and the rules and regulations promulgated thereunder with respect to matters set forth in Sections 5 and 6, and any failure
to comply with such requirements shall be deemed a failure to comply with Section 5 or 6, as applicable, provided, however, that
to the fullest extent not prohibited by applicable law, any references in these Bylaws to the 1934 Act or the rules and regulations promulgated
thereunder are not intended to and shall not limit the requirements applicable to proposals and/or nominations for the election to the
Board of Directors to be considered pursuant to Sections 5 or 6. Nothing in the Bylaws shall be deemed to affect any rights of holders
of any class or series of preferred stock to nominate and elect directors pursuant to and to the extent provided in any applicable provision
of the Certificate of Incorporation.
Section 7. Notice of Meetings. Except as otherwise provided by applicable law or the Certificate of Incorporation or the Bylaws, notice, given
in writing or by electronic transmission, of each meeting of stockholders shall be given not less than ten nor more than 60 days before
the date of the meeting to each stockholder entitled to vote at such meeting. Such notice shall be given in the manner provided in Section
232 of the DGCL and shall specify the date, time, place, if any, in the case of special meetings, the purpose or purposes of the meeting,
the record date for determining stockholders entitled to vote at the meeting, if such record date is different from the record date for
determining stockholders entitled to notice of the meeting, and the means of remote communications, if any, by which stockholders and
proxyholders may be deemed to be present in person and vote at any such meeting. If mailed, notice is given when deposited in the United
States mail, postage prepaid, directed to the stockholder at such stockholder’s address as it appears on the records of the corporation.
If sent via electronic transmission, notice is given when directed to such stockholder’s electronic mail address unless (a) the
stockholder has notified the corporation in writing or by electronic transmission of an objection to receiving notice by electronic mail
or (b) electronic transmission of such notice is prohibited by applicable law. Notice of the time, place, if any, and purpose of any meeting
of stockholders (to the extent required) may be waived in writing, signed by the person entitled to notice thereof, or by electronic transmission
by such person, either before or after such meeting, and will be waived by any stockholder by his or her attendance thereat in person,
by remote communication, if applicable, or by proxy, except when the stockholder attends a meeting for the express purpose of objecting,
at the beginning of the meeting, to the transaction of any business because the meeting is not lawfully called or convened. Any stockholder
so waiving notice of such meeting shall be bound by the proceedings of any such meeting in all respects as if due notice thereof had been
given.
Section 8. Quorum and Vote Required. At all meetings of stockholders, except where otherwise provided by statute or by the Certificate of Incorporation,
or by the Bylaws, the presence, in person, by remote communication, if applicable, or by proxy duly authorized, of the holders of a majority
of the voting power of the outstanding shares of stock entitled to vote at the meeting shall constitute a quorum for the transaction of
business. In the absence of a quorum, any meeting of stockholders may be adjourned, with or without notice, other than announcement at
the meeting or in a manner otherwise permitted by DGCL, from time to time, either by the chairperson of the meeting or by vote of the
holders of a majority of the voting power of the shares represented thereat and entitled to vote thereon, but no other business shall
be transacted at such meeting. The stockholders present at a duly called or convened meeting, at which a quorum is present, may continue
to transact business until adjournment, notwithstanding the withdrawal of enough stockholders to leave less than a quorum.
Unless a different or minimum vote is required by
statute or by applicable stock exchange rules, or by the Certificate of Incorporation or the Bylaws, in which case such different or minimum
vote shall be the applicable vote on the matter, in all matters other than the election of directors, the affirmative vote of the holders
of a majority of the voting power of the shares present in person, by remote communication, if applicable, or represented by proxy duly
authorized at the meeting and voting affirmatively or negatively (excluding abstentions and broker non-votes) on such matter shall be
the act of the stockholders. Except as otherwise provided by statute or by applicable stock exchange rules, the Certificate of Incorporation
or the Bylaws, directors shall be elected by a plurality of the votes of the shares present in person, by remote communication, if applicable,
or represented by proxy duly authorized at the meeting and entitled to vote generally on the election of directors. Where a separate vote
by a class or classes or series is required, except where otherwise provided by statute or by the Certificate of Incorporation or the
Bylaws or any applicable stock exchange rules, the holders of a majority of the voting power of the outstanding shares of such class or
classes or series, present in person, by remote communication, if applicable, or represented by proxy duly authorized, shall constitute
a quorum entitled to take action with respect to that vote on that matter. Unless a different or minimum vote is required by statute or
by the Certificate of Incorporation or the Bylaws or any applicable stock exchange rules, in which case such different or minimum vote
shall be the applicable vote on the matter, the affirmative vote of the holders of a majority (plurality, in the case of the election
of directors) of the voting power of the shares of such class or classes or series present in person, by remote communication, if applicable,
or represented by proxy duly authorized at the meeting and voting affirmatively or negatively (excluding abstention and broker non-votes)
on such matter shall be the act of such class or classes or series.
Section 9. Adjournment and Notice of Adjourned Meetings. Any meeting of stockholders, whether annual or special, may be adjourned from time to
time either by the chairperson of the meeting or by the vote of the holders of a majority of the voting power of the shares present in
person, by remote communication, if applicable, or represented by proxy duly authorized at the meeting and entitled to vote thereon. When
a meeting is adjourned to another time or place, if any, (including an adjournment taken to address a technical failure to convene or
continue a meeting using remote communication) notice need not be given of the adjourned meeting if the time and place, if any, thereof
and the means of remote communication, if any, by which stockholders and proxyholders may be deemed present in person and may vote at
such meeting are announced at the meeting at which the adjournment is taken. or are (i) displayed, during the time scheduled for the meeting,
on the same electronic network used to enable stockholders and proxy holders to participate in the meeting by means of remote communication
or (ii) set forth in the notice of meeting given in accordance with Section 7. At the adjourned meeting, the corporation may transact
any business that might have been transacted at the original meeting. If the adjournment is for more than 30 days or if after the adjournment
a new record date is fixed for the adjourned meeting, a notice of the adjourned meeting shall be given to each stockholder of record entitled
to vote at the meeting. If after the adjournment a new record date for determination of stockholders entitled to vote is fixed for the
adjourned meeting, the Board of Directors shall fix as the record date for determining stockholders entitled to notice of such adjourned
meeting the same or an earlier date as that fixed for determination of stockholders entitled to vote at the adjourned meeting, and shall
give notice of the adjourned meeting to each stockholder of record as of the record date so fixed for notice of such adjourned meeting.
Section 10. Voting Rights. For the purpose of determining those stockholders entitled to vote at any meeting of the stockholders or adjournment
thereof, except as otherwise provided by applicable law, only persons in whose names shares stand on the stock records of the corporation
on the record date shall be entitled to vote at any meeting of stockholders. Every person entitled to vote shall have the right to do
so either in person, by remote communication, if applicable, or by an agent or agents authorized by a proxy granted in accordance with
Delaware law. An agent so appointed need not be a stockholder. Every proxy must be authorized by an instrument in writing or by a transmission
permitted by law, including Rule 14a-19 promulgated under the 1934 Act, filed in accordance with the procedure established for the meeting
and signed by the stockholder or by such stockholder’s attorney-in-fact. No proxy shall be voted after three years from its date
of creation unless the proxy provides for a longer period. A proxy shall be irrevocable if it states that it is irrevocable and if, and
only as long as, it is coupled with an interest sufficient in law to support an irrevocable power. A stockholder may revoke any proxy
which is not irrevocable by attending the meeting and voting in person or by delivering to the Secretary of the corporation a revocation
of the proxy or a new proxy bearing a later date. Voting at meetings of stockholders need not be by written ballot. Any stockholder directly
or indirectly soliciting proxies from other stockholders must use a proxy card color other than white, which shall be reserved for the
exclusive use of the Board of Directors.
Section 11. Joint Owners of Stock. If shares or other securities having voting power stand of record in the names of two or more persons, whether
fiduciaries, members of a partnership, joint tenants, tenants in common, tenants by the entirety, or otherwise, or if two or more persons
have the same fiduciary relationship respecting the same shares, unless the Secretary is given written notice to the contrary and is furnished
with a copy of the instrument or order appointing them or creating the relationship wherein it is so provided, their acts with respect
to voting shall have the following effect: (a) if only one votes, his or her act binds all; (b) if more than one votes, the
act of the majority so voting binds all; (c) if more than one votes, but the vote is evenly split on any particular matter, each
faction may vote the securities in question proportionally, or may apply to the Delaware Court of Chancery for relief as provided in Section 217(b)
of the DGCL. If the instrument filed with the Secretary shows that any such tenancy is held in unequal interests, a majority or even-split
for the purpose of subsection (c) shall be a majority or even-split in interest.
Section 12. List of Stockholders. The corporation shall prepare, no later than the tenth day before each meeting of stockholders, a complete list
of the stockholders entitled to vote at said meeting, arranged in alphabetical order, showing the address of each stockholder and the
number and class of shares registered in the name of each stockholder; provided, however, if the record date for determining the stockholders
entitled to vote is less than ten days before the meeting date, the list shall reflect all of the stockholders entitled to vote as of
the tenth day before the meeting date. Such list shall be open to the examination of any stockholder, for any purpose germane to the meeting,
(a) on a reasonably accessible electronic network, provided that the information required to gain access to such list is provided
with the notice of the meeting, or (b) during ordinary business hours, at the principal place of business of the corporation. In the event
that the corporation determines to make the list available on an electronic network, the corporation may take reasonable steps to ensure
that such information is available only to stockholders of the corporation.
Section 13. Action without Meeting.
No action shall be taken by the
stockholders of the corporation except at an annual or special meeting of stockholders duly called in accordance with the Bylaws, and
no action shall be taken by the stockholders by written consent.
Section 14. Remote Communication. For the purposes of the Bylaws, if authorized by the Board of Directors in its sole discretion, and subject
to such guidelines and procedures as the Board of Directors may adopt, stockholders and proxyholders may, by means of remote communication:
(a)
participate in a meeting of stockholders; and
(b)
be deemed present in person and vote at a meeting of stockholders whether such meeting is to be held at a designated place or solely
by means of remote communication, provided that (i) the corporation shall implement reasonable measures to verify that each person deemed
present and permitted to vote at the meeting by means of remote communication is a stockholder or proxyholder, (ii) the corporation shall
implement reasonable measures to provide such stockholders and proxyholders a reasonable opportunity to participate in the meeting and
to vote on matters submitted to the stockholders, including an opportunity to read or hear the proceedings of the meeting substantially
concurrently with such proceedings, and (iii) if any stockholder or proxyholder votes or takes other action at the meeting by means of
remote communication, a record of such vote or other action shall be maintained by the corporation.
Section 15. Organization.
(a) At every meeting of stockholders, the Chairperson of the Board of Directors, or, if a Chairperson has not been appointed, is absent
or refuses to act, the Chief Executive Officer, or if no Chief Executive Officer is then serving or the Chief Executive Officer is absent
or refuses to act, the President, or, if the President is absent or refuses to act, a chairperson of the meeting designated by the Board
of Directors, or, if the Board of Directors does not designate such chairperson, a chairperson of the meeting chosen by a majority of
the voting power of the stockholders entitled to vote, present in person or by proxy duly authorized, shall act as chairperson of the
meeting of stockholders. The Chairperson of the Board of Directors may appoint the Chief Executive Officer as chairperson of the meeting.
The Secretary, or, in his or her absence, an Assistant Secretary or other officer or other person directed to do so by the chairperson
of the meeting, shall act as secretary of the meeting.
(b) The Board of Directors shall be entitled to make such rules or regulations for the conduct of meetings of stockholders as it shall
deem necessary, appropriate or convenient. Subject to such rules and regulations of the Board of Directors, if any, the chairperson of
the meeting shall have the right and authority to convene and (for any or no reason) to recess and/or adjourn the meeting, to prescribe
such rules, regulations and procedures and to do all such acts as, in the judgment of such chairperson, are necessary, appropriate or
convenient for the proper conduct of the meeting, including, without limitation, establishing an agenda or order of business for the meeting,
rules and procedures for maintaining order at the meeting and the safety of those present, limitations on participation in such meeting
to stockholders of record of the corporation and their duly authorized and constituted proxies and such other persons as the chairperson
shall permit, restrictions on entry to the meeting after the time fixed for the commencement thereof, limitations on the time allotted
to questions or comments by participants and regulation of the opening and closing of the polls for balloting on matters that are to be
voted on by ballot. The date and time of the opening and closing of the polls for each matter upon which the stockholders will vote at
the meeting shall be announced at the meeting. Unless and to the extent determined by the Board of Directors or the chairperson of the
meeting, meetings of stockholders shall not be required to be held in accordance with rules of parliamentary procedure.
(c) The corporation may and shall, if required by applicable law, in advance of any meeting of stockholders, appoint one or more inspectors
to act at the meeting and make a written report thereof. The corporation may designate one or more persons as alternate inspectors to
replace any inspector who fails to act. If no inspector or alternate is able to act at a meeting of stockholders, the chairperson of the
meeting shall appoint one or more inspectors to act at the meeting. Each inspector, before entering upon the discharge of the duties of
inspector, shall take and sign an oath faithfully to execute the duties of inspector with strict impartiality and according to the best
of such inspector’s ability. The inspectors shall: (1) ascertain the number of shares outstanding and the voting power of each;
(2) determine the shares represented at a meeting and the validity of proxies and ballots; (3) count all votes and ballots; (4) determine
and retain for a reasonable period a record of the disposition of any challenges made to any determination by the inspectors; and (5)
certify their determination of the number of shares represented at the meeting, and their count of all votes and ballots. The inspectors
may appoint or retain other persons or entities to assist the inspectors in the performance of the duties of the inspectors. In determining
the validity and counting of proxies and ballots, the inspectors shall be limited to an examination of the proxies, any envelopes submitted
with those proxies, any information provided in accordance with Sections 211(e) or 212(c)(2) of the DGCL or any information provided pursuant
to Sections 211(a)(2)b.(i) or (iii) of the DGCL, ballots and the regular books and records of the corporation, except that the inspectors
may consider other reliable information for the limited purpose of reconciling proxies and ballots submitted by or on behalf of banks,
brokers, their nominees or similar persons which represent more votes than the holder of a proxy is authorized by the record owner to
cast or more votes than the stockholder holds of record. If the inspectors consider other reliable information for the limited purpose
permitted herein, the inspectors at the time they make their certification pursuant to Section 231(b)(5) of the DGCL shall specify the
precise information considered by them including the person or persons from whom they obtained the information, when the information was
obtained, the means by which the information was obtained and the basis for the inspectors’ belief that such information is accurate
and reliable.
ARTICLE
IV
Directors
Section 16. Number and Term of Office. The authorized number of directors of the corporation shall be fixed in accordance with the Certificate
of Incorporation. Directors need not be stockholders unless so required by the Certificate of Incorporation.
Section 17. Powers. The business and affairs of the corporation shall be managed by or under the direction of the Board of Directors, except as
may be otherwise provided by the Certificate of Incorporation or the DGCL.
Section 18. Classes of Directors. The directors shall be divided into classes as and to the extent provided in the Certificate of Incorporation,
except as otherwise required by applicable law.
Section 19. Vacancies. Vacancies or newly created directorships on the Board of Directors shall be filled as provided in the Certificate of Incorporation,
except as otherwise required by applicable law.
Section 20. Resignation. Any director may resign at any time by delivering his or her notice in writing or by electronic transmission to the Board
of Directors or the Secretary. Such resignation shall take effect at the time of delivery of the notice or at any later time specified
therein. Acceptance of such resignation shall not be necessary to make it effective. When one or more directors shall resign from the
Board of Directors, effective at a future date, a majority of the directors then in office, including those who have so resigned, shall
have power to fill such vacancy or vacancies, the vote thereon to take effect when such resignation or resignations shall become effective,
and each director so chosen shall hold office for the unexpired portion of the term of the director whose place shall be vacated and until
his or her successor shall have been duly elected and qualified or until his or her earlier death, resignation or removal.
Section 21. Removal.
(a) Subject
to any rights of any series of preferred stock to remove directors elected by such series of preferred stock, neither the Board of Directors
nor any individual director may be removed from office without cause.
(b) Subject
to any limitation imposed by applicable law and any rights of any series of preferred stock to remove directors elected by such series
of preferred stock, any individual director or the entire Board of Directors may be removed from office with cause by the affirmative
vote of the holders of 662/3% of the voting power of all the then-outstanding shares of capital stock of the corporation
entitled to vote generally at an election of directors.
Section 22. Meetings.
(a) Regular Meetings. Unless otherwise restricted by the Certificate of Incorporation, regular meetings of the Board of Directors may
be held at any time or date and at any place within or without the State of Delaware that has been designated by the Board of Directors
and publicized among all directors, either orally or in writing, by telephone, including a voice-messaging system or other system designed
to record and communicate messages, or by electronic mail or other electronic means. No further notice shall be required for regular meetings
of the Board of Directors.
(b) Special Meetings. Unless otherwise restricted by the Certificate of Incorporation, special meetings of the Board of Directors may
be held at any time and place within or without the State of Delaware as designated and called by the Chairperson of the Board of Directors,
the Chief Executive Officer or the Board of Directors.
(c) Meetings by Electronic Communications Equipment. Any member of the Board of Directors, or of any committee thereof, may participate
in a meeting by means of conference telephone or other communications equipment by means of which all persons participating in the meeting
can hear each other, and participation in a meeting by such means shall constitute presence in person at such meeting.
(d) Notice of Special Meetings. Notice of the time and place, if any, of all special meetings of the Board of Directors shall be transmitted
orally or in writing, by telephone, including a voice messaging system or other system or technology designed to record and communicate
messages, or by electronic mail or other electronic means, during normal business hours, at least 24 hours before the date and time of
the meeting. If notice is sent by U.S. mail, it shall be sent by first class mail, postage prepaid, at least three days before the date
of the meeting.
(e) Waiver of Notice. Notice of any meeting of the Board of Directors may be waived in writing, or by electronic transmission, at any
time before or after the meeting and will be waived by any director by attendance thereat, except when the director attends the meeting
for the express purpose of objecting, at the beginning of the meeting, to the transaction of any business because the meeting is not lawfully
called or convened. The transaction of all business at any meeting of the Board of Directors, or any committee thereof, however called
or noticed, or wherever held, shall be as valid as though it had been transacted at a meeting duly held after regular call and notice,
if a quorum be present and if, either before or after the meeting, each of the directors not present who did not receive notice shall
sign a written waiver of notice or shall waive notice by electronic transmission. All such waivers shall be filed with the corporate records
or made a part of the minutes of the meeting.
Section 23. Quorum and Voting.
(a) Unless the Certificate of Incorporation requires a greater number, and except with respect to questions related to indemnification
arising under Section 47 for which a quorum shall be one-third of the exact number of directors fixed from time to time by the Board of
Directors in accordance with the Certificate of Incorporation, a quorum of the Board of Directors shall consist of a majority of the total
number of directors then serving on the Board of Directors or, if greater, one-third of the exact number of directors fixed from time
to time by the Board of Directors in accordance with the Certificate of Incorporation. At any meeting whether a quorum be present or otherwise,
a majority of the directors present may adjourn from time to time until the time fixed for the next regular meeting of the Board of Directors,
without notice other than by announcement at the meeting.
(b) At each meeting of the Board of Directors at which a quorum is present, all questions and business shall be determined by the affirmative
vote of a majority of the directors present, unless a different vote be required by applicable law, the Certificate of Incorporation or
the Bylaws.
Section 24. Action without Meeting. Unless otherwise restricted by the Certificate of Incorporation or the Bylaws, any action required or permitted
to be taken at any meeting of the Board of Directors or of any committee thereof may be taken without a meeting, if all members of the
Board of Directors or committee, as the case may be, consent thereto in writing or by electronic transmission. Such consent or consents
shall be filed with the minutes of proceedings of the Board of Directors or committee. After an action is taken, such filing shall be
in paper form if the minutes are maintained in paper form and shall be in electronic form if the minutes are maintained in electronic
form.
Section 25. Fees and Compensation. Directors shall be entitled to such compensation for their services as may be approved by the Board of Directors,
or a committee thereof to which the Board of Directors has delegated such responsibility and authority, including, if so approved, by
resolution of the Board of Directors or a committee thereof to which the Board of Directors has delegated such responsibility and authority,
a fixed sum and reimbursement of expenses incurred, if any, for attendance at each regular or special meeting of the Board of Directors
and at any meeting of a committee of the Board of Directors, as well as reimbursement for other reasonable expenses incurred with respect
to duties as a member of the Board of Directors or any committee thereof. Nothing herein contained shall be construed to preclude any
director from serving the corporation in any other capacity as an officer, agent, employee, or otherwise and receiving compensation therefor.
Section 26. Committees.
(a) Executive Committee. The Board of Directors may appoint an Executive Committee to consist of one or more members of the Board of Directors.
The Executive Committee, to the extent permitted by applicable law and provided in the resolution of the Board of Directors shall have
and may exercise all the powers and authority of the Board of Directors in the management of the business and affairs of the corporation,
and may authorize the seal of the corporation to be affixed to all papers that may require it; but no such committee shall have the power
or authority in reference to (i) approving or adopting, or recommending to the stockholders, any action or matter (other than the
election or removal of directors) expressly required by the DGCL to be submitted to stockholders for approval, or (ii) adopting,
amending or repealing any Bylaw of the corporation.
(b) Other Committees. The Board of Directors may, from time to time, appoint such other committees as may be permitted by applicable law.
Such other committees appointed by the Board of Directors shall consist of one or more members of the Board of Directors and shall have
such powers and perform such duties as may be prescribed by the resolution or resolutions creating such committees, but in no event shall
any such committee have the powers denied to the Executive Committee in the Bylaws.
(c) Term. The Board of Directors, subject to any requirements of any outstanding series of preferred stock and the provisions of subsections (a)
or (b) of this Section 26, may at any time increase or decrease the number of members of a committee or terminate the existence of
a committee. The membership of a committee member shall terminate on the date of such committee member’s death, such person’s
resignation from the committee or on such date that the committee member, for any reason, is no longer a member of the Board of Directors.
The Board of Directors may at any time for any reason remove any individual committee member and the Board of Directors may fill any committee
vacancy created by death, resignation, removal or increase in the number of members of the committee. The Board of Directors may designate
one or more directors as alternate members of any committee, who may replace any absent or disqualified member at any meeting of the committee,
and, in addition, in the absence or disqualification of any member of a committee, the member or members thereof present at any meeting
and not disqualified from voting, whether or not such member or members constitute a quorum, may unanimously appoint another member of
the Board of Directors to act at the meeting in the place of any such absent or disqualified member.
(d) Meetings. Unless the Board of Directors shall otherwise provide, regular meetings of the Executive Committee or any other committee
appointed pursuant to this Section 26 shall be held at such times and places, if any, as are determined by the Board of Directors,
or by any such committee, and when notice thereof has been given to each member of such committee, no further notice of such regular meetings
need be given thereafter. Special meetings of any such committee may be held at such place, if any, that has been determined from time
to time by such committee, and may be called by any director who is a member of such committee, upon notice to the members of such committee
of the time and place, if any, of such special meeting given in the manner provided for the giving of notice to members of the Board of
Directors of the time and place, if any, of special meetings of the Board of Directors. Notice of any meeting of any committee may be
waived in writing or by electronic transmission at any time before or after the meeting and will be waived by any director by attendance
thereat, except when the director attends such meeting for the express purpose of objecting, at the beginning of the meeting, to the transaction
of any business because the meeting is not lawfully called or convened. Unless otherwise provided by the Board of Directors in the resolutions
authorizing the creation of the committee, a majority of the authorized number of members of any such committee shall constitute a quorum
for the transaction of business, and the act of a majority of those present at any meeting at which a quorum is present shall be the act
of such committee.
Section 27. Duties of Chairperson of the Board of Directors and Lead Independent Director.
(a) The Chairperson of the Board of Directors, when present, shall preside at all meetings of the stockholders and the Board of Directors.
The Chairperson of the Board of Directors shall perform such other duties customarily associated with the office and shall also perform
such other duties and have such other powers, as the Board of Directors shall designate from time to time.
(b) The Chairperson of the Board of Directors, or if the Chairperson is not an independent director, one of the independent directors,
may be designated by the Board of Directors as lead independent director to serve until replaced by the Board of Directors (“Lead
Independent Director”). The Lead Independent Director will preside over meetings of the independent directors and perform such other
duties as may be established or delegated by the Board of Directors.
Section 28.
Interested Directors. No contract or transaction between the corporation and one or more of its directors or officers, or between
the corporation and any other corporation, partnership, association or other organization in which one or more of the corporation’s
directors or officers are directors or officers or have a financial interest, shall be void or voidable solely for this reason, or solely
because the director or officer is present at or participates in the meeting of the Board of Directors or committee thereof that authorizes
the contract or transaction, or solely because any such director’s or officer’s vote is counted for such purpose if: (a) the
material facts as to the director’s or officer’s relationship or interest and as to the contract or transaction are disclosed
or are known to the Board of Directors or the committee and the Board of Directors or committee in good faith authorizes the contract
or transaction by the affirmative vote of a majority of the disinterested directors, even though the disinterested directors be less than
a quorum; (b) the material facts as to the director’s or officer’s relationship or interest and as to the contract or transaction
are disclosed or are known to the stockholders entitled to vote thereon and the contract or transaction is specifically approved in good
faith by vote of the stockholders; or (c) the contract or transaction is fair as to the corporation as of the time it is authorized, approved
or ratified by the Board of Directors, a committee thereof or the stockholders. Common or interested directors may be counted in determining
the presence of a quorum at a meeting of the Board of Directors or of a committee that authorizes the contract or transaction.
Section 29. Organization. At every meeting of the directors, the Chairperson of the Board of Directors, or, if a Chairperson has not been appointed
or is absent, the Lead Independent Director, or if a Lead Independent Director has not been appointed or is absent, the Chief Executive
Officer (if a director), or, if a Chief Executive Officer is absent, the President (if a director), or if the President is absent, the
most senior Vice President (if a director), or, in the absence of any such person, a chairperson of the meeting chosen by a majority of
the directors present, shall preside over the meeting. The Secretary, or in his or her absence, any Assistant Secretary or other officer,
director or other person directed to do so by the person presiding over the meeting, shall act as secretary of the meeting.
ARTICLE
V
Officers
Section 30. Officers Designated. The officers of the corporation shall include, if and when designated by the Board of Directors, the Chief Executive
Officer, the President, one or more Vice Presidents, the Secretary, the Chief Financial Officer and the Treasurer. The Board of Directors
may also appoint one or more Assistant Secretaries and Assistant Treasurers and such other officers and agents with such powers and duties
as it shall deem appropriate or necessary. The Board of Directors may assign such additional titles to one or more of the officers as
it shall deem appropriate. Any one person may hold any number of offices of the corporation at any one time unless specifically prohibited
therefrom by applicable law, the Certificate of Incorporation or the Bylaws. The salaries and other compensation of the officers of the
corporation shall be fixed by or in the manner designated by the Board of Directors or by a committee thereof to which the Board of Directors
has delegated such responsibility.
Section 31. Tenure and Duties of Officers.
(a) General. All officers shall hold office at the pleasure of the Board of Directors and until their successors shall have been duly
elected and qualified, subject to the officer’s earlier death, resignation or removal. If the office of any officer becomes vacant
for any reason, the vacancy may be filled by the Board of Directors or by a committee thereof to which the Board of Directors has delegated
such responsibility or, if so authorized by the Board of Directors, by the Chief Executive Officer or another officer of the corporation.
(b) Duties of Chief Executive Officer. The Chief Executive Officer shall preside at all meetings of the stockholders and, if a director,
at all meetings of the Board of Directors, unless a Chairperson of the Board of Directors or Lead Independent Director has been appointed
and is present. The Chief Executive Officer shall be the chief executive officer of the corporation and, subject to the supervision, direction
and control of the Board of Directors, shall have the general powers and duties of supervision, direction, management and control of the
business and officers of the corporation as are customarily associated with the position of Chief Executive Officer. To the extent that
a Chief Executive Officer has been appointed and no President has been appointed, all references in the Bylaws to the President shall
be deemed references to the Chief Executive Officer. The Chief Executive Officer shall perform other duties customarily associated with
the office and shall also perform such other duties and have such other powers, as the Board of Directors shall designate from time to
time.
(c) Duties of President. The President shall preside at all meetings of the stockholders and, if a director, at all meetings of the Board
of Directors, unless a Chairperson of the Board of Directors, Lead Independent Director, or Chief Executive Officer has been appointed
and is present. Unless another officer has been appointed Chief Executive Officer of the corporation, the President shall be the chief
executive officer of the corporation and, subject to the supervision, direction and control of the Board of Directors, shall have the
general powers and duties of supervision, direction, management and control of the business and officers of the corporation as are customarily
associated with the position of President. The President shall perform other duties customarily associated with the office and shall also
perform such other duties and have such other powers, as the Board of Directors (or the Chief Executive Officer, if the Chief Executive
Officer and President are not the same person and the Board of Directors has delegated the designation of the President’s duties
to the Chief Executive Officer) shall designate from time to time.
(d) Duties of Vice Presidents. A Vice President may assume and perform the duties of the President in the absence or disability of the
President or whenever the office of President is vacant (unless the duties of the President are being filled by the Chief Executive Officer).
A Vice President shall perform other duties customarily associated with the office and shall also perform such other duties and have such
other powers as the Board of Directors or the Chief Executive Officer, or, if the Chief Executive Officer has not been appointed or is
absent, the President shall designate from time to time.
(e) Duties of Secretary and Assistant Secretary. The Secretary shall attend all meetings of the stockholders and of the Board of Directors
and shall record all acts, votes and proceedings thereof in the minute books of the corporation. The Secretary shall give notice in conformity
with the Bylaws of all meetings of the stockholders and of all meetings of the Board of Directors and any committee thereof requiring
notice. The Secretary shall perform all other duties provided for in the Bylaws and other duties customarily associated with the office
and shall also perform such other duties and have such other powers, as the Board of Directors or the Chief Executive Officer, or if no
Chief Executive Officer is then serving, the President shall designate from time to time. The Chief Executive Officer, or if no Chief
Executive Officer is then serving, the President may direct any Assistant Secretary or other officer to assume and perform the duties
of the Secretary in the absence or disability of the Secretary, and each Assistant Secretary shall perform other duties customarily associated
with the office and shall also perform such other duties and have such other powers as the Board of Directors or the Chief Executive Officer,
or if no Chief Executive Officer is then serving, the President shall designate from time to time.
(f) Duties of Chief Financial Officer. The Chief Financial Officer shall keep or cause to be kept the books of account of the corporation
in a thorough and proper manner and shall render statements of the financial affairs of the corporation in such form and as often as required
by the Board of Directors, the Chief Executive Officer, or the President. The Chief Financial Officer, subject to the order of the Board
of Directors, shall have the custody of all funds and securities of the corporation. The Chief Financial Officer shall perform other duties
customarily associated with the office and shall also perform such other duties and have such other powers as the Board of Directors or
the Chief Executive Officer, or if no Chief Executive Officer is then serving, the President shall designate from time to time. To the
extent that a Chief Financial Officer has been appointed and no Treasurer has been appointed, all references in the Bylaws to the Treasurer
shall be deemed references to the Chief Financial Officer. The President may direct the Treasurer, if any, or any Assistant Treasurer
to assume and perform the duties of the Chief Financial Officer in the absence or disability of the Chief Financial Officer.
(g) Duties of Treasurer and Assistant Treasurer. Unless another officer has been appointed Chief Financial Officer of the corporation,
the Treasurer shall be the chief financial officer of the corporation, shall keep or cause to be kept the books of account of the corporation
in a thorough and proper manner and shall render statements of the financial affairs of the corporation in such form and as often as required
by the Board of Directors, the Chief Executive Officer or the President. Unless another officer has been appointed Chief Financial Officer
of the corporation, the Treasurer, subject to the order of the Board of Directors, shall have the custody of all funds and securities
of the corporation. The Treasurer shall perform other duties customarily associated with the office and shall also perform such other
duties and have such other powers as the Board of Directors or the Chief Executive Officer, or if no Chief Executive Officer is then serving,
the President shall designate from time to time. The Chief Executive Officer, or if no Chief Executive Officer is then serving, the President
may direct any Assistant Treasurer or other officer to assume and perform the duties of the Treasurer in the absence or disability of
the Treasurer, and each Assistant Treasurer shall perform other duties commonly incident to the office and shall also perform such other
duties and have such other powers as the Board of Directors or the Chief Executive Officer, or if no Chief Executive Officer is then serving,
the President shall designate from time to time.
Section 32. Delegation of Authority. The Board of Directors may from time to time delegate the powers or duties of any officer to any other officer
or agent, notwithstanding any provision hereof.
Section 33. Resignations. Any officer may resign at any time by giving notice in writing or by electronic transmission to the Board of Directors,
the Chairperson of the Board of Directors, the Chief Executive Officer, the President or the Secretary. Any such resignation shall be
effective when received by the person or persons to whom such notice is given, unless a later time is specified therein, in which event
the resignation shall become effective at such later time. Unless otherwise specified in such notice, the acceptance of any such resignation
shall not be necessary to make it effective. Any resignation shall be without prejudice to the rights, if any, of the corporation under
any contract with the resigning officer.
Section 34. Removal. Any officer may be removed from office at any time, either with or without cause, by the Board of Directors, or by any committee
thereof or any superior officer upon whom such power of removal may have been conferred by the Board of Directors.
ARTICLE
VI
Execution Of Corporate Instruments And Voting Of Securities Owned By The Corporation
Section 35. Execution of Corporate Instruments. The Board of Directors may, in its discretion, determine the method and designate the signatory
officer or officers, or other person or persons, to execute, sign or endorse on behalf of the corporation any corporate instrument or
document, or to sign on behalf of the corporation the corporate name without limitation, or to enter into contracts on behalf of the corporation,
except where otherwise provided by applicable law or the Bylaws, and such execution or signature shall be binding upon the corporation.
All checks and drafts drawn on
banks or other depositaries on funds to the credit of the corporation or in special accounts of the corporation shall be signed by such
person or persons as the Board of Directors shall from time to time authorize so to do.
Unless otherwise specifically
determined by the Board of Directors or otherwise required by applicable law, the execution, signing or endorsement of any corporate instrument
or document may be effected manually, by facsimile or (to the extent permitted by applicable law and subject to such policies and procedures
as the corporation may have in effect from time to time) by electronic signature.
Unless authorized or ratified
by the Board of Directors or within the agency power of an officer, no officer, agent or employee shall have any power or authority to
bind the corporation by any contract or engagement or to pledge its credit or to render it liable for any purpose or for any amount.
Section 36. Voting of Securities Owned by the Corporation. All stock and other securities of or interests in other corporations or entities owned
or held by the corporation for itself, or for other parties in any capacity, shall be voted, and all proxies with respect thereto shall
be executed, by the person authorized so to do by resolution of the Board of Directors, or, in the absence of such authorization, by the
Chairperson of the Board of Directors, the Chief Executive Officer, the President, or any Vice President.
ARTICLE
VII
Shares Of Stock
Section 37. Form and Execution of Certificates. The shares of the corporation shall be represented by certificates, or shall be uncertificated
if so provided by resolution or resolutions of the Board of Directors. Certificates for the shares of stock, if any, shall be in such
form as is consistent with the Certificate of Incorporation and applicable law. Every holder of stock in the corporation represented by
certificates shall be entitled to have a certificate signed by or in the name of the corporation by any two authorized officers of the
corporation, certifying the number, and the class or series, of shares owned by such holder in the corporation. Any or all of the signatures
on the certificate may be facsimiles. In case any officer, transfer agent, or registrar who has signed or whose facsimile signature has
been placed upon a certificate shall have ceased to be such officer, transfer agent, or registrar before such certificate is issued, it
may be issued with the same effect as if he were such officer, transfer agent, or registrar at the date of issue.
Section 38. Lost Certificates. A new certificate or certificates shall be issued in place of any certificate or certificates theretofore issued
by the corporation alleged to have been lost, stolen, or destroyed, upon the making of an affidavit of that fact by the person claiming
the certificate of stock to be lost, stolen, or destroyed. The corporation may require, as a condition precedent to the issuance of a
new certificate or certificates, the owner of such lost, stolen, or destroyed certificate or certificates, or the owner’s legal
representative, to agree to indemnify the corporation in such manner as it shall require or to give the corporation a surety bond in such
form and amount as it may direct as indemnity against any claim that may be made against the corporation with respect to the certificate
alleged to have been lost, stolen, or destroyed.
Section 39. Transfers.
(a) Transfers of record of shares of stock of the corporation shall be made only upon its books by the holders thereof, in person or by
attorney duly authorized and, in the case of stock represented by certificate, upon the surrender of a properly endorsed certificate
or certificates for a like number of shares.
(b) The corporation shall have power to enter into and perform any agreement with any number of stockholders of any one or more classes
or series of stock of the corporation to restrict the transfer of shares of stock of the corporation of any one or more classes or series
owned by such stockholders in any manner not prohibited by the DGCL.
Section 40. Fixing Record Dates.
(a) In order that the corporation may determine the stockholders entitled to notice of or to vote at any meeting of stockholders or any
adjournment thereof, the Board of Directors may fix a record date, which record date shall not precede the date upon which the resolution
fixing the record date is adopted by the Board of Directors, and which record date shall, subject to applicable law, not be more than
60 nor less than ten days before the date of such meeting. If the Board of Directors so fixes a record date for determining the stockholders
entitled to notice of any meeting of stockholders, such date shall also be the record date for determining the stockholders entitled to
vote at such meeting, unless the Board of Directors determines, at the time it fixes the record date for determining the stockholders
entitled to notice of such meeting, that a later date on or before the date of the meeting shall be the record date for determining the
stockholders entitled to vote at such meeting. If no record date is fixed by the Board of Directors, the record date for determining stockholders
entitled to notice of or to vote at a meeting of stockholders shall be at the close of business on the day immediately preceding the day
on which notice is given, or if notice is waived, at the close of business on the day immediately preceding the day on which the meeting
is held. A determination of stockholders of record entitled to notice of or to vote at a meeting of stockholders shall apply to any adjournment
of the meeting; provided, however, that the Board of Directors may fix a new record date for the adjourned meeting in accordance
with the provisions of this Section 40(a).
(b) In order that the corporation may determine the stockholders entitled to receive payment of any dividend or other distribution or
allotment of any rights or the stockholders entitled to exercise any rights in respect of any change, conversion or exchange of stock,
or for the purpose of any other lawful action, the Board of Directors may fix, in advance, a record date, which record date shall not
precede the date upon which the resolution fixing the record date is adopted, and which record date shall be not more than 60 days prior
to such action. If no record date is fixed, the record date for determining stockholders for any such purpose shall be at the close of
business on the day on which the Board of Directors adopts the resolution relating thereto.
Section 41. Registered Stockholders. The corporation shall be entitled to recognize the exclusive right of a person registered on its books as
the owner of shares to receive dividends, and to vote as such owner, and shall not be bound to recognize any equitable or other claim
to or interest in such share or shares on the part of any other person whether or not it shall have express or other notice thereof, except
as otherwise provided by the laws of Delaware.
Section 42. Additional Powers of the Board. In addition to, and without limiting, the powers set forth in the Bylaws, the Board of Directors shall
have power and authority to make all such rules and regulations as it shall deem expedient concerning the issue, transfer, and registration
of certificates for shares of stock of the corporation, including the use of uncertificated shares of stock, subject to the provisions
of the DGCL, other applicable law, the Certificate of Incorporation and the Bylaws. The Board of Directors may appoint and remove transfer
agents and registrars of transfers, and may require all stock certificates to bear the signature of any such transfer agent and/or any
such registrar of transfers.
ARTICLE
VIII
Other Securities Of The Corporation
Section 43. Execution of Other Securities. All bonds, debentures and other corporate securities of the corporation, other than stock certificates
(covered in Section 37), may be signed by the Chairperson of the Board of Directors, the Chief Executive Officer, the President or
any Vice President, or such other person as may be authorized by the Board of Directors; provided, however, that where any such
bond, debenture or other corporate security shall be authenticated by the manual signature, or where permissible facsimile signature,
of a trustee under an indenture pursuant to which such bond, debenture or other corporate security shall be issued, the signatures of
the persons signing and attesting the corporate seal on such bond, debenture or other corporate security may be the imprinted facsimile
of the signatures of such persons. Interest coupons appertaining to any such bond, debenture or other corporate security, authenticated
by a trustee as aforesaid, shall be signed by the Treasurer or an Assistant Treasurer of the corporation or such other person as may be
authorized by the Board of Directors, or bear imprinted thereon the facsimile signature of such person. In case any officer who shall
have signed or attested any bond, debenture or other corporate security, or whose facsimile signature shall appear thereon or on any such
interest coupon, shall have ceased to be such officer before the bond, debenture or other corporate security so signed or attested shall
have been delivered, such bond, debenture or other corporate security nevertheless may be adopted by the corporation and issued and delivered
as though the person who signed the same or whose facsimile signature shall have been used thereon had not ceased to be such officer of
the corporation.
ARTICLE
IX
Dividends
Section 44. Declaration of Dividends. Dividends upon the capital stock of the corporation, subject to the provisions of the Certificate of Incorporation
and applicable law, if any, may be declared by the Board of Directors. Dividends may be paid in cash, in property, or in shares of the
capital stock, or other securities of the corporation, subject to the provisions of the Certificate of Incorporation and applicable law.
Section 45. Dividend Reserve. Before payment of any dividend, there may be set aside out of any funds of the corporation available for dividends
such sum or sums as the Board of Directors from time to time, in its absolute discretion, determines proper as a reserve or reserves to
meet contingencies, or for equalizing dividends, or for repairing or maintaining any property of the corporation, or for such other purpose
or purposes as the Board of Directors shall determine to be conducive to the interests of the corporation, and the Board of Directors
may modify or abolish any such reserve in the manner in which it was created.
ARTICLE
X
Fiscal Year
Section 46. Fiscal Year. The fiscal year of the corporation shall be fixed by resolution of the Board of Directors.
ARTICLE
XI
Indemnification
Section 47. Indemnification of Directors, Executive Officers, Employees and Other Agents.
(a) Directors and Executive Officers. The corporation shall indemnify to the full extent
permitted under and in any manner permitted under the DGCL or any other applicable law, any person who was or is made or threatened to
be made a party to or is otherwise involved (as a witness or otherwise) in any threatened, pending, or completed action, suit, or proceeding,
whether civil, criminal, administrative, or investigative (hereinafter, a “Proceeding”), by reason of the fact
that such person is or was a director or executive officer (for the purposes of this Article XI, “executive officers”
shall be those persons designated by the corporation as (a) executive officers for purposes of the disclosures required in the corporation’s
proxy and periodic reports or (b) officers for purposes of Section 16 of the 1934 Act) of the corporation, or while serving as a director
or executive officer of the corporation, is or was serving at the request of the corporation as a director, officer, employee, or agent
of another corporation, partnership, joint venture, trust, or other enterprise, including service with respect to an employee benefit
plan (collectively, “Another Enterprise”), against expenses (including attorneys’ fees), judgments, fines
(including ERISA excise taxes or penalties) and amounts paid in settlement actually and reasonably incurred by him or her in connection
with such Proceeding if he or she acted in good faith and in a manner he or she reasonably believed to be in or not opposed to the best
interests of the corporation, and, with respect to any criminal action or proceeding, had no reasonable cause to believe his or her conduct
was unlawful; provided, however, that the corporation may modify the extent of such indemnification by individual contracts with
its directors and executive officers; and, provided, further, that the corporation shall not be required to indemnify or advance
expenses to any director or executive officer in connection with any proceeding (or part thereof) initiated by such person unless (i)
such indemnification is expressly required to be made by applicable law, (ii) the proceeding was authorized by the Board of Directors
of the corporation, (iii) such indemnification is provided by the corporation, in its sole discretion, pursuant to the powers vested
in the corporation under the DGCL or any other applicable law or (iv) such indemnification is required to be made under subsection (d)
of this Section 47.
(b) Other Officers, Employees and Other Agents. The corporation shall have power to indemnify (including the power to advance expenses
in a manner consistent with subsection (c) of this Section 47) its other officers, employees
and other agents as set forth in the DGCL or any other applicable law. The Board of Directors shall have the power to delegate the determination
of whether indemnification shall be given to any such person (except executive officers) to such officers or other persons as the Board
of Directors shall determine.
(c) Expenses. The corporation shall advance to any person who was or is a party or is threatened to be made a party to any threatened,
pending or completed Proceeding, by reason of the fact that such person is or was a director or executive officer,
of the corporation, or is or was serving at the request of the corporation as a director or executive officer of Another Enterprise, prior
to the final disposition of the Proceeding, promptly following request therefor, all expenses (including attorneys’ fees) incurred
by any director or executive officer in connection with such Proceeding provided, however, that if the DGCL requires, an advancement of
expenses incurred by a director or executive officer in his or her capacity as a director or executive officer (and not in any other capacity
in which service was or is rendered by such indemnitee, including, without limitation, service to an employee benefit plan) shall be made
only upon delivery to the corporation of an undertaking (hereinafter an “undertaking”), by or on behalf of such
indemnitee, to repay all amounts so advanced if it shall ultimately be determined by final judicial decision from which there is no further
right to appeal (hereinafter a “final adjudication”) that such indemnitee is not entitled to be indemnified
or entitled to advancement for such expenses under this Section 47 or otherwise.
Notwithstanding the foregoing,
unless otherwise determined pursuant to paragraph (d) of this Section 47, no advance shall be made by the corporation to an executive
officer of the corporation (except by reason of the fact that such executive officer is or was a director of the corporation in which
event this paragraph shall not apply) in any Proceeding, if a determination is reasonably and promptly made (i) by a majority vote
of directors who were not parties to the Proceeding, even if not a quorum, or (ii) by a committee of such directors designated by
a majority vote of such directors, even though less than a quorum, or (iii) if there are no such directors, or such directors so direct,
by independent legal counsel in a written opinion, that the facts known to the decision-making party at the time such determination is
made demonstrate clearly and convincingly that such person acted in bad faith or in a manner that such person did not believe to be in
or not opposed to the best interests of the corporation.
(d) Enforcement. Without the necessity of entering into an express contract, all rights to indemnification and advances to directors and
executive officers under this Section 47 shall be deemed to be contractual rights, shall vest when the person becomes a director or executive
officer of the corporation, shall continue as vested contract rights even if such person ceases to be a director or executive officer
of the corporation, and shall be effective to the same extent and as if provided for in a contract between the corporation and the director
or executive officer. Any right to indemnification or advancement of expenses granted by this Section 47 to a director or executive officer
shall be enforceable by or on behalf of the person holding such right in any court of competent jurisdiction if (i) the claim for
indemnification or advancement of expenses is denied, in whole or in part, or (ii) no disposition of a claim for indemnification
is made within 90 days of request therefor. To the fullest extent permitted by applicable law, the claimant in such enforcement action,
if successful in whole or in part, shall be entitled to be paid also the expense of prosecuting the claim. In connection with any claim
for indemnification, the corporation shall be entitled to raise as a defense to any such action that the claimant has not met the standards
of conduct that make it permissible under the DGCL or any other applicable law for the corporation to indemnify the claimant for the amount
claimed. In connection with any claim by an executive officer of the corporation (except in any Proceeding, by reason of the fact that
such executive officer is or was a director of the corporation) for advances, the corporation shall be entitled to raise a defense as
to any such action clear and convincing evidence that such person acted in bad faith or in a manner that such person did not believe to
be in or not opposed to the best interests of the corporation, or with respect to any criminal action or proceeding that such person acted
without reasonable cause to believe that his or her conduct was lawful. Neither the failure of the corporation (including its Board of
Directors, independent legal counsel or its stockholders) to have made a determination prior to the commencement of such action that indemnification
of the claimant is proper in the circumstances because he or she has met the applicable standard of conduct set forth in the DGCL or any
other applicable law, nor an actual determination by the corporation (including its Board of Directors, independent legal counsel or its
stockholders) that the claimant has not met such applicable standard of conduct, shall be a defense to the action or create a presumption
that claimant has not met the applicable standard of conduct. In any suit brought by a director or executive officer to enforce a right
to indemnification or to an advancement of expenses hereunder, or brought by the corporation to recover an advancement of expenses pursuant
to the terms of an undertaking, the burden of proving that the director or executive officer is not entitled to be indemnified, or to
such advancement of expenses, under this Section 47 or otherwise shall be on the corporation.
(e) Non-Exclusivity of Rights. The rights conferred on any person by this Section 47 shall not be exclusive of any other right that such
person may have or hereafter acquire under any applicable statute, provision of the Certificate of Incorporation, Bylaws, agreement, vote
of stockholders or disinterested directors or otherwise, both as to action in his or her official capacity and as to action in another
capacity while holding office. The corporation is specifically authorized to enter into individual contracts with any or all of its directors,
officers, employees or agents respecting indemnification and advances, to the fullest extent not prohibited by the DGCL, or by any other
applicable law.
(f) Survival of Rights. The rights conferred on any person by this Section 47 shall continue as to a person who has ceased to be a director,
executive officer, other officer, employee or other agent and shall inure to the benefit of the heirs, executors and administrators of
such a person.
(g) Insurance. To the fullest extent permitted by the DGCL or any other applicable law, the corporation, upon approval by the Board of
Directors, may purchase and maintain insurance on behalf of any person required or permitted to be indemnified pursuant to this Section
47.
(h) Amendments. Any repeal or modification of this Section 47 shall only be prospective and shall not affect the rights under this Section
47 as in effect at the time of the alleged occurrence of any action or omission to act that is the cause of any Proceeding against any
current or former director or executive officer of the corporation.
(i) Saving Clause. If this Article XI or any portion hereof shall be invalidated on any ground by any court of competent jurisdiction,
then the corporation shall nevertheless indemnify and advance expenses to each director and executive officer to the full extent not prohibited
by any applicable portion of this Article XI that shall not have been invalidated, or by any other applicable law. If this Article XI
shall be invalid due to the application of the indemnification and advancement provisions of another jurisdiction, then the corporation
shall indemnify and advance expenses to each director and executive officer to the full extent under any other applicable law.
(j) Certain Definitions and Construction of Terms. For the purposes of Article XI of the Bylaws, the following definitions and rules of
construction shall apply:
(i) The term “Proceeding” shall be broadly construed and shall include, without limitation, the investigation,
preparation, prosecution, defense, settlement, arbitration and appeal of, and the giving of testimony in, any threatened, pending or completed
action, suit or proceeding, whether civil, criminal, administrative or investigative.
(ii) The term “expenses” shall be broadly construed and shall include, without limitation, court costs, attorneys’
fees, witness fees, fines, amounts paid in settlement or judgment and any other costs and expenses of any nature or kind incurred in connection
with any Proceeding.
(iii) The term the “corporation” shall include, in addition to the resulting corporation, any constituent corporation
(including any constituent of a constituent) absorbed in a consolidation or merger that, if its separate existence had continued, would
have had power and authority to indemnify its directors, officers, and employees or agents, so that any person who is or was a director,
officer, employee or agent of such constituent corporation, or is or was serving at the request of such constituent corporation as a director,
officer, employee or agent of another corporation, partnership, joint venture, trust, employee benefit plan or other enterprise, shall
stand in the same position under the provisions of this Section 47 with respect to the resulting or surviving corporation as he would
have with respect to such constituent corporation if its separate existence had continued.
(iv) References to a “director,” “executive officer,” “officer,”
“employee,” or “agent” of the corporation shall include, without limitation, situations
where such person is serving at the request of the corporation as, respectively, a director, executive officer, officer, employee, trustee
or agent of another corporation, partnership, joint venture, trust or other enterprise.
(v) References to “Another Enterprise” shall include employee benefit plans; references to “fines”
shall include any excise taxes assessed on a person with respect to an employee benefit plan; and references to “serving at
the request of the corporation” shall include any service as a director, officer, employee or agent of the corporation that
imposes duties on, or involves services by, such director, officer, employee, or agent with respect to an employee benefit plan, its participants,
or beneficiaries; and a person who acted in good faith and in a manner such person reasonably believed to be in the interest of the participants
and beneficiaries of an employee benefit plan shall be deemed to have acted in a manner “not opposed to the best interests
of the corporation” as referred to in this Section 47.
ARTICLE
XII
Notices
Section 48. Notices.
(a) Notice to Stockholders. Notice to stockholders of stockholder meetings shall be given as provided in Section 7. Without limiting the
manner by which notice may otherwise be given effectively to stockholders under any agreement or contract with such stockholder, and except
as otherwise required by applicable law, written notice to stockholders for purposes other than stockholder meetings may be sent by U.S.
mail or nationally recognized overnight courier, or by electronic mail or other electronic means in accordance with Section 232 of the
DGCL.
(b) Notice to Directors. Any notice required to be given to any director may be given by the method stated in subsection (a), as
otherwise provided in the Bylaws (including by any of the means specified in Section 22(d)), or by overnight delivery service. Any notice
sent by overnight delivery service or U.S. mail shall be sent to such address as such director shall have filed in writing with the Secretary,
or, in the absence of such filing, to the last known post office address of such director.
(c) Affidavit of Mailing. An affidavit of mailing, executed by a duly authorized and competent employee of the corporation or its transfer
agent appointed with respect to the class of stock affected, or other agent, specifying the name and address or the names and addresses
of the stockholder or stockholders, or director or directors, to whom any such notice or notices was or were given, and the time and method
of giving the same, shall in the absence of fraud, be prima facie evidence of the facts therein contained.
(d) Methods of Notice. It shall not be necessary that the same method of giving notice be employed in respect of all recipients of notice,
but one permissible method may be employed in respect of any one or more, and any other permissible method or methods may be employed
in respect of any other or others.
(e) Notice to Person with Whom Communication is Unlawful. Whenever notice is required to be given, under applicable law or any provision
of the Certificate of Incorporation or Bylaws of the corporation, to any person with whom communication is unlawful, the giving of such
notice to such person shall not be required and there shall be no duty to apply to any governmental authority or agency for a license
or permit to give such notice to such person. Any action or meeting which shall be taken or held without notice to any such person with
whom communication is unlawful shall have the same force and effect as if such notice had been duly given. In the event that the action
taken by the corporation is such as to require the filing of a certificate under any provision of the DGCL, the certificate shall state,
if such is the fact and if notice is required, that notice was given to all persons entitled to receive notice except such persons with
whom communication is unlawful.
(f) Notice to Stockholders Sharing an Address. Except as otherwise prohibited under the DGCL, any notice given under the provisions of
the DGCL, the Certificate of Incorporation or the Bylaws shall be effective if given by a single written notice to stockholders who share
an address if consented to by the stockholders at that address to whom such notice is given. Such consent shall have been deemed to have
been given if such stockholder fails to object in writing to the corporation within 60 days of having been given notice by the corporation
of its intention to send the single notice. Any consent shall be revocable by the stockholder by written notice to the corporation.
ARTICLE
XIII
Amendments
Section 49. Amendments. Subject to the limitations set forth in Section 47(h) or the provisions of the Certificate of Incorporation, the Board
of Directors is expressly empowered to adopt, amend or repeal the Bylaws of the corporation. Any adoption, amendment or repeal of the
Bylaws of the corporation by the Board of Directors shall require the approval of a majority of the authorized number of directors.
The stockholders also shall have power to adopt, amend or repeal the Bylaws of the corporation; provided, however, that, in addition
to any vote of the holders of any class or series of stock of the corporation required by applicable law or by the Certificate of Incorporation,
such action by stockholders shall require the affirmative vote of the holders of at least 662/3%
of the voting power of all of the then-outstanding shares of the capital stock of the corporation entitled to vote generally in the election
of directors, voting together as a single class.
Exhibit 10.2
SUBSCRIPTION AGREEMENT
MedTech Acquisition Corporation
48 Maple Avenue
Greenwich, CT 06830
Ladies and Gentlemen:
In connection with the proposed business combination
(the “Transaction”) between MedTech Acquisition Corporation, a Delaware corporation (the “Company”)
and TriSalus Life Sciences, Inc., a Delaware corporation (the “Target”), pursuant to that certain Agreement and
Plan of Merger, dated as of November 11, 2022, as amended by that certain First Amendment to Agreement and Plan of Merger, dated
April 4, 2023 and as further amended by that certain Second Amendment to Agreement and Plan of Merger, dated May 13, 2023 (as
amended thereto and from time to time, the “Merger Agreement”), by and among, the Company, Target, MTAC Merger Sub, Inc.,
a Delaware corporation and wholly-owned subsidiary of the Company (the “Merger Sub”), the Company is seeking commitments
to purchase shares of the Company’s to-be-authorized class of preferred stock, par value $0.0001 per share (the “Preferred
Stock”) that will be designated as “Series A Preferred Stock”, for a purchase price of $10.00 per share (the
“Per Share Price” and the aggregate of such Per Share Price for all Preferred Shares (as defined below) being referred
to herein as the “Purchase Price”), in a private placement to be conducted by the Company (the “Offering”).
The
Company is entering into this subscription agreement (this “Subscription Agreement”) effective as of the date it executes
a counterpart signature hereto. The Company is also entering into separate subscription agreements (the “Other Subscription
Agreements” and together with this Subscription Agreement, the “Subscription Agreements”) in the Offering
with certain other subscribers (the “Other Subscribers”), pursuant to which the Other Subscribers, severally and not
jointly, have agreed to purchase shares of Preferred Stock (the “Preferred Shares”) on the closing date of the Transaction.
In connection therewith, the undersigned subscriber (the “Subscriber”) and the Company agree as follows:
1. Subscription.
The Subscriber hereby subscribes for and agrees to purchase from the Company, and the Company agrees to issue and sell to the Subscriber,
upon payment of the Purchase Price, such number of Preferred Shares as is set forth on the signature page of this Subscription Agreement
and at the Per Share Price and on the terms provided for herein (the “Subscription”). Upon issuance, each Preferred
Share will be initially convertible into one (1) share (a “Conversion Share”, and together with the Preferred
Shares, the “Company Shares”) of the Company’s common stock, par value $0.0001 per share (the “Common
Stock”). The Preferred Stock shall have the rights, powers, preferences and privileges set forth in the Certificate of Designations
(the “Certificate of Designations”) substantially in the form attached hereto as Exhibit A.
2. Closing;
Delivery of Shares. The closing of the sale of Preferred Shares contemplated hereby (the
“Closing”, and the date that the Closing actually occurs, the “Closing Date”) is contingent upon
the concurrent consummation of the Transaction (the “Transaction Closing”). The Closing shall occur on the date of,
and immediately prior to and conditioned upon the effectiveness of the Transaction Closing. At least five (5) Business Days (as defined
below) before the anticipated Closing Date, the Company shall deliver written notice to the Subscriber (the “Closing Notice”)
specifying (a) the anticipated Closing Date and (b) the wire instructions for delivery of the Purchase Price to the Company.
No later than two (2) Business Days prior to the anticipated Closing Date as set forth in the Closing Notice, the Subscriber shall
deliver the Purchase Price for the Preferred Shares by wire transfer of U.S. dollars in immediately available funds to the account specified
by the Company in the Closing Notice (which account shall be segregated from other accounts maintained by the Company), such funds to
be held by the Company in escrow until the Closing. Upon satisfaction (or, if applicable, waiver) of the conditions set forth in Section 3,
the Company shall deliver to the Subscriber (i) at the Closing, the Preferred Shares in book entry form, free and clear of any restrictions
(other than those arising under this Subscription Agreement or applicable securities laws) in the name of the Subscriber (or its nominee
or custodian in accordance with its delivery instructions), and (ii) as promptly as practicable after the Closing, evidence from
the Company’s transfer agent of the issuance to the Subscriber of the Preferred Shares on and as of the Closing Date. Promptly upon
request and in any event no later than two (2) Business Days prior to the Closing, the Subscriber shall deliver all such other information
as is reasonably requested in order for the Company to issue the Preferred Shares to the Subscriber, including, without limitation, the
legal name of the person in whose name the Preferred Shares are to be issued (or the Subscriber’s nominee in accordance with its
delivery instructions) and a duly completed and executed Internal Revenue Service Form W-9 or appropriate Form W-8, as applicable.
In the event that the consummation of the Transaction does not occur within five (5) Business Days after the anticipated Closing
Date specified in the Closing Notice, unless otherwise agreed to in writing by the Company and the Subscriber, the Company shall promptly
(but in no event later than seven (7) Business Days after the anticipated Closing Date specified in the Closing Notice) return the
entire Purchase Price so delivered by the Subscriber to the Company by wire transfer in immediately available funds to the account specified
by the Subscriber, and any book entries shall be deemed cancelled. Notwithstanding such return or cancellation (x) a failure to close
on the anticipated Closing Date shall not, by itself, be deemed to be a failure of any of the conditions to Closing set forth in Section 3
to be satisfied or waived on or prior to the Closing Date, and (y) unless and until this Subscription Agreement is terminated in
accordance with Section 8 herein, the Subscriber shall remain obligated (A) to redeliver funds to the Company following the
Company’s delivery to the Subscriber of a new Closing Notice in accordance with this Section 2 and (B) to consummate the
Closing upon satisfaction of the conditions set forth in Section 3. For the purposes of this Subscription Agreement, “Business
Day” means any day other than a Saturday or Sunday, or any other day on which banks located in New York, New York are required
or authorized by law to be closed for business.
3. Closing
Conditions. In addition to the conditions set forth in Section 2:
(a) General
Conditions. The Closing is also subject to the satisfaction or valid waiver by each party of the conditions that, on the Closing Date:
(i) no
suspension of the qualification of the Company’s Common Stock for offering or sale or trading in any jurisdiction, or initiation
or threatening of any proceedings for any of such purposes, shall have occurred;
(ii) no
applicable governmental authority shall have enacted, rendered, issued, promulgated, enforced or entered any judgment, order, law, rule or
regulation (whether temporary, preliminary or permanent) which is then in effect and has the effect of making consummation of the transactions
contemplated hereby illegal or otherwise restraining or prohibiting consummation of the transactions contemplated hereby, and no governmental
authority shall have instituted or threatened in writing a proceeding seeking to impose any such restraint or prohibition;
(iii) the
Common Stock to be issued in the Transaction shall have been approved for listing on the Nasdaq Capital Market (the “Trading
Market”), subject to official notice of issuance, and a Listing of Additional Shares notification form shall have been filed
for the Conversion Shares with the Trading Market; and
(iv) all
conditions precedent to the Transaction Closing set forth in the Merger Agreement, as it may be amended from time to time, shall have
been satisfied or waived (other than those conditions which, by their nature, are to be satisfied at the Transaction Closing), with the
closing of the Transaction scheduled to occur substantially concurrently with the Closing.
(b) Company
Conditions. The obligations of the Company to consummate the Closing are also subject to the satisfaction or valid waiver by the Company
of the additional conditions that, on the Closing Date:
(i) all
representations and warranties of the Subscriber contained in this Subscription Agreement shall be true and correct in all material respects
(other than representations and warranties that are qualified as to materiality, which representations and warranties shall be true in
all respects) at and as of the Closing Date (except for representations and warranties made as of a specific date, which shall be true
and correct in all material respects (other than representations and warranties that are qualified as to materiality, which representations
and warranties shall be true in all respects) as of such date), and consummation of the Closing shall constitute a reaffirmation by the
Subscriber of each of the representations, warranties and agreements of the Subscriber contained in this Subscription Agreement as of
the Closing Date;
(ii) the
Company shall have filed the Certificate of Designations with the Secretary of State of the State of Delaware; and
(iii) the
Subscriber shall have performed, satisfied and complied in all material respects with all covenants, agreements and conditions required
by this Subscription Agreement to be performed, satisfied or complied with by it at or prior to Closing.
(c) Subscriber
Conditions. The obligations of the Subscriber to consummate the Closing are also subject to the satisfaction or valid waiver by the
Subscriber of the additional conditions that, on the Closing Date:
(i) all
representations and warranties of the Company contained in this Subscription Agreement shall be true and correct in all material respects
(other than representations and warranties that are qualified as to materiality or Material Adverse Effect (as defined herein), which
representations and warranties shall be true in all respects) at and as of the Closing Date (except for representations and warranties
made as of a specific date, which shall be true and correct in all material respects (other than representations and warranties that are
qualified as to materiality or Material Adverse Effect, which representations and warranties shall be true in all respects) as of such
date), and consummation of the Closing shall constitute a reaffirmation by the Company of each of the representations, warranties and
agreements of the Company contained in this Subscription Agreement as of the Closing Date;
(ii) the
Company shall have performed, satisfied and complied in all material respects with all covenants, agreements and conditions required by
this Subscription Agreement to be performed, satisfied or complied with by it at or prior to Closing;
(iii) the
Company shall have filed the Certificate of Designations, substantially in the form attached hereto as Exhibit A, with the
Secretary of State of the State of Delaware; and
(iv) no
amendment or modification of the Merger Agreement (as the same exists on the date hereof as provided to the Subscriber) shall have occurred
that would reasonably be expected to materially and adversely affect the economic benefits that the Subscriber would reasonably expect
to receive under this Subscription Agreement.
4. Company
Representations and Warranties. The Company represents and warrants to the Subscriber that:
(a) Organization
and Qualification. The Company is a corporation duly organized, validly existing and in good standing under the laws of the State
of Delaware. The Company has the corporate power and authority to own, lease and operate its properties and conduct its business as presently
conducted and to enter into, deliver and perform its obligations under this Subscription Agreement.
(b) Authorization;
Enforcement. This Subscription Agreement has been duly authorized, executed and delivered by the Company and is enforceable against
the Company in accordance with its terms, except as may be limited or otherwise affected by (i) bankruptcy, insolvency, fraudulent
conveyance, reorganization, moratorium or other laws relating to or affecting the rights of creditors generally, and (ii) principles
of equity, whether considered at law or equity.
(c) Issuance.
The Preferred Shares will, upon the filing of the Certificate of Designations with the Secretary of State of the State of Delaware, be
duly authorized, and when issued, sold and delivered to the Subscriber against full payment therefor in accordance with the terms of this
Subscription Agreement, such Preferred Shares will be validly issued, fully paid and non-assessable and will not have been issued in violation
of or subject to any preemptive or similar rights created under the Company’s certificate of incorporation, as amended to date,
the Acquiror Charter (as such term is defined in the Merger Agreement), the Certificate of Designations, the Company’s bylaws, or
similar organization documents, as applicable and in each case as amended (together, the “Organizational Documents”).
The Conversion Shares underlying the Preferred Shares will, upon the filing of the Certificate of Designations with the Secretary of State
of the State of Delaware, be duly authorized and, when issued and delivered to the Subscriber upon conversion pursuant to the Certificate
of Designations, such Conversion Shares will be validly issued, fully paid and non-assessable and will not have been issued in violation
of or subject to any preemptive or similar rights created under the Organizational Documents.
(d) No
Conflicts. The execution, delivery and performance of this Subscription Agreement, including the issuance and sale of the Preferred
Shares and the consummation of the transactions contemplated hereby, will be done in accordance with the Nasdaq marketplace rules, and
(i) will not conflict with or result in a material breach or material violation of any of the terms or provisions of, or constitute
a material default under, or result in the creation or imposition of any lien, charge or encumbrance upon any of the property or assets
of the Company or any of its subsidiaries pursuant to the terms of any indenture, mortgage, deed of trust, loan agreement, license, lease
or any other agreement or instrument to which the Company or any of its subsidiaries is a party or by which the Company or any of its
subsidiaries is bound or to which any of the property or assets of the Company is subject, which would have a material adverse effect
on the business, properties, assets, liabilities, operations, financial condition, stockholders’ equity or results of operations
of the Company (a “Material Adverse Effect”) or materially affect the validity of the Shares or the legal authority
or ability of the Company to perform in all material respects its obligations under the terms of this Subscription Agreement; (ii) result
in any violation of the provisions of the Organizational Documents; or (iii) result in any violation of any statute or any judgment,
order, rule or regulation of any court or governmental agency or body, domestic or foreign, having jurisdiction over the Company
or any of its properties that would have a Material Adverse Effect or materially affect the validity of the Preferred Shares or the legal
authority or ability of the Company to perform in all material respects its obligations under the terms of this Subscription Agreement.
(e) Filings,
Consents and Approvals. Assuming the accuracy of the representations and warranties of the Subscriber in Section 5, the Company
is not required to obtain any consent, waiver, authorization or order of, give any notice to, or make any filing or registration with,
any court or other federal, state, local or other governmental authority, self-regulatory organization or other person in connection with
the execution, delivery and performance by the Company of this Subscription Agreement (including, without limitation, the issuance of
the Preferred Shares), other than (i) any required filing of a Notice of Exempt Offering of Securities on Form D with U.S. Securities
and Exchange Commission (the “Commission”) under Regulation D of the Securities Act of 1933, as amended (the “Securities
Act”), (ii) the filing of the registration statement pursuant to Section 7 below, (iii) the filings required
by applicable state or federal securities laws, (iv) any filings or notices required by Nasdaq, including with respect to obtaining
stockholder approval, if applicable, (v) filings required to consummate the Transaction as contemplated by the Merger Agreement,
(vi) the filing of the Certificate of Designations with the Secretary of State of the State of Delaware, and (vii) any consent,
waiver, authorization or order of, notice to, or filing or registration, the failure of which to obtain would not be reasonably expected
to have, individually or in the aggregate, a Material Adverse Effect.
(f) Capitalization.
As of the date of this Subscription Agreement, the authorized share capital of the Company consists of (i) 100,000,000 shares of
Class A common stock, par value $0.0001 per share (“Class A Common Stock”), (ii) 10,000,000 shares of
Class B common stock, par value $0.0001 per share (“Class B Common Stock”) and (iii) 1,000,000 shares
of preferred stock, par value $0.0001 per share (“Preferred Shares”). As of the date of this Subscription Agreement
(iv) 7,394,793 shares of Class A Common Stock are issued and outstanding, all of which are validly issued, fully paid and non-assessable
and not subject to any preemptive rights, (v) 1 share of Class B Common Stock is issued and outstanding and is validly issued,
fully paid and non-assessable and not subject to any preemptive rights, and (vi) 13,266,666 warrants, each exercisable to purchase
one share of Class A Common Stock, are issued and outstanding. As of the date of this Subscription Agreement, there are no Preferred
Shares issued and outstanding. In addition to the warrants that are currently outstanding, on May 24, 2022 the Company issued a convertible
promissory note to Sponsor (as such term is defined in Section 3(j) below) in the principal amount of up to $1,500,000, all
or a portion of which can be converted by Sponsor into additional warrants at a conversion price of $1.50 per warrant, with each such
warrant entitling the holder thereof to purchase one share of Class A Common Stock. Upon the filing of the Acquiror Charter (as such
term is defined in the Merger Agreement) with the Secretary of State of the State of Delaware, each share of Class A Common Stock
and each share of Class B Common Stock shall automatically be reclassified, redesignated and changed into one validly issued, fully
paid and non-assessable share of Common Stock in accordance with such Acquiror Charter, and upon the filing of the Certificate of Designations
with the Secretary of State of the State of Delaware, the Company shall have authorized the Preferred Stock issuable hereunder. Except
as set forth above and pursuant to the Other Subscription Agreements, or as otherwise set forth or otherwise described in the Merger Agreement
(as may be amended from time to time) and the other agreements and arrangements referred to therein or in the SEC Reports (as defined
below), and except as described below with respect to the Company’s arrangements with Magnetar Capital LLC (“Magnetar”)
as of the date hereof, there are no outstanding options, warrants or other rights to subscribe for, purchase or acquire from the Company
shares of Common Stock or other equity interests in the Company, or securities convertible into or exchangeable or exercisable for such
equity interests. As set forth in the SEC Reports, the Company is also a party to that certain non-binding term sheet by and among Magnetar,
the Company and Target, for the sale and issuance by the Company of up to $50,000,000 of 8.0% senior secured convertible notes to Magnetar
concurrently with the closing of the Transaction (the “Magnetar Convertible Notes”), a copy of which was filed as an
exhibit to the Current Report on Form 8-K that was filed by the Company on November 14, 2022. Such term sheet further provides
that the Magnetar Convertible Notes would have a three-year maturity and would be convertible into shares of Common Stock at an initial
conversion price of $10.00 per share, with conversion price resets and certain anti-dilution rights. Such term sheet further contemplates
the grant to Magnetar of the option to purchase up to an additional $50,000,000 Magnetar Convertible Notes during the two-year period
following the Closing Date (resulting in the potential issuance of up to $100,000,000 of such Magnetar Convertible Notes). There is no
assurance, however, that the Company will issue and sell the Magnetar Convertible Notes on the terms set forth in the non-binding term
sheet or at all, and neither the Closing nor the Transaction Closing is conditioned upon the consummation of the sale of Magnetar Convertible
Notes or similar securities. The Company makes no representations or warranties as to the timing or likelihood that it will consummate
the transactions contemplated by its term sheet with Magnetar. Except for Merger Sub, as of the date hereof, the Company has no subsidiaries
and does not own, directly or indirectly, interests or investments (whether equity or debt) in any person, whether incorporated or unincorporated.
As of the date of this Subscription Agreement, there are no shareholder agreements, voting trusts or other agreements or understandings
to which the Company is a party or by which it is bound relating to the voting of any securities of the company, other than (1) as
set forth in the SEC Reports and (2) as contemplated by the Merger Agreement (as it may be amended from time to time).
(g) Registration
of Common Stock. The issued and outstanding shares of Common Stock are registered pursuant to Section 12(b) of the Securities
Exchange Act of 1934, as amended (the “Exchange Act”), and are listed for trading on the Trading Market under the symbol
“MTAC.” The Company has taken no action that is designed to terminate the registration of the Common Stock under the Exchange
Act.
(h) Regulatory
Actions. Except for such matters as have not had and would not be reasonably be expected to have, individually or in the aggregate,
a Material Adverse Effect, there is no (i) action, suit, claim or other proceeding, in each case by or before any governmental authority
pending, or, to the knowledge of the Company, threatened against the Company or (ii) judgment, decree, injunction, ruling or order
of any governmental entity outstanding against the Company.
(i) Compliance.
The Company is in compliance with all applicable laws, except where such non-compliance would not reasonably be expected to have a Material
Adverse Effect. The Company has not received any written communication from a governmental entity that alleges that the Company is not
in compliance with or is in default or violation of any applicable law, except where such non-compliance, default or violation would not,
individually or in the aggregate, be reasonably expected to have a Material Adverse Effect.
(j) Broker
Fees. The Company has not entered into any agreement or arrangement entitling any agent, broker, investment banker, financial advisor
or other person to any broker’s or finder’s fee or any other commission or similar fee in connection with the transactions
contemplated by this Subscription Agreement for which the Subscriber could become liable. Other than compensation payable to Ceros Financial
Service, Inc., as placement agent (the “Placement Agent”) (consisting of a cash fee of 10% of the gross proceeds
raised from Subscribers (subject to certain exceptions) and an expense reimbursement), which such compensation is to be paid by MedTech
Acquisition Sponsor LLC, a Delaware limited liability company (the “Sponsor”) on behalf of the Company, the Company
is not aware of any person that has been or will be paid (directly or indirectly) remuneration for solicitation of the Subscriber in connection
with the sale of any shares of Preferred Stock in the Offering.
(k) Private
Placement. Assuming the accuracy of the Subscriber’s representations and warranties set forth in Section 5, in connection
with the offer, sale and delivery of the Preferred Shares in the manner contemplated by this Subscription Agreement, it is not necessary
to register the Preferred Shares under the Securities Act. Neither the Company nor anyone acting on its behalf has, directly or indirectly,
offered the Preferred Shares or any similar securities for sale to, or solicited any offer to buy the Preferred Shares or any similar
securities from, or otherwise approached or negotiated in respect thereof with, any person other than the Subscriber, the Other Subscribers,
and a limited number of other accredited investors, each of which has been offered the Preferred Shares at a private sale for investment.
The Preferred Shares (i) were not offered by any form of general solicitation or general advertising and (ii) are not being
offered in a manner involving a public offering under, or in a distribution in violation of, the Securities Act or any state securities
laws.
(l) SEC
Reports; Financial Statements. The Company has filed all forms, reports, statements, schedules, proxies, registration statements and
other documents required to be filed by the Company with the Commission prior to the date of this Subscription Agreement (the “SEC
Reports”). As of their respective dates, all SEC Reports complied in all material respects with the applicable requirements
of the Securities Act, the Exchange Act and the rules and regulations of the Commission promulgated thereunder, and none of the SEC
Reports, when filed, contained any untrue statement of a material fact or omitted to state a material fact required to be stated therein
or necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading. The
financial statements of the Company included in the SEC Reports comply in all material respects with applicable accounting requirements
and the rules and regulations of the Commission with respect thereto as in effect at the time of filing and fairly present in all
material respects the financial position of the Company as of and for the dates thereof and the results of operations and cash flows for
the periods then ended, subject, in the case of unaudited statements, to normal, year-end audit adjustments. A copy of each SEC Report
is available to the Subscriber via the Commission’s EDGAR system. Notwithstanding the foregoing, this representation and warranty
shall not apply to any statement or information in the SEC Reports that relates to (i) the topics referenced in the Commission’s
“Staff Statement on Accounting and Reporting Considerations for Warrants Issued by Special Purpose Acquisition Companies”
on April 12, 2021 or (ii) the classification of the Company’s common stock as permanent or temporary equity, or any subsequent
guidance, statements or interpretations issued by the Commission or the staff of the Commission, including guidance, statements or interpretations
relating to the foregoing or to other accounting matters, including matters relating to initial public offering securities or expenses
(collectively, the “SEC Guidance”), and no correction, amendment or restatement of any of the Company’s SEC Reports
due to the SEC Guidance shall be deemed to be a breach of any representation or warranty by the Company.
(m) No
Side Letters. Other than the Other Subscription Agreements (including those executed on June 7, 2023), the Merger Agreement (as
it may be amended from time to time), the Magnetar Convertible Notes as well as any definitive documents related to or entered into in
connection with the convertible note financing contemplated by the Company’s term sheet with Magnetar, the Company has not entered
into any side letter or similar agreement with any Other Subscriber or any other investor in connection with such Other Subscriber’s
or investor’s direct or indirect investment in the Company through the Offering. No Other Subscription Agreement includes terms
and conditions that are materially more advantageous to any such Other Subscriber than the Subscriber hereunder, and such Other Subscription
Agreements have not been amended or modified in any material respect following the date of this Subscription Agreement. All Other Subscribers
are purchasing the Preferred Shares for the same Per Share Price.
(n) No
Disqualification Events. No “bad actor” disqualifying event described in Rule 506(d)(1)(i)-(viii) of the Securities
Act (a “Disqualification Event”) is applicable to the Company or, to the knowledge of the Company, any Covered Person
(as defined below), except for a Disqualification Event as to which Rule 506(d)(2)(ii–iv) or (d)(3), is applicable. “Covered
Person” means, with respect to the Company as an “issuer” for purposes of Rule 506 promulgated under the Securities
Act, any person listed in the first paragraph of Rule 506(d)(1).
The Company understands that the foregoing representations
and warranties shall be deemed material to and have been relied upon by the Subscriber.
5. Subscriber
Representations, Warranties and Covenants. The Subscriber represents and warrants to the
Company that:
(a) Subscriber
Status. At the time the Subscriber was offered the Preferred Shares, it was, and as of the date hereof, the Subscriber is (i) an
“accredited investor” (within the meaning of Rule 501 of Regulation D under the Securities Act) (an “Accredited
Investor”) or an “Institutional Account” (within the meaning of FINRA Rule 4512(c)) (an “Institutional
Account”), as indicated in the questionnaire attached as Exhibit B hereto (an “Investor Questionnaire”),
and (ii) is acquiring the Preferred Shares and the Conversion Shares underlying the Preferred Shares only for its own account and
not for the account of others, and not on behalf of any other account or person or with a view to, or for offer or sale in connection
with, any distribution thereof in violation of the Securities Act. The Subscriber, if not an individual, is not an entity formed for the
specific purpose of acquiring the Preferred Shares or the Conversion Shares.
(b) Nature
of Investment. The Subscriber understands that the Preferred Shares are being offered in a transaction not involving any public offering
within the meaning of the Securities Act and that neither the Preferred Shares deliverable at the Closing, nor the Conversion Shares underlying
the Preferred Shares deliverable at the Closing, have been registered under the Securities Act. The Subscriber understands that neither
the Preferred Shares, nor the Conversion Shares underlying the Preferred Shares, may be resold, transferred, pledged or otherwise disposed
of by the Subscriber absent an effective registration statement under the Securities Act except (i) to the Company or a subsidiary
thereof, (ii) to non-U.S. persons pursuant to offers and sales that occur outside the United States within the meaning of Regulation
S under the Securities Act or (iii) pursuant to another applicable exemption from the registration requirements of the Securities
Act, and in each of cases (i) and (iii) in accordance with any applicable securities laws of the states and other jurisdictions
of the United States, and that any certificates (if any) or any book-entry shares representing the Preferred Shares delivered at the Closing
and the Conversion Shares underlying such Preferred Shares shall contain a legend or restrictive notation to such effect, and as a result
of such restrictions, the Subscriber may not be able to readily resell the Preferred Shares or the Conversion Shares underlying the Preferred
Shares, and may be required to bear the financial risk of an investment in the Preferred Shares or the Conversion Shares underlying the
Preferred Shares for an indefinite period of time. The Subscriber acknowledges and agrees that neither the Preferred Shares nor the Conversion
Shares underlying the Preferred Shares will be immediately eligible for offer, resale, transfer, pledge or disposition pursuant to Rule 144
promulgated under the Securities Act (“Rule 144”), until at least one year following the Company’s filing
of certain required information with the Commission after the Closing Date. The Subscriber understands that it has been advised to consult
legal counsel prior to making any offer, resale, pledge or transfer of any of the Preferred Shares or the Conversion Shares underlying
the Preferred Shares. The Subscriber acknowledges and agrees that the effectiveness of the registration statement registering the resale
of the Conversion Shares underlying the Preferred Shares pursuant to Section 7 is not a condition to the Closing of this Offering.
(c) Reliance
on Exemptions. The Subscriber understands that the Preferred Shares are being offered and sold to it in reliance on specific exemptions
from the registration requirements of United States federal and state securities laws and that the Company is relying in part upon the
truth and accuracy of, and such Subscriber’s compliance with, the representations, warranties, agreements, acknowledgements and
understandings of such Subscriber set forth herein in order to determine the availability of such exemptions and the eligibility of such
Subscriber to acquire the Preferred Shares as well as the Conversion Shares underlying the Preferred Shares.
(d) Authorization
and Enforcement. The execution, delivery and performance by the Subscriber of this Subscription Agreement are within the powers of
the Subscriber, have been duly authorized and will not constitute or result in a breach or default under or conflict with any federal
or state statute, rule or regulation applicable to the Subscriber, any order, ruling or regulation of any court or other tribunal
or of any governmental commission or agency, or any agreement or other undertaking, to which the Subscriber is a party or by which the
Subscriber is bound, and, if the Subscriber is not an individual, will not violate any provisions of the Subscriber’s charter documents,
including its incorporation or formation papers, bylaws, indenture of trust or partnership or operating agreement, as may be applicable.
The signature on this Subscription Agreement is genuine, and the signatory, if the Subscriber is an individual, has legal competence and
capacity to execute the same or, if the Subscriber is not an individual the signatory has been duly authorized to execute the same, and
this Subscription Agreement constitutes a legal, valid and binding obligation of the Subscriber, enforceable against the Subscriber in
accordance with its terms, except as may be limited or otherwise affected by (i) bankruptcy, insolvency, fraudulent conveyance, reorganization,
moratorium or other laws relating to or affecting the rights of creditors generally, and (ii) principles of equity, whether considered
at law or equity. If the Subscriber is not an individual, the Subscriber has been duly formed or incorporated and is validly existing
in good standing under the laws of its jurisdiction of incorporation or formation. At the Closing, the Subscriber will have sufficient
funds to pay the Purchase Price pursuant to Section 2.
(e) Other
Representations. The Subscriber understands and agrees that the Subscriber is purchasing the Preferred Shares directly from the Company.
The Subscriber further acknowledges that there have been no representations, warranties, covenants and agreements made to the Subscriber
by the Company, or any of its officers or directors, expressly (other than those representations, warranties, covenants and agreements
included in this Subscription Agreement) or by implication.
(f) Tax
Treatment. The Subscriber’s acquisition and holding of the Preferred Shares, as well as any Conversion Shares underlying the
Preferred Shares, will not constitute or result in a non-exempt prohibited transaction under Section 406 of the Employee Retirement
Income Security Act of 1974, as amended, Section 4975 of the Internal Revenue Code of 1986, as amended, or any applicable similar
law.
(g) Receipt
of Disclosure. The Subscriber acknowledges and agrees that the Subscriber has received such information as the Subscriber deems necessary
in order to make an investment decision with respect to the Preferred Shares and the Conversion Shares underlying the Preferred Shares.
Without limiting the generality of the foregoing, the Subscriber acknowledges that it has had the opportunity to review the SEC Reports
and has been afforded (i) the opportunity to ask such questions as it has deemed necessary of, and to receive answers from, representatives
of the Company concerning the terms and conditions of the Offering and the merits and risks of investing in the Preferred Shares and the
Conversion Shares underlying the Preferred Shares; (ii) access to information about the Company and the Target and their respective
financial condition, results of operations, business, properties, management and prospects sufficient to enable it to evaluate its investment,
including without limitation, risk factors relating to the Offering, the Company and the Target delivered by the Company to the Subscriber
(the “Risk Factors”); and (iii) the opportunity to obtain such additional information that the Company possesses
or can acquire without unreasonable effort or expense that is necessary to make an informed investment decision with respect to the investment.
Except for the representations, warranties and agreements of the Company expressly set forth in this Subscription Agreement, the Subscriber
is relying exclusively on its own sources of information, investment analysis and due diligence (including professional advice it deems
appropriate) with respect to the Transaction, the Preferred Shares, the Conversion Shares underlying the Preferred Shares, and the business,
condition (financial and otherwise), management, operations, properties and prospects of the Company and the Target, including but not
limited to all business, legal, regulatory, accounting, credit and tax matters.
(h) No
General Solicitation. The Subscriber became aware of this Offering of the Preferred Shares solely by means of direct contact between
the Subscriber and the Company, the Placement Agent or a representative of the Company or the Placement Agent, and the Preferred Shares
were offered to the Subscriber solely by direct contact between the Subscriber and the Company, the Placement Agent or a representative
of the Company or the Placement Agent. If the Subscriber is a client of the Placement Agent, the Subscriber affirms and acknowledges that
the Subscriber has had a pre-existing, substantive relationship with the Placement Agent since on or before November 13, 2022; if
the Subscriber is not a client of the Placement Agent, the Subscriber affirms and acknowledges that the Subscriber has had, since on or
before November 13, 2022, a pre-existing, substantive relationship with the Company, the Sponsor and/or the individual members of
the Sponsor. The Subscriber acknowledges that the Preferred Shares (i) were not offered by any form of general solicitation or general
advertising and (ii) are not being offered in a manner involving a public offering under, or in a distribution in violation of, the
Securities Act, or any state securities laws.
(i) Investment
Risks. The Subscriber acknowledges that it is aware that there are substantial risks incident to the purchase and ownership of the
Preferred Shares and the Conversion Shares underlying such Preferred Shares, including those set forth in the SEC Reports and in the Risk
Factors. The Subscriber is able to fend for itself in the transactions contemplated herein and has such knowledge and experience in financial
and business matters as to be capable of evaluating the merits and risks of an investment in the Preferred Shares and the Conversion Shares
underlying such Preferred Shares, and the Subscriber has sought such accounting, legal and tax advice as the Subscriber has considered
necessary to make an informed investment decision. Alone, or together with any professional advisor(s), the Subscriber has adequately
analyzed and fully considered the risks of an investment in the Preferred Shares and the Conversion Shares underlying such Preferred Shares
and determined that the Preferred Shares are a suitable investment for the Subscriber and that the Subscriber is able at this time and
in the foreseeable future to bear the economic risk of a total loss of the Subscriber’s investment in the Company. The Subscriber
acknowledges specifically that a possibility of total loss exists.
(j) Compliance.
The Subscriber understands and agrees that no federal or state agency has passed upon or endorsed the merits of this Offering of the Preferred
Shares or made any findings or determination as to the fairness of this investment or the accuracy or adequacy of the Company’s
reports, schedules, forms, statements and other documents required to be filed by the Company under the Securities Act and the Exchange
Act, including pursuant to Section 13(a) or 15(d) thereof.
(k) OFAC/Patriot
Act. The Subscriber is not (i) a person or entity named on the List of Specially Designated Nationals and Blocked Persons administered
by the U.S. Treasury Department’s Office of Foreign Assets Control (“OFAC”) or in any Executive Order issued
by the President of the United States and administered by OFAC (“OFAC List”), or a person or entity prohibited by any
OFAC sanctions program, (ii) a Designated National as defined in the Cuban Assets Control Regulations, 31 C.F.R. Part 515, or
(iii) a non-U.S. shell bank or providing banking services indirectly to a non-U.S. shell bank (collectively, a “Prohibited
Investor”). The Subscriber agrees to provide law enforcement agencies, if requested thereby, such records as required by applicable
law, provided that the Subscriber is permitted to do so under applicable law. If the Subscriber is a financial institution subject to
the Bank Secrecy Act (31 U.S.C. Section 5311 et seq.), as amended by the USA PATRIOT Act of 2001, and its implementing regulations
(collectively, the “BSA/PATRIOT Act”), the Subscriber maintains policies and procedures reasonably designed to comply
with applicable obligations under the BSA/PATRIOT Act. To the extent required, it maintains policies and procedures reasonably designed
for the screening of its investors against the OFAC sanctions programs, including the OFAC List. To the extent required, it maintains
policies and procedures reasonably designed to ensure that the funds held by the Subscriber and used to purchase the Shares were legally
derived.
(l) No
Reliance on Placement Agent; Acknowledgment of Conflicts. In making its decision to purchase the Preferred Shares, the Subscriber
has relied solely upon independent investigation made by the Subscriber and the representations and warranties of the Company set forth
herein. Without limiting the generality of the foregoing, the Subscriber has not relied on any statements or other information provided
by the Placement Agent or anyone other than the Company concerning the Company, Target or the Preferred Shares or the offer and sale of
the Preferred Shares. The Subscriber acknowledges and agrees that no disclosure or offering document has been prepared by the Placement
Agent specifically for the offer and sale of the Preferred Shares. The Placement Agent and its members, directors, officers, employees,
representatives and controlling persons have made no independent investigation with respect to the Company, the Preferred Shares and the
Conversion Shares underlying such Preferred Shares or the accuracy, completeness or adequacy of any information supplied to the Subscriber
by the Company. In connection with the issue and purchase of the Preferred Shares, the Placement Agent has not made any recommendations
regarding an investment in the Company or the Preferred Shares or acted as the Subscriber’s financial advisor or fiduciary. The
Subscriber hereby further acknowledges and affirms his, her or its understanding that Christopher Dewey, the Chief Executive Officer of
the Company and a Managing Member of the Sponsor, is also a managing director and indirect minority owner of the Placement Agent, and
that the matters described in any Subscription Agreement and the fees in connection therewith may give rise to potential conflicts of
interest or the appearance thereof. The Subscriber consents to (and agrees, to the extent applicable and permitted by applicable law,
on behalf of itself and its equity holders, to waive any claims the Subscriber or its equity holders may have based on any actual or potential
conflicts of interest that may arise or result from) the Placement Agent acting as placement agent to the Company and receiving any compensation
in connection with, any of the activities described in any Subscription Agreement. The Subscriber acknowledges that the Placement Agent
does not assume any responsibility for independent verification of, or the accuracy or completeness of, any information or projections
provided to the Subscriber hereunder.
(m) No
Broker. No broker or finder has acted on behalf of the Subscriber in connection with the sale of the Preferred Shares pursuant to
this Subscription Agreement in such a way as to create any liability on the Company.
(n) No
Short Sales. The Subscriber hereby agrees that neither it, nor any person or entity acting on its behalf or pursuant to any understanding
with the Subscriber, shall, directly or indirectly, engage in any hedging activities or execute any Short Sales with respect to the securities
of the Company from the date hereof until the Closing or the earlier termination of this Subscription Agreement in accordance with its
terms (other than pledges in the ordinary course of business as part of prime brokerage arrangements). “Short Sales”
shall include, without limitation, all “short sales” as defined in Rule 200 promulgated under Regulation SHO under the
Exchange Act and all types of direct and indirect stock pledges (other than pledges in the ordinary course of business as part of prime
brokerage arrangements), forward sale contracts, options, puts, calls, swaps and similar arrangements (including on a total return basis),
and sales and other transactions through non-U.S. broker dealers or foreign regulated brokers.
(o) No
Status as a Group Member. Except as expressly disclosed in a Schedule 13D or Schedule 13G (or amendments thereto) filed by the Subscriber
with the Commission with respect to the beneficial ownership of the Company’s outstanding securities prior to the date hereof, the
Subscriber is not currently (and at all times through Closing will refrain from being or becoming) a member of a “group” (within
the meaning of Section 13(d)(3) or Section 14(d)(2) of the Exchange Act, or any successor provision), including any
group acting for the purpose of acquiring, holding or disposing of equity securities of the Company (within the meaning of Rule 13d-5(b)(1) under
the Exchange Act).
(p) Future
Information. The Subscriber acknowledges that (i) the Company and Target and any of their respective affiliates, control persons,
officers, directors, employees, agents or representatives currently may have, and later may come into possession of, information regarding
the Company and Target that is not known to the Subscriber and that may be material to a decision to purchase the Preferred Shares, (ii) the
Subscriber has determined to purchase the Preferred Shares notwithstanding its lack of knowledge of such information, and (iii) none
of the Company or Target or any of their respective affiliates, control persons, officers, directors, employees, agents or representatives
shall have liability to the Subscriber, and the Subscriber hereby, to the extent permitted by law, on behalf of itself and its equity
holders, waives and releases any claims it may have against the Company, Target and their respective affiliates, control persons, officers,
directors, employees, agents or representatives, with respect to the nondisclosure of such information.
(q) Diligence
Disclaimer. Neither the due diligence investigation conducted by the Subscriber in connection with making its decision to acquire
the Preferred Shares nor any representations and warranties made by the Subscriber herein shall modify, amend or affect the Subscriber’s
right to rely on the truth, accuracy and completeness of the Company’s representations and warranties contained herein.
(r) Residency.
Such Subscriber’s residence (if an individual) or offices in which its investment decision with respect to the Preferred Shares
was made (if an entity) are located at the address immediately below such Subscriber’s name on its signature page hereto.
6. Additional
Covenants.
(a) Transfer
Restrictions.
(i) The
Company Shares (as well as any shares of Common Stock that may be issued as a dividend on the Holder’s Preferred Shares in accordance
with the Certificate of Designations) may only be resold, transferred, pledged or otherwise disposed of in compliance with state and federal
securities laws. In connection with any transfer of the Company Shares (as well as any shares of Common Stock that may be issued as a
dividend on the Holder’s Preferred Shares in accordance with the Certificate of Designations), other than a transfer pursuant to
(A) an effective registration statement, (B) Rule 144 under the Securities Act or (C) any transfer for which the Company’s
transfer agent will not require an opinion, the Company shall require the transferor thereof to provide to the Company an opinion of counsel
selected by the transferor and reasonably acceptable to the Company, the form and substance of which opinion shall be reasonably satisfactory
to the Company, to the effect that such transfer does not require registration of such transferred shares under the Securities Act and
any other documentation reasonably requested by the Company or the Company’s transfer agent; provided that as a condition of any
such transfer other than (A), (B) or (C) above, such transferee shall agree in writing to be bound by the terms of this Subscription
Agreement (including a representation pursuant to Exhibit B of this Subscription Agreement that such transferee is an “accredited
investor” (as defined in Rule 501(a) under the Securities Act)); provided, further, that any transfer pursuant to (A),
(B) or (C) above is subject to receipt by the Company of a representation letter or other documentation reasonably requested
by the Company or the Company’s transfer agent. The Subscriber shall be permitted to transfer the Company Shares (as well as any
shares of Common Stock that may be issued as a dividend on the Holder’s Preferred Shares in accordance with the Certificate of Designations)
to the Company.
(ii) The
Company acknowledges and agrees that the Subscriber may from time to time pledge pursuant to a bona fide margin agreement with a broker-dealer
registered under the Exchange Act, or grant a security interest in some or all of the Company Shares (as well as any shares of Common
Stock that may be issued as a dividend on the Holder’s Preferred Shares in accordance with the Certificate of Designations) to a
financial institution that is an “accredited investor” as defined in Rule 501(a) under the Securities Act and, if
required under the terms of such arrangement, the Subscriber may transfer such pledged or secured shares to the pledgees or secured parties;
provided that, any such Company Shares (as well as any shares of Common Stock that may be issued as a dividend on the Holder’s Preferred
Shares in accordance with the Certificate of Designations) to be transferred shall be required to include any applicable legends, including
the legend contemplated by Section 6(a)(iii) herein, and if required by its Transfer Agent, be in physical certificated
form; provided, further, that in no event shall the Company be required to, or be required to instruct the Transfer Agent to, deliver
Company Shares (or any shares of Common Stock that may be issued as a dividend on the Holder’s Preferred Shares in accordance with
the Certificate of Designations) to such pledgee or secured parties without legends if such legends are required as determined by the
Company in consultation with its counsel. Such a pledge or transfer would not be subject to approval of the Company and no legal opinion
of legal counsel of the pledgee, secured party or pledgor shall be required in connection therewith; further, no notice shall be required
of such pledge; provided that the Subscriber and its pledgee shall be required to comply with other provisions of Section 6
hereof in order to effect a sale, transfer or assignment of the Company Shares (as well as any shares of Common Stock that may be issued
as a dividend on the Holder’s Preferred Shares in accordance with the Certificate of Designations) to such pledgee. In addition,
the Subscriber shall be permitted to transfer the Company Shares (as well as any shares of Common Stock that may be issued as a dividend
on the Holder’s Preferred Shares in accordance with the Certificate of Designations) to one or more affiliates of the Subscriber,
provided that, any such affiliate transferee of such Subscriber shall agree in writing to be bound by the terms of this Subscription Agreement
(including a representation pursuant to Exhibit B of this Subscription Agreement that such transferee is an “accredited investor”
(as defined in Rule 501(a) under the Securities Act); provided, that, any such transfer is conditioned upon the receipt from
the Subscriber or such affiliate transferee of any documentation reasonably requested by the Company or the Company’s transfer agent.
(iii) The
Subscriber agrees to the imprinting, so long as is required by this Subscription Agreement, of a legend on any of the Company Shares (as
well as any shares of Common Stock that may be issued as a dividend on the Holder’s Preferred Shares in accordance with the Certificate
of Designations), and after the consummation of the Transaction, the Company Shares (as well as any shares of Common Stock that may be
issued as a dividend on the Holder’s Preferred Shares in accordance with the Certificate of Designations), in the following form:
THIS SECURITY HAS NOT BEEN REGISTERED WITH THE SECURITIES AND
EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT
OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE
REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION
REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE FEDERAL, STATE AND FOREIGN SECURITIES LAWS.
(iv) The
Subscriber agrees with the Company that the Subscriber will sell any Company Shares (as well as any shares of Common Stock that may be
issued as a dividend on the Holder’s Preferred Shares in accordance with the Certificate of Designations) pursuant to either the
registration requirements of the Securities Act, including any applicable prospectus delivery requirements, or an exemption therefrom,
and that if Company Shares (or any shares of Common Stock that may be issued as a dividend on the Holder’s Preferred Shares in accordance
with the Certificate of Designations) are sold pursuant to a registration statement, they will be sold in compliance with the plan of
distribution set forth therein, and acknowledges that the removal of the restrictive legend from instruments representing Company Shares
(as well as any shares of Common Stock that may be issued as a dividend on the Holder’s Preferred Shares in accordance with the
Certificate of Designations), and after the consummation of the Transaction, the Company Shares (as well as any shares of Common Stock
that may be issued as a dividend on the Holder’s Preferred Shares in accordance with the Certificate of Designations), as set forth
in this Section 6 is predicated upon the Company’s reliance upon this understanding.
(v) Subscriber
acknowledges and agrees that it does not currently have, and it will not before Closing enter into, any binding commitment to transfer
any of the Company Shares or any of its rights or obligations under this Subscription Agreement.
(b) Public
Disclosure. The Company shall by 5:30pm ET on the fourth (4th) Business Day following the date on which the Company accepts and countersigns
this Subscription Agreement (the “Disclosure Time”), file a Current Report on Form 8-K with the Commission (the
“Disclosure Document”) disclosing all material terms of this Subscription Agreement and the transactions contemplated
hereby, and any other material, nonpublic information that the Company has provided to the Subscriber or any of the Subscriber’s
affiliates, attorneys, agents or representatives at any time prior to the filing of the Disclosure Document and including as exhibits
to the Disclosure Document, the form of this Subscription Agreement (in each case, without redaction). Upon the issuance of such Disclosure
Document, to the Company’s knowledge, the Subscriber and Subscriber’s affiliates, attorneys, agents and representatives shall
not be in possession of any material, non-public information received from the Company or any of its affiliates, officers, directors,
or employees or agents, and the Subscriber shall no longer be subject to any confidentiality or similar obligations under any current
agreement, whether written or oral with the Company or any of its respective affiliates. Notwithstanding the foregoing, no party shall
publicly disclose the name of any other party, or include the name of any other party in any filing with the Commission or any regulatory
agency or Trading Market, without the prior written consent of the party being disclosed, except (a) as required by federal securities
law in connection with any registration statement contemplated by Section 7 and (b) to the extent such disclosure is required
by law or Trading Market regulations, in which case prior notice of such disclosure permitted under this clause (b) shall be made
to the other party. The Subscriber will promptly provide any information reasonably requested by the Company for any regulatory application
or filing made or approval sought in connection with the Transaction (including filings with the Commission).
(c) Certain
Transactions and Confidentiality. The Subscriber covenants that neither it, nor any person or entity acting on its behalf or pursuant
to any understanding with it will (i) execute any purchases or sales of any of the Company’s securities or (ii) will engage
in any Short Sales with respect to securities of the Company; in each instance during the period commencing at the time that the Subscriber
first learned of the transactions contemplated hereunder and ending at such time that the transactions contemplated by this Agreement
are first publicly announced pursuant to the Disclosure Document as described in Section 6(b). The Subscriber covenants that
until such time as the transactions contemplated by this Agreement are publicly disclosed by the Company pursuant to the Disclosure Document
as described in Section 6(b), the Subscriber will maintain the confidentiality of the existence and terms of this transaction.
(d) Subscriber
Undertaking. The Company may request from the Subscriber such additional information as the Company may deem necessary to evaluate
the eligibility of the Subscriber to acquire the Preferred Shares, and the Subscriber shall provide such information to the Company upon
such request to the extent readily available and to the extent consistent with the Subscriber’s internal policies and procedures,
and provided that the Company agrees to keep confidential any such information provided by the Subscriber.
7. Registration
of Shares.
(a) The
Company agrees that, within thirty (30) calendar days following the Closing Date, the Company will submit to or file with the Commission
(at the Company’s sole cost and expense) a registration statement (the “Registration Statement”) registering
the resale of the Conversion Shares underlying the Preferred Shares and the Company shall use its commercially reasonable efforts to have
the Registration Statement declared effective as soon as practicable after the filing thereof, but in any event no later than the earlier
of (1) ninety (90) calendar days following the Closing Date (or one hundred twenty (120) calendar days after the Closing Date if
the Registration Statement is reviewed by, and comments thereto are provided by, the Commission) and (2) the tenth (10th)
calendar day after the date the Company is notified orally or in writing by the staff of the Commission that the Registration Statement
will not be “reviewed” or will not be subject to further review (the earlier of clauses (1) or (2), the “Effectiveness
Deadline”); provided, however, that (i) if the Effectiveness Deadline falls on a Saturday, Sunday or other day that
the Commission is closed for business, the Effectiveness Deadline shall be extended to the next Business Day on which the Commission is
open for business and (ii) if the Commission is closed for operations due to a government shutdown, the Effectiveness Deadline shall
be extended by the same number of Business Days that the Commission remains closed. The Company will use its commercially reasonable efforts
to provide a draft of the Registration Statement to the Subscriber for review at least two (2) Business Days in advance of the filing
of the Registration Statement. In no event shall the Subscriber be identified as a statutory underwriter in the Registration Statement
unless in response to a comment or request from the staff of the Commission or another regulatory agency; provided, however, that if the
Commission requests that the Subscriber be identified as a statutory underwriter in the Registration Statement, the Subscriber will have
an opportunity to withdraw from the Registration Statement. Notwithstanding the foregoing, if the Commission prevents the Company from
including any or all of the shares proposed to be registered under the Registration Statement due to limitations on the use of Rule 415
of the Securities Act for the resale of the Conversion Shares underlying the Preferred Shares by the applicable stockholders or otherwise,
such Registration Statement shall register for resale such number of Conversion Shares underlying the Preferred Shares which is equal
to the maximum number of Conversion Shares underlying the Preferred Shares as is permitted by the Commission. In such event, the number
of Conversion Shares underlying the Preferred Shares, or other shares to be registered for each selling stockholder named in the Registration
Statement, shall be reduced pro rata among all such selling stockholders. The Company agrees that, except for such times as the Company
is permitted hereunder to suspend the use of the prospectus forming part of the Registration Statement, the Company will use its commercially
reasonable efforts to cause such Registration Statement to remain effective with respect to each Subscriber until the earliest to occur
of (i) two (2) years from the effective date of such Registration Statement, (ii) the date on which Subscriber ceases to
hold any Company Shares issued pursuant to this Subscription Agreement and covered by such Registration Statement and (iii) the first
date on which such Subscriber can sell all of its Conversion Shares underlying the Preferred Shares issued pursuant to this Subscription
Agreement (or securities received in exchange therefor) and covered by such Registration Statement under Rule 144 without limitation
as to the manner of sale or the amount of such securities that may be sold and without the requirement for the Company to be in compliance
with the current public information required under Rule 144(c)(1) (or Rule 144(i)(2), if applicable) (the earliest of clauses
(i), (ii) and (iii), the “End Date”). Prior to the End Date, the Company will use commercially reasonable efforts
to obtain the withdrawal of any order suspending the effectiveness of any Registration Statement as soon as reasonably practicable. The
Company will use its commercially reasonable efforts to (x) deliver all the necessary documentation to cause the Company’s
transfer agent to remove all restrictive legends from any Registrable Securities (as defined below) being sold under the Registration
Statement or pursuant to Rule 144 at the time of sale of such Registrable Securities, and (y) cause its legal counsel to deliver
the necessary legal opinions, if any, to the transfer agent in connection with the instruction under subclause (x) upon the receipt
of such supporting documentation, if any, as reasonably requested by such counsel. The Company will use commercially reasonable efforts
to file all reports, and provide all customary and reasonable cooperation, reasonably necessary to enable Holder to resell Registrable
Securities pursuant to the Registration Statement or Rule 144 (when Rule 144 becomes available to the Subscribers), as applicable,
and update or amend the Registration Statement as necessary to include Registrable Securities. “Registrable Securities”
shall mean, as of any date of determination, the Conversion Shares underlying the Preferred Shares, any shares of Common Stock that may
be issued as a dividend on the Holder’s Preferred Shares in accordance with the Certificate of Designations, and any other equity
security issued or issuable with respect to the Conversion Shares underlying the Preferred Shares by way of share split, dividend, distribution,
recapitalization, merger, exchange, replacement or similar event, provided, however, that such securities shall cease to be Registrable
Securities at the earliest of (A) three (3) years from the date of original issuance, (B) the date all Conversion Shares
underlying the Preferred Shares held by a Holder may be sold by such Holder without volume or manner of sale limitations pursuant to Rule 144
and without the requirement for the Company to be in compliance with the current public information required under Rule 144(c)(1) (or
Rule 144(i)(2), if applicable), (B) the date on which such securities have actually been sold by a Holder or such Holder otherwise
ceases to hold such securities, or (C) when such securities shall have ceased to be outstanding. “Holder” shall
mean the Subscriber or any affiliate of the Subscriber to which the rights under this Section 7 shall have been assigned in accordance
with the terms and conditions of this Agreement (and any such affiliates, also a “Subscriber” hereunder). The Subscriber
agrees to disclose its beneficial ownership, as determined in accordance with Rule 13d-3 of the Exchange Act, of the securities of
the Company held by the Subscriber to the Company (or its successor) upon reasonable request to assist the Company in making the determination
described above. The Company’s obligations to include the Registrable Securities in the Registration Statement are contingent upon
the Subscriber furnishing in writing to the Company a completed selling stockholder questionnaire in customary form that contains such
information regarding the Subscriber, the securities of the Company held by the Subscriber and the intended method of disposition of the
Registrable Securities as shall be reasonably requested by the Company to effect the registration of the Registrable Securities, and shall
execute such documents in connection with such registration as the Company may reasonably request that are customary of a selling stockholder
in similar situations provided that the Subscriber shall not in connection with the foregoing be required to execute any lock-up or similar
agreement or otherwise be subject to any contractual restriction on the ability to transfer the Conversion Shares underlying the Preferred
Shares. The Subscriber shall not be entitled to use the Registration Statement for an underwritten offering of Registrable Securities.
Notwithstanding anything to the contrary in this Subscription Agreement, the Company may delay filing, postpone effectiveness or suspend
the use of the Registration Statement if (A) it determines that, in order for the Registration Statement to not contain a material
misstatement or omission, an amendment thereto would be needed, (B) such filing, effectiveness or use would reasonably be expected
to materially affect a bona fide business or financing transaction of the Company or would require premature disclosure of information
that would reasonably be expected to materially adversely affect or be seriously detrimental the Company or require the inclusion in such
Registration Statement of financial statements that are unavailable to the Company for reasons beyond the Company’s control or any
other material non-public information, (C) it so determines during any customary blackout or similar period or as permitted hereunder,
(D) the majority of the board determines to delay the filing or initial effectiveness of, or suspend use of, such Registration Statement
and such delay or suspension arises out of, or is a result of, or is related to or is in connection with the SEC Guidance or future Commission
guidance directed at special purpose acquisition companies, or any related disclosure or related matters, or (E) necessary in connection
with the preparation and filing of a post-effective amendment to such Registration Statement following the filing of the Company’s
Annual Report on Form 10-K for its first completed fiscal year following the effective date of such Registration Statement (each
such circumstance, a “Suspension Event”); provided, that, (i) the Company shall not so delay filing, postpone
effectiveness, or suspend the use of the Registration Statement for a period of more than sixty (60) consecutive days or more than two
(2) times in any three hundred sixty (360) day period and (ii) the Company shall use commercially reasonable efforts to make
the Registration Statement available for the sale by the Subscriber of its Registrable Securities as soon as practicable thereafter. Upon
receipt of any written notice from the Company (which notice shall not contain any material non-public information regarding the Company)
of the happening of (i) an issuance by the Commission of any stop order suspending the effectiveness of the Registration Statement
or the initiation of any proceedings for such purpose, (ii) any Suspension Event during the period that the Registration Statement
is effective or (iii) if as a result of a Suspension Event the Registration Statement or related prospectus contains any untrue statement
of a material fact or omits to state any material fact required to be stated therein or necessary to make the statements therein, in light
of the circumstances under which they were made (in the case of the prospectus) not misleading, the Subscriber agrees that (I) it
will immediately discontinue offers and sales of the Registrable Securities under the Registration Statement until the Subscriber receives
copies of a supplemental or amended prospectus (which the Company agrees to promptly prepare) that corrects the misstatement(s) or
omission(s) referred to above and receives notice that any post-effective amendment has become effective or unless otherwise notified
by the Company that it may resume such offers and sales (the “Subscriber Suspension Obligations”), and (II) it
will maintain the confidentiality of any information included in such written notice delivered by the Company unless otherwise required
by law or subpoena. If so directed by the Company, the Subscriber will deliver to the Company or, in the Subscriber’s sole discretion
destroy, all copies of the prospectus covering the Registrable Securities in the Subscriber’s possession; provided, however, that
this obligation to deliver or destroy all copies of the prospectus covering such Registrable Securities shall not apply (X) to the
extent the Subscriber is required to retain a copy of such prospectus (a) in order to comply with applicable legal, regulatory, self-regulatory
or professional requirements or (b) in accordance with a bona fide pre-existing document retention policy or (Y) to copies stored
electronically on archival servers as a result of automatic data back-up. For as long as the Subscriber holds Registrable Securities,
the Company shall use commercially reasonable efforts to file all reports for so long as the condition in Rule 144(c)(1) (or
Rule 144(i)(2), if applicable) is required to be satisfied. At its expense, the Company shall advise the Subscriber within two (2) business
days: (i) when the Registration Statement or any post-effective amendment thereto has become effective; (ii) of any request
by the Commission for amendments or supplements to the Registration Statement or the prospectus included therein or for additional information
relating to the Registration Statement or the prospectus; (iii) of the issuance by the Commission of any stop order suspending the
effectiveness of the Registration Statement or the initiation of any proceedings for such purpose; and (iv) of the receipt by the
Company of any notification with respect to the suspension of the qualification of the Registrable Securities included therein for sale
in any jurisdiction or the initiation or threatening in writing of any proceeding for such purpose.
(b) The
Company shall indemnify and hold harmless the Subscriber (to the extent a seller under the Registration Statement), the officers, directors,
agents and employees of the Subscriber, each person who controls the Subscriber (within the meaning of Section 15 of the Securities
Act or Section 20 of the Exchange Act) and the officers, directors, agents and employees of each such controlling person, to the
fullest extent permitted by applicable law, from and against any and all losses, claims, damages, liabilities, costs (including, without
limitation, reasonable and documented attorneys’ fees) and expenses (collectively, “Losses”) that arise out of
or are based upon any untrue or alleged untrue statement of a material fact contained in the Registration Statement, any prospectus included
in the Registration Statement or any form of prospectus or in any amendment or supplement thereto or in any preliminary prospectus included
in the Registration Statement, or arising out of or relating to any omission or alleged omission to state a material fact required to
be stated therein or necessary to make the statements therein (in the case of any prospectus or form of prospectus or supplement thereto,
in light of the circumstances under which they were made) not misleading, except to the extent that such untrue statements, alleged untrue
statements, omissions or alleged omissions are (1) based upon information regarding the Subscriber furnished in writing to the Company
by the Subscriber expressly for use therein or that the Subscriber has omitted a material fact from such information or (2) result
from or in connection with any offers or sales effected by the Subscriber in violation of the Subscriber Suspension Obligations. The Company
shall notify the Subscriber promptly of the institution, threat in writing or assertion of any proceeding arising from or in connection
with the transactions contemplated by this Section 7 of which the Company is aware. Such indemnity shall remain in full force and
effect regardless of any investigation made by or on behalf of an indemnified party and shall survive the transfer of the Company Shares
by the Subscriber. Notwithstanding the forgoing, the Company’s indemnification obligations shall not apply to amounts paid in settlement
of any Losses or action if such settlement is effected without the prior written consent of the Company (which consent shall not be unreasonably
withheld or delayed).
(c) The
Subscriber shall, severally and not jointly with any Other Subscriber in the offering contemplated by this Subscription Agreement, indemnify
and hold harmless the Company, its directors, officers, agents and employees, each person who controls the Company (within the meaning
of Section 15 of the Securities Act and Section 20 of the Exchange Act), and the directors, officers, agents or employees of
such controlling persons, to the fullest extent permitted by applicable law, from and against all Losses arising out of or based upon
any untrue or alleged untrue statement of a material fact contained in any Registration Statement, any prospectus included in the Registration
Statement, or any form of prospectus, or in any amendment or supplement thereto or in any preliminary prospectus, or arising out of or
relating to any omission or alleged omission of a material fact required to be stated therein or necessary to make the statements therein
(in the case of any prospectus, or any form of prospectus or supplement thereto, in light of the circumstances under which they were made)
not misleading to the extent, but only to the extent, that such untrue statements, alleged untrue statements, omissions or alleged omissions
are based upon information regarding the Subscriber furnished in writing to the Company by the Subscriber expressly for use therein. In
no event shall the liability of the Subscriber be greater in amount than the dollar amount of the net proceeds received by the Subscriber
upon the sale of the Registrable Securities giving rise to such indemnification obligation. Notwithstanding the forgoing, the Subscriber
indemnification obligations shall not apply to amounts paid in settlement of any Losses or action if such settlement is effected without
the prior written consent of the Subscriber (which consent shall not be unreasonably withheld or delayed).
(d) Any
person or entity entitled to indemnification herein shall (A) give prompt written notice to the indemnifying party of any claim with
respect to which it seeks indemnification (provided that the failure to give prompt notice shall not impair any person’s or entity’s
right to indemnification hereunder to the extent such failure has not prejudiced the indemnifying party) and (B) unless in such indemnified
party’s reasonable judgment a conflict of interest between such indemnified and indemnifying parties may exist with respect to such
claim, permit such indemnifying party to assume the defense of such claim with counsel reasonably satisfactory to the indemnified party.
If such defense is assumed, the indemnifying party shall not be subject to any liability for any settlement made by the indemnified party
without its consent (but such consent shall not be unreasonably withheld, conditioned or delayed). An indemnifying party who is not entitled
to, or elects not to, assume the defense of a claim shall not be obligated to pay the fees and expenses of more than one counsel for all
parties indemnified by such indemnifying party with respect to such claim, unless in the reasonable judgment of any indemnified party
a conflict of interest may exist between such indemnified party and any other of such indemnified parties with respect to such claim.
No indemnifying party shall, without the consent of the indemnified party, consent to the entry of any judgment or enter into any settlement
which cannot be settled in all respects by the payment of money (and such money is so paid by the indemnifying party pursuant to the terms
of such settlement) or which settlement includes a statement or admission of fault and culpability on the part of such indemnified party
or which does not include as an unconditional term thereof the giving by the claimant or plaintiff to such indemnified party of a release
from all liability in respect to such claim or litigation.
(e) The
indemnification provided for under this Subscription Agreement shall remain in full force and effect regardless of any investigation made
by or on behalf of the indemnified party or any officer, director or controlling person or entity of such indemnified party and shall
survive the transfer of securities.
(f) If
the indemnification provided under this Section 7 from the indemnifying party is unavailable or insufficient to hold harmless an
indemnified party in respect of any Losses with respect to which such indemnified party is entitled to indemnification hereunder, then
the indemnifying party, in lieu of indemnifying the indemnified party, shall contribute to the amount paid or payable by the indemnified
party as a result of such Losses in such proportion as is appropriate to reflect the relative fault of the indemnifying party and the
indemnified party, as well as any other relevant equitable considerations; provided, however, the liability of the Subscriber shall be
limited to the net proceeds received by such Subscriber from the sale of Registrable Securities giving rise to such indemnification obligation.
The relative fault of the indemnifying party and indemnified party shall be determined by reference to, among other things, whether any
action in question, including any untrue or alleged untrue statement of a material fact or omission or alleged omission to state a material
fact, was made by (or not made by, in the case of an omission), or relates to information supplied by (or not supplied by, in the case
of an omission), or on behalf of such indemnifying party or indemnified party, and the indemnifying party’s and indemnified party’s
relative intent, knowledge, access to information and opportunity to correct or prevent such action. The amount paid or payable by a party
as a result of the Losses shall be deemed to include, subject to the limitations set forth in this Section 7, any legal or other
fees, charges or expenses reasonably incurred by such party in connection with any investigation or proceeding. No person guilty of fraudulent
misrepresentation (within the meaning of Section 11(f) of the Securities Act) shall be entitled to contribution pursuant to
this Section 7(f) from any person or entity who was not guilty of such fraudulent misrepresentation. Notwithstanding anything
to the contrary herein, in no event will any party be liable for punitive damages in connection with this Subscription Agreement or the
transactions contemplated hereby.
8. Termination.
This Subscription Agreement shall terminate and be void and of no further force and effect, and all rights and obligations of the parties
hereunder shall terminate without any further liability on the part of any party in respect thereof, upon the earlier to occur of: (a) the
mutual written agreement of each of the parties hereto to terminate this Subscription Agreement, with the prior written consent of the
Target not to be unreasonably withheld, delayed or conditioned (which the parties hereto expressly acknowledge and agree, is an express
third-party beneficiary of this Section 8(a)); (b) such date and time as the Merger Agreement is terminated in accordance with
its terms; or (c) September 22, 2023 (other than as a result of a breach by the Subscriber of its obligations hereunder); provided
that (i) nothing herein will relieve any party from liability for any willful breach hereof prior to the time of termination, and
each party will be entitled to any remedies at law or in equity to recover losses, liabilities or damages arising from such breach. The
Company shall notify the Subscriber of the termination of the Merger Agreement promptly after the termination of such agreement and (ii) the
provisions of Sections 9 through 11 will survive any termination of this Subscription Agreement and continue indefinitely.
9. Trust
Account Waiver. The Subscriber hereby represents and warrants that it has read the SEC Reports,
including the final prospectus of the Company, dated as of December 17, 2020 and filed with the Commission (File Nos. 333-251037
and 333-251451), and understands that the Company has established a trust account (the “Trust Account”) containing
the proceeds of its initial public offering (the “IPO”) and the overallotment shares acquired by its underwriters and
from certain private placements occurring simultaneously with the IPO (including interest accrued from time to time thereon) for the benefit
of the Company’s public stockholders (including overallotment shares acquired by the Company’s underwriters, the “Public
Stockholders”). For and in consideration of the Company entering into this Subscription Agreement, and for other good and valuable
consideration, the receipt and sufficiency of which is hereby acknowledged, the Subscriber hereby agrees that notwithstanding anything
to the contrary contained in this Subscription Agreement, the Subscriber does not now and shall not at any time hereafter have, and waives
any and all right, title and interest, or any claims of any kind it has or may have in the future as a result of, or arising out of, this
Subscription Agreement, the transactions contemplated hereby or the Company Shares, in or to any monies held in the Trust Account (or
any distributions therefrom directly or indirectly to Public Stockholders (“Public Distributions”)), and agrees not
to seek recourse or make or bring any action, suit, claim or other proceeding against the Trust Account or Public Distributions as a result
of, or arising out of, this Subscription Agreement, the transactions contemplated hereby or the Company Shares, regardless of whether
such claim arises based on contract, tort, equity or any other theory of legal liability. To the extent the Subscriber commences any action
or proceeding based upon, in connection with, as a result of or arising out of, this Subscription Agreement, the transactions contemplated
hereby or the Company Shares, which proceeding seeks, in whole or in part, monetary relief against the Company or its representatives,
the Subscriber hereby acknowledges and agrees that the Subscriber’s sole remedy shall be against funds held outside of the Trust
Account (other than Public Distributions) and that such claim shall not permit the Subscriber (or any person claiming on its behalf or
in lieu of any of it) to have any claim against the Trust Account (including any distributions therefrom) or any amounts contained therein.
Notwithstanding anything else in this Section 9 to the contrary, nothing herein shall be deemed to limit the Subscriber’s right,
title, interest or claim to the Trust Account by virtue of the Subscriber’s record or beneficial ownership of Common Stock acquired
by any means other than pursuant to this Subscription Agreement, including but not limited to any redemption right with respect to any
such securities of the Company.
10. Miscellaneous.
(a) Transferability.
Neither this Subscription Agreement nor any rights that may accrue to the Subscriber hereunder (other than the Company Shares acquired
hereunder, if any, subject to applicable securities laws and the rights set forth in Section 7) may be transferred or assigned by
the Subscriber without the prior written consent of the Company, and any purported transfer or assignment without such consent shall be
null and void ab initio. Notwithstanding the foregoing, prior to the Closing the Subscriber may assign all of its rights and obligations
under this Subscription Agreement to an affiliate of the Subscriber, or to any fund or account managed by the same investment manager
as the Subscriber, that is an Accredited Investor or an Institutional Account, so long as the Subscriber provides the Company with at
least five (5) Business Days’ prior written notice of such assignment and a completed Investor Questionnaire duly executed
by such assignee; provided, further that (i) such assignee will be deemed to have made to the Company each of the representations,
warranties and covenants of the Subscriber set forth in Section 5 as of the date of such assignment and as of the Closing Date, and
(ii) no such assignment by the Subscriber will relieve the Subscriber of its obligations under this Subscription Agreement, and the
Subscriber will remain secondarily liable under this Subscription Agreement for the obligations of the assignee hereunder.
(b) Company
Reliance. The Subscriber acknowledges that the Company, the Placement Agent, the Target and others will rely on the acknowledgments,
understandings, agreements, representations and warranties of the Subscriber contained in this Subscription Agreement, provided, however,
that the Closing may only be enforced against the Subscriber by the Company. Prior to the Closing, the Subscriber agrees to promptly notify
the Company if any of the acknowledgments, understandings, agreements, representations and warranties set forth herein are no longer accurate
in any material respect.
(c) Survival.
All the agreements, representations and warranties made by each party hereto in this Subscription Agreement shall survive the Closing.
(d) Amendments
and Waivers. This Subscription Agreement may not be amended, modified or waived except by an instrument in writing, signed by the
party against whom enforcement of such amendment, modification or waiver is sought. Section 4, Section 5, this Section 10(d),
Section 10(n) and Section 11 of this Subscription Agreement may not be amended, modified, terminated or waived in any manner
that is material and adverse to the Placement Agent without the written consent of the Placement Agent.
(e) Entire
Agreement. This Subscription Agreement constitutes the entire agreement, and supersedes all other prior agreements, understandings,
representations and warranties, both written and oral, among the parties, with respect to the subject matter hereof (other than any confidentiality
agreement entered into by the Company and the Subscriber in connection with the Offering).
(f) Successors
and Assigns. This Subscription Agreement shall be binding upon, and inure to the benefit of the parties hereto, the Target, solely
as an express third-party beneficiary of Section 8(a) and their heirs, executors, administrators, successors, legal representatives,
and permitted assigns, and the agreements, representations, warranties, covenants and acknowledgments contained herein shall be deemed
to be made by, and be binding upon, such heirs, executors, administrators, successors, legal representatives and permitted assigns.
(g) Severability.
If any provision of this Subscription Agreement shall be invalid, illegal or unenforceable, the validity, legality or enforceability of
the remaining provisions of this Subscription Agreement shall not in any way be affected or impaired thereby and shall continue in full
force and effect.
(h) Counterparts.
This Subscription Agreement may be executed in one or more counterparts (including by facsimile or electronic mail or in .pdf) and by
different parties in separate counterparts, with the same effect as if all parties hereto had signed the same document. All counterparts
so executed and delivered shall be construed together and shall constitute one and the same agreement.
(i) Specific
Performance. The parties hereto agree that irreparable damage would occur in the event that any of the provisions of this Subscription
Agreement were not performed in accordance with their specific terms or were otherwise breached. It is accordingly agreed that the parties
shall be entitled to an injunction or injunctions to prevent breaches of this Subscription Agreement and to enforce specifically the terms
and provisions of this Subscription Agreement, this being in addition to any other remedy to which such party is entitled at law, in equity,
in contract, in tort or otherwise. The parties hereto acknowledge and agree that the Company shall be entitled to specifically enforce
the Subscriber’s obligations to fund the Subscription and the provisions of the Subscription Agreement, in each case, on the terms
and subject to the conditions set forth herein. The parties hereto further acknowledge and agree: (i) to waive any requirement for
the security or posting of any bond in connection with any such equitable remedy; (ii) not to assert that a remedy of specific enforcement
pursuant to this Section 10(i) is unenforceable, invalid, contrary to applicable law or inequitable for any reason; and (iii) to
waive any defenses in any action for specific performance, including the defense that a remedy at law would be adequate.
(j) JURY
TRIAL. THIS SUBSCRIPTION AGREEMENT SHALL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH, THE LAWS OF THE STATE OF DELAWARE, WITHOUT
REGARD TO THE PRINCIPLES OF CONFLICTS OF LAWS THAT WOULD OTHERWISE REQUIRE THE APPLICATION OF THE LAW OF ANY OTHER STATE. EACH PARTY HERETO
HEREBY WAIVES ANY RIGHT TO A JURY TRIAL IN CONNECTION WITH ANY LITIGATION PURSUANT TO THIS SUBSCRIPTION AGREEMENT AND THE TRANSACTIONS
CONTEMPLATED HEREBY.
(k) Notices.
All notices, consents, waivers and other communications hereunder shall be in writing and shall be deemed to have been duly given (i) when
delivered in person, (ii) when delivered by email, with affirmative confirmation of receipt, (iii) one (1) Business Day
after being sent, if sent by reputable, internationally recognized overnight courier service or (iv) three (3) Business Days
after being mailed, if sent by registered or certified mail, prepaid and return receipt requested, in each case to the applicable party
at the addresses set forth on the applicable signature pages hereto.
(l) Headings
and Certain Defined Terms. The headings set forth in this Subscription Agreement are for convenience of reference only and shall not
be used in interpreting this Subscription Agreement. In this Subscription Agreement, unless the context otherwise requires: (i) whenever
required by the context, any pronoun used in this Subscription Agreement shall include the corresponding masculine, feminine or neuter
forms, and the singular form of nouns, pronouns and verbs shall include the plural and vice versa; (ii) “including” (and
with correlative meaning “include”) means including without limiting the generality of any description preceding or succeeding
such term and shall be deemed in each case to be followed by the words “without limitation”; and (iii) the words “herein”,
“hereto” and “hereby” and other words of similar import in this Subscription Agreement shall be deemed in each
case to refer to this Subscription Agreement as a whole and not to any particular portion of this Subscription Agreement. As used in this
Subscription Agreement, the term: (x) “person” shall refer to any individual, corporation, partnership, trust, limited
liability company or other entity or association, including any governmental or regulatory body, whether acting in an individual, fiduciary
or any other capacity; (y) “affiliate” shall mean, with respect to any specified person, any other person or group of
persons acting together that, directly or indirectly, through one or more intermediaries controls, is controlled by or is under common
control with such specified person (where the term “control” (and any correlative terms) means the possession, direct or indirect,
of the power to direct or cause the direction of the management and policies of such person, whether through the ownership of voting securities,
by contract or otherwise); and (z) “representative” with respect to any person shall mean such person’s affiliates
and its and its affiliate’s respective directors, officers, employees, consultants, advisors, agents and other representatives.
(m) Further
Assurances. At Closing, the parties hereto shall execute and deliver such additional documents and take such additional actions as
the parties may reasonably deem practical and necessary in order to consummate the Offering as contemplated by this Subscription Agreement.
(n) Third-Party
Beneficiary. The parties hereto agree that the Placement Agent is an express third-party beneficiary of the representations, warranties
and covenants of the Company contained in Section 4, the representations, warranties and convents of the Subscriber contained in
Section 5, and its express rights set forth in Section 10(f) and this Section 10(n). The parties further agree that
the Target is an express third-party beneficiary of the provisions of Section 8(a).
(o) Share
Adjustment. If any change in the number, type or classes of authorized shares of the Company (including the Company Shares), other
than as contemplated by the Merger Agreement (as may be amended from time to time) or any agreement contemplated by the Transaction, shall
occur between the date hereof and immediately prior to the Closing by reason of reclassification, recapitalization, stock split (including
reverse stock split) or combination, exchange or readjustment of shares, or any stock dividend, the number of Preferred Shares issued
to the Subscriber shall be appropriately adjusted to reflect such change.
11. Non-Reliance
and Exculpation. The Subscriber acknowledges that it is not relying upon, and has not relied
upon, any statement, representation or warranty made by any person other than the statements, representations and warranties contained
in this Subscription Agreement in making its investment or decision to invest in the Company. The Subscriber agrees that neither (i) any
Other Subscriber pursuant to the Other Subscription Agreements (including the controlling persons, members, officers, directors, partners,
agents, or employees of any such Other Subscriber) nor (ii) the Placement Agent, its affiliates or any of its affiliates’ control
persons, officers, directors, employees or other representatives, shall be liable to the Subscriber pursuant to this Subscription Agreement
for any action heretofore or hereafter taken or omitted to be taken by any of them in connection with the purchase of the Preferred Shares.
The Subscriber acknowledges that neither the Placement Agent nor its representatives: (a) shall be liable to the Subscriber for any
improper payment made in accordance with the information provided by the Company; (b) make any representation or warranty, or have
any responsibilities as to the validity, accuracy, value or genuineness of any information, certificates or documentation delivered by
or on behalf of the Company pursuant to this Subscription Agreement or the Merger Agreement (together with any related documents, the
“Transaction Documents”); or (c) shall be liable to the Subscriber (whether in tort, contract or otherwise) (x) for
any action taken, suffered or omitted by any of them in good faith and reasonably believed to be authorized or within the discretion or
rights or powers conferred upon it by this Subscription Agreement or any Transaction Document or (y) for anything which any of them
may do or refrain from doing in connection with this Subscription Agreement or any Transaction Document, except for their gross negligence,
willful misconduct or bad faith.
{SIGNATURE PAGES FOLLOW}
IN WITNESS WHEREOF, the parties hereto have caused
this Subscription Agreement to be duly executed as of the below date on which the Subscription is accepted by the Company:
|
MEDTECH ACQUISITION CORPORATION |
|
|
|
|
|
By: |
|
|
|
Name: |
David Matlin |
|
|
Title: |
Chief Financial Officer |
|
|
Date: |
|
Address
for Notice:
48 Maple Avenue
Greenwich,
CT 06830
Attn: David Matlin
Email: matlin@mpasset.com
with a copy (which will not constitute notice) to:
Foley & Lardner LLP
100 N. Tampa Street, Suite 2700
Tampa, FL 33602
Attn: Kevin M. Shuler
Email: kshuler@foley.com
Cooley LLP
10265 Science Center Dr.
San Diego, California 92121
Attn: Matthew Browne
Email: mbrowne@cooley.com
{SUBSCRIBER SIGNATURE PAGE TO THE MTAC SUBSCRIPTION
AGREEMENT}
IN WITNESS WHEREOF, the undersigned has personally
executed this Subscription Agreement, or otherwise caused this Subscription Agreement to be duly executed by its authorized signatory,
as of the date forth below.
Signature
of Subscriber or Authorized Signatory of Subscriber: |
|
Name of Authorized Signatory: |
|
|
|
Title of Authorized Signatory: |
|
Address for Notice to Subscriber: |
|
Address for Delivery of Preferred Shares to Subscriber (if not same
as address for notice):
Subscription
Amount: $__________________ |
|
Number of Preferred Shares: |
|
|
Exhibit A
Certificate of Designations
CERTIFICATE OF DESIGNATIONS, PREFERENCES AND
RIGHTS OF
SERIES A CONVERTIBLE PREFERRED STOCK
OF TRISALUS LIFE SCIENCES, INC.
Pursuant to Section 151 of the
General Corporation Law of the State of Delaware
The undersigned, pursuant to the provisions of Section 151 of
the General Corporation Law of the State of Delaware (the “DGCL”), does hereby certify that, pursuant to the authority
expressly vested in the Board of Directors of TriSalus Life Sciences, Inc., a Delaware corporation (the “Corporation”),
by the Second Amended and Restated Certificate of Incorporation of the Corporation, the Board of Directors has by resolution duly provided
for the issuance of and created a series of preferred stock of the Corporation, par value $0.0001 per share, and in order to fix the
designation and amount and the voting powers, preferences and relative, participating, optional and other special rights, and the qualifications,
limitations and restrictions, of such series of preferred stock, has duly adopted resolutions setting forth such rights, powers and preferences,
and the qualifications, limitations and restrictions thereof, of such series of preferred stock as set forth in this Certificate of Designations,
Preferences and Rights of Series A Convertible Preferred Stock (this “Certificate of Designations”). This Certificate
of Designations will be effective as of [●], 2023.
Section 1.
Number of Shares and Designation. [●] shares of preferred stock of the Corporation shall constitute a series of preferred
stock designated as Series A Convertible Preferred Stock (the “Preferred Stock”). The number of shares of Preferred
Stock may be increased (to the extent of the Corporation’s authorized and unissued preferred stock) by further resolution duly
adopted by the Board of Directors and the filing of a certificate of increase with the Secretary of State of the State of Delaware.
Section 2.
Rank. Each share of Preferred Stock shall rank equally in all respects and shall be subject to the provisions herein. The
Preferred Stock shall, with respect to payment of dividends, rights (including as to the distribution of assets) upon liquidation, dissolution
or winding up of the affairs of the Corporation, or otherwise (i) rank senior to the Corporation’s common stock, par
value $0.0001 per share (the “Common Stock”), and any other class or series of equity securities of the Corporation,
hereafter created, that by its terms does not expressly rank senior to, or on parity with, the Preferred Stock as to payment of dividends
or rights (including as to the distribution of assets) upon liquidation, dissolution or winding up of the affairs of the Corporation,
or otherwise (all of such equity securities, including the Common Stock, are collectively referred to herein as “Junior Securities”),
(ii) rank junior to any class or series of equity securities of the Corporation, hereafter created without violation of this
Certificate of Designations, that by its terms expressly ranks senior to the Preferred Stock as to payment of dividends or rights (including
as to the distribution of assets) upon liquidation, dissolution or winding up of the affairs of the Corporation, or otherwise (all of
such equity securities are collectively referred to herein as “Senior Securities”), and (iii) rank on
parity with any class or series of equity securities of the Corporation, hereafter created without violation of this Certificate of Designations,
that expressly provides that it ranks pari passu with the Preferred Stock as to payment of dividends or rights (including as to
the distribution of assets) upon liquidation, dissolution or winding up of the affairs of the Corporation (all of such equity securities
are collectively referred to herein as “Parity Securities”). The respective definitions of Junior Securities, Senior
Securities and Parity Securities shall also include any securities, rights or options exercisable or exchangeable for or convertible
into any of the Junior Securities, Senior Securities or Parity Securities, as the case may be.
Section 3.
Definitions.
(a) As used herein, the following terms shall have the meanings
set forth below or in the section cross-referenced below, as applicable, whether used in the singular or the plural:
“10-Day VWAP” means the average of the daily VWAP
of the Common Stock for each Trading Day in the ten (10)-Trading Day period immediately prior to, but excluding, the applicable determination
date.
“Accrued Dividend Fundamental Transaction Shares”
has the meaning set forth in Section 7(g)(i).
“Accrued Dividends” means, as of any date, with
respect to any share of Preferred Stock, all dividends that have accrued pursuant to Section 4(a)(ii) but that have
not been paid as of such date.
“Actual Dividend PIK Payment Shares” has the meaning
set forth in Section 4(a)(iii).
“Affiliate” means, with respect to any Person,
any other Person directly or indirectly controlling, controlled by or under common control with, such Person.
“Alternate Consideration”
has the meaning set forth in Section 7(g).
“Annual Dividend Payment Date” means [●]1
of each year (each, an “Anniversary Date”), commencing on the first Anniversary Date immediately following the
Original Issuance Date; provided, that if any such Anniversary Date is not a Business Day then the “Annual Dividend Payment
Date” shall be the next Business Day immediately following such Anniversary Date.
“Annual Dividend Payment Record Date” has the meaning
set forth in Section 4(a)(iv).
“Annual Dividends” has the meaning set forth in
Section 4(a)(ii).
“Beneficially Own” and “Beneficial Ownership”
has the meaning given such term in Rule 13d-3 under the Exchange Act, and a Person’s beneficial ownership of Capital Stock
shall be calculated in accordance with the provisions of such rule, but without taking into account any contractual restrictions or limitations
on voting or other rights; provided, however, that for purposes of determining beneficial ownership, a Person shall be
deemed to be the beneficial owner of any security which may be acquired by such Person, whether within sixty (60) days or thereafter,
upon the conversion, exchange or exercise of any warrants, options, rights or other securities.
“Board of Directors” means the board of directors
of the Corporation or any committee thereof duly authorized to act on behalf of such board of directors for the purposes in question.
“Business Day” means any day that is not a Saturday,
a Sunday or any other day on which commercial banks are generally required or authorized by law to be closed in New York City, New York.
“Buy-In” has the meaning set forth in Section 6(b)(vi).
“By-laws” means the Amended and Restated By-Laws
of the Corporation, as amended from time to time.
“Capital Stock” of any Person means any and all
shares, interests (including partnership interests), rights to purchase, warrants, options, participations or other equivalents of or
interests in (however designated) equity of such Person, including any preferred stock, but excluding any debt securities convertible
into such equity.
“Certificate of Designations” has the meaning set
forth in the preamble.
“Certificate of Incorporation” means the Second
Amended and Restated Certificate of Incorporation of the Corporation, as amended from time to time.
“Close of Business” means 5:00 p.m., New York City
time.
“Common Stock” has the meaning set forth in Section 2.
“Common Stock Dividend Record Date” has the meaning
set forth in Section 4(a)(iv).
1 NTD: To include anniversary of closing date (MM/DD).
“control” (including the terms “controlling”,
“controlled by” and “under common control with”), with respect to the relationship between or among
two or more Persons, means the possession, directly or indirectly, of the power to direct or cause the direction of the affairs or management
of a Person, whether through the ownership of voting securities, as trustee or executor, by contract or otherwise.
“Conversion Date” has the meaning set forth in
Section 6(b)(iii).
“Conversion Notice” has the meaning set forth in
Section 6(b)(i).
“Conversion Price” means, as of any date, the Initial
Conversion Price, as adjusted pursuant to Section 7.
“Conversion Right” has the meaning set forth in
Section 6(a)(i).
“Convertible Securities” means indebtedness or
shares of Capital Stock convertible into or exchangeable for Common Stock.
“Corporation” has the meaning set forth in the
preamble.
“DGCL” has the meaning set forth in the preamble.
“Dividend PIK Amount” has the meaning set forth
in Section 4(a)(iii).
“Dividend Rate” has the meaning set forth in Section 4(a)(ii).
“Exchange Act” means the Securities Exchange Act
of 1934, as amended from time to time, and the rules and regulations promulgated thereunder.
“Ex-Date” means, when used with respect to any
distribution, the first date on which the Common Stock or other securities in question do not have the right to receive the distribution
giving rise to an adjustment to the Conversion Price.
“Floor Price” means an amount equal to [●]2.
“Fundamental Transaction” means, at
any time while the Preferred Stock is outstanding, any transaction whereby:
(i) the
Corporation, directly or indirectly, in one or more related transactions effects any merger or consolidation or other similar business
combination of the Corporation with or into another Person, in each case, pursuant to which the Common Stock will be converted
into, or exchanged for, cash, securities or other property of the Corporation or another Person;
(ii) the
Corporation, directly or indirectly, effects any sale, lease, license, assignment, transfer, conveyance or other disposition (including
in connection with any Liquidation) of all or substantially all of its assets in one or a series
of related transactions;
(iii) any,
direct or indirect, purchase offer, tender offer or exchange offer (whether by the Corporation or another Person) is completed pursuant
to which holders of Common Stock are permitted to sell, tender or exchange their shares for other securities, cash or property and has
been accepted by the holders of 50% or more of the outstanding Common Stock;
2 NTD: This will be equal to the greater of (i) $2.00
or (ii) twenty percent (20%) of the highest Minimum Price (as defined in Nasdaq Listing Rule 5635(d)) calculation made with respect to
MTAC’s Class A Common Stock, as determined based on the respective dates that Subscription Agreement(s) are executed and delivered
by MTAC (if such agreements are executed on different dates).
(iv) the
Corporation, directly or indirectly, in one or more related transactions effects any reclassification, reorganization or recapitalization
of the Common Stock or any compulsory share exchange pursuant to which the Common Stock is effectively converted into or exchanged for
other securities, cash or property; or
(v) the
Corporation, directly or indirectly, in one or more related transactions consummates a stock or share purchase agreement or other business
combination (including, without limitation, a reorganization, recapitalization, spin-off or scheme of arrangement) with another
Person whereby such other Person acquires more than 50% of the outstanding shares of Common Stock (not including any shares of Common
Stock held by the other Person or other Persons making or party to, or associated or affiliated with the other Persons making or party
to, such stock or share purchase agreement or other business combination).
“Fundamental Transaction Date” has the meaning
set forth in Section 7(g).
“Holder” means, at any time, any Person in whose
name shares of Preferred Stock are registered, which may be treated by the Corporation as the absolute owner of such shares of Preferred
Stock for the purpose of making payment and settling the related conversions and for all other purposes.
“Initial Conversion Price” means with respect to
each share of Preferred Stock, $10.00 per share.
“Issuance Date” means, with respect to a share
of Preferred Stock, the date of issuance of such share of Preferred Stock.
“Junior Securities” has the meaning set forth in
Section 2.
“Liquidation” means the voluntary or involuntary
liquidation, dissolution or winding up of the Corporation.
“Liquidation Preference” means, with respect to
each share of Preferred Stock, $10.00 per share, as adjusted for any stock dividend, stock split,
reverse stock split, combination or similar event affecting the Preferred Stock.
“NASDAQ” means The Nasdaq Stock Market LLC (or
its successor).
“Options” means rights, options or warrants to
subscribe for, purchase or otherwise acquire Common Stock or Convertible Securities.
“Original Issuance Date” means [●], 2023.
“Parity Securities” has the meaning set forth in
Section 2.
“Participating Dividends” has the meaning set forth
in Section 4(a)(i).
“Payment Period” means, with respect to a share
of Preferred Stock, the period beginning on the day after the preceding Annual Dividend Payment Date (or if no Annual Dividend Payment
Date has occurred since the Issuance Date of such share of Preferred Stock, the Issuance Date) to and including the next Annual Dividend
Payment Date; provided that, for the purpose of determining the amount of Accrued Dividends for any Payment Period, the Payment
Period shall be calculated based on the actual number of days elapsed during such Payment Period on either an actual 365-or 366-day year,
as applicable.
“Person” means an individual, entity or group (within
the meaning of Section 13(d)(3) or 14(d)(2) of the Exchange Act).
“Preferred Stock” has the meaning set forth in
Section 1.
“Register” means the securities register maintained
in respect of the Preferred Stock by the Transfer Agent.
“Securities Act” means the Securities Act of 1933,
as amended.
“Senior Securities” has the meaning set forth in
Section 2.
“Share Delivery Date” has the meaning set forth
in Section 6(b)(ii).
“Subsidiary” or “Subsidiaries”
means, with respect to any Person, any other Person of which (i) if a corporation, a majority of the total voting power of
shares of capital stock entitled (without regard to the occurrence of any contingency) to vote in the election of directors thereof is
at the time owned or controlled, directly or indirectly, by that Person or one or more of the other Subsidiaries of that Person or a
combination thereof, or (ii) if a limited liability company, partnership, association or other business entity (other than
a corporation), a majority of partnership or other similar ownership interest thereof is at the time owned or controlled, directly or
indirectly, by that Person or one or more other Subsidiaries of that Person or a combination thereof and for this purpose, a Person or
Persons owns a majority ownership interest in such a business entity (other than a corporation) if such Person or Persons shall be allocated
a majority of such business entity’s gains or losses or shall be or control any managing director or general partner of such business
entity (other than a corporation). For the purposes hereof, the term “Subsidiary” shall include all Subsidiaries of such
Subsidiary.
“Threshold Amount” means 19.90% of the number of
shares of Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock pursuant to an applicable
Conversion Notice.
“Trading Day” means a day on which the NASDAQ is
open for the transaction of business.
“Transfer Agent” means, Continental Stock Transfer &
Trust Company, the current transfer agent of the Corporation, with a mailing address of 1 State Street 30th Floor, New York, NY 10004
and an email address of cstmail@continentalstock.com and any successor transfer agent of the Corporation.
“VWAP” means, for any date, if the Common Stock
is then listed or quoted on the NASDAQ (or its successor) or another U.S. national securities exchange, the per share daily volume weighted
average price of the Common Stock for such date (or the nearest preceding date) on the NASDAQ (or its successor) or another U.S. national
securities exchange on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (or, if Bloomberg ceases to publish
such price, any successor service reasonably chosen by the Corporation) (based on a Trading Day from 9:30 a.m. (New York City time)
to 4:02 p.m. (New York City time)) (or if such volume weighted average price is unavailable, the market price of one share of the
Common Stock on such Trading Day determined, using a volume-weighted average method, by a nationally recognized investment banking firm
retained for this purpose by the Corporation).
(b) In addition to the above definitions, unless the context
requires otherwise:
(i) any reference to any statute, regulation, rule or
form as of any time shall mean such statute, regulation, rule or form as amended or modified and shall also include any successor
statute, regulation, rule or form from time to time;
(ii) the word “including” shall be deemed
to be followed by the words “without limitation”;
(iii) references to “$” or “dollars”
means the lawful coin or currency the United States of America; and
(iv) references to “Section” are references
to Sections of this Certificate of Designations.
Section 4.
Dividends.
(a) Holders of the issued and outstanding shares of Preferred
Stock shall be entitled to receive, out of the assets of the Corporation legally available for the payment of dividends, dividends on
the terms described below:
(i) Holders of shares of Preferred Stock
shall be entitled to participate equally and ratably with the holders of shares of Common Stock in all dividends paid on the shares of
Common Stock (other than dividends paid in the form of Common Stock, Convertible Securities or Options) as if immediately prior to each
Common Stock Dividend Record Date, all shares of Preferred Stock then outstanding were converted into shares of Common Stock. Dividends
payable pursuant to this Section 4(a)(i) (the “Participating Dividends”) shall be payable on the
same date that such dividends are payable to holders of shares of Common Stock, and no dividends shall be payable to holders of shares
of Common Stock unless the full dividends contemplated by this Section 4(a)(i) are paid at the same time to the Holders
of the Preferred Stock.
(ii) In addition to any dividends pursuant
to Section 4(a)(i), the Corporation shall pay, subject to Section 4(c), if, as and when declared by the Board
of Directors, out of funds of the Corporation legally available therefor, on each Annual Dividend Payment Date for the applicable Payment
Period or Payment Periods dividends on each outstanding share of Preferred Stock (the “Annual Dividends”) at a rate
per annum (calculated on the basis of an actual 365- or 366-day year, as applicable) equal to 8.00% of the Liquidation Preference
per share of Preferred Stock (the “Dividend Rate”), payable in accordance with Section 4(a)(iii) below.
Subject to Section 4(c), Annual Dividends shall accrue and accumulate on a daily basis from the Issuance Date of such share,
whether or not declared and whether or not the Corporation has funds legally available for the payment of such dividends and shall be
payable annually in arrears, if, as and when so authorized and declared by the Board of Directors, on each Annual Dividend Payment Date,
commencing on the first Annual Dividend Payment Date following the Issuance Date of such share. Accrued Dividends, to the extent unpaid,
shall in all cases be payable upon a Liquidation pursuant to Section 5, upon a conversion of the Preferred Stock following
a Fundamental Transaction pursuant to Section 7(g)(i), or upon any conversion of the Preferred Stock pursuant to Section 6(a)(i) or
Section 6(a)(ii). Annual Dividend payments shall be aggregated per Holder and shall be made to the nearest cent (with $0.005
being rounded upward).
(iii) The Annual Dividends may, at the option
of the Corporation in its sole discretion, be paid (A) in cash, (B) by delivery of shares of Common Stock, or (C) by delivery
of any combination of cash and shares of Common Stock; provided that, if the Corporation elects to pay all or any part of the
total amount of an Annual Dividend in shares of Common Stock (such amount with respect to any Annual Dividend Payment Date, the “Dividend
PIK Amount”), the number of shares of Common Stock to be delivered shall be determined by dividing the Dividend PIK Amount
by the 10-Day VWAP with respect to such Annual Dividend Payment Date; provided that, where the Corporation has determined in its
sole discretion to pay a Dividend PIK Amount, if the 10-Day VWAP with respect to such Annual Dividend Payment Date is less than
the Floor Price, (A) the number of shares of Common Stock that are permitted to be delivered in partial payment of the Dividend
PIK Amount (the “Actual Dividend PIK Payment Shares”) shall be calculated by dividing (v) the Dividend PIK Amount
by (w) the Floor Price and (B) the portion of the Annual Dividend that is not paid by delivery of the Actual Dividend PIK Payment
Shares shall be payable in cash, which amount shall be calculated as (x) the total Dividend PIK Amount less (y)(i) the product
of the Actual Dividend PIK Payment Shares multiplied by (ii) the 10-Day VWAP.
(iv) Each Participating Dividend or Annual
Dividend shall be paid pro rata to the Holders of shares of Preferred Stock entitled thereto. Each Participating Dividend or Annual Dividend
shall be payable to the Holders of Preferred Stock as they appear on the Register at the Close of Business on the record date designated
by the Board of Directors for such dividends, which (i) with respect to Participating Dividends, shall be the same day as
the record date for the payment of dividends to the holders of shares of Common Stock (the “Common Stock Dividend Record Date”),
and (ii) with respect to Annual Dividends, shall be not more than thirty (30) days nor less than ten (10) days preceding
the applicable Annual Dividend Payment Date (such date, an “Annual Dividend Payment Record Date”).
(b) Without the consent of the Holders representing at least
a majority of the then-issued and outstanding shares of Preferred Stock, the Corporation shall not (i) declare, pay or set
aside for payment any dividends or distributions upon any Junior Securities or (ii) repurchase, redeem or otherwise acquire
any Junior Securities (other than repurchases, redemptions or acquisitions of shares of Junior Securities with respect to equity awards
(including in connection with “cashless” or “net” exercises of Options, payment of the exercise or purchase price
of Options, or to satisfy tax withholding obligations due as a result of the exercise of Options or delivery of equity awards) under
any equity incentive plan or similar arrangements of the Corporation or its Subsidiaries) for any consideration or pay any moneys or
make available for a sinking fund for the redemption of any shares of such Junior Securities, unless, in each case, (A) immediately
before and after the taking of such action, the fair value of the Corporation’s assets would exceed the sum of its debts (including
for this purpose the aggregate Liquidation Preference and the aggregate Accrued Dividends of the Preferred Stock), (B) immediately
after the taking of such action, the Corporation, in its good faith judgment, would be able to pay all of its debts (including the aggregate
Liquidation Preference and the aggregate Accrued Dividends of the Preferred Stock) as they are reasonably expected to come due and (C) such
action is otherwise in compliance with applicable law.
(c) If the Fundamental Transaction Date or Conversion Date of
any share of Preferred Stock is after an Annual Dividend Payment Record Date for a declared Annual Dividend on the Preferred Stock but
occurs on or prior to the next Annual Dividend Payment Date, then the Holder of such share at the Close of Business on such Annual Dividend
Payment Record Date will be entitled, notwithstanding the related Fundamental Transaction or conversion, as applicable, to receive, on
or, at the Corporation’s election, before such Annual Dividend Payment Date, such declared Annual Dividend on such share. Except
as provided in this Section 4(c), Annual Dividends on any share of Preferred Stock will cease to accumulate from and after
the Fundamental Transaction Date or Conversion Date, as applicable.
Section 5.
Liquidation Rights.
(a) In the event of any Liquidation, each Holder shall be entitled
to receive liquidating distributions out of the assets of the Corporation legally available for distribution to stockholders of the Corporation,
before any payment or distribution of any assets of the Corporation shall be made or set apart for holders of any Junior Securities,
including the Common Stock, for such Holder’s shares of Preferred Stock in an amount equal to the greater of (i) the
sum of (A) the aggregate Liquidation Preference and (B) the aggregate Accrued Dividends of such shares as of
the date of the Liquidation, and (ii) the amount such Holder would have received had such shares of Preferred Stock, immediately
prior to such Liquidation, been converted into shares of Common Stock pursuant to Section 6, without regard to any of the
limitations on conversion or convertibility contained therein.
(b) In the event the assets of the Corporation available for
distribution to stockholders of the Corporation upon a Liquidation shall be insufficient to pay in full the amounts payable with respect
to all outstanding shares of Preferred Stock pursuant to Section 5(a), such assets, or the proceeds thereof, shall be distributed
among the Holders ratably in proportion to the full respective liquidating distributions to which they would otherwise be respectively
entitled upon such Liquidation.
(c) Neither the sale, conveyance, exchange or transfer (for cash,
shares of stock, securities or other consideration) of all or substantially all of the assets, capital stock or business of the Corporation
(other than in connection with the liquidation, dissolution or winding up of the Corporation) nor the merger, consolidation, share exchange,
statutory exchange or any other business combination transaction of the Corporation into or with any other Person shall by itself be
deemed to be a Liquidation for purposes of this Section 5.
Section 6. Conversion.
(a) Conversion of Preferred Stock.
(i) Optional Conversion. Subject to
and in accordance with the provisions of this Section 6, each Holder of shares of Preferred Stock shall have the right, at
any time and from time to time, at such Holder’s option, to convert all or any portion of such Holder’s shares of Preferred
Stock into fully paid and non-assessable shares of Common Stock (the “Conversion Right” and such shares of Common
Stock are sometimes referred to hereinafter as, the “Conversion Shares”) by providing the Corporation, with the Conversion
Notice (as defined in Section 6(b)(i) below). Upon a Holder’s election to exercise its Conversion Right pursuant
to the Conversion Notice, each share of Preferred Stock for which the Conversion Right is exercised shall be converted into such number
of Conversion Shares equal to the quotient of (A) the sum of (1) the Liquidation Preference and (2) if
the Corporation has not otherwise paid the Accrued Dividends to the Holder, the Accrued Dividends on such share as of the Conversion
Date, divided by (B) the Conversion Price of such share in effect at the time of conversion.
(ii) Automatic Conversion. On the
four year anniversary of the Original Issuance Date, all then outstanding shares of Preferred Stock shall automatically convert into
fully paid and non-assessable shares of Common Stock, with each share of Preferred Stock automatically converted into such number of
shares of Common Stock equal to the quotient of (A) the sum of (1) the Liquidation Preference and (2) if
the Corporation has not otherwise paid the Accrued Dividends to the Holder, the Accrued Dividends on such share as of the Conversion
Date, divided by (B) the Conversion Price of such share in effect at the time of conversion.
(iii) Fractional Shares. No fractional
shares of Common Stock shall be issued upon the conversion of any shares of Preferred Stock. If more than one share of Preferred Stock
subject to conversion is held by the same Holder, the number of full shares of Common Stock issuable upon conversion thereof shall be
computed on the basis of the sum of (A) the aggregate Liquidation Preference and (B) the aggregate Accrued Dividends
as of the Conversion Date on all shares of Preferred Stock so subject for which the Corporation has not otherwise paid such Accrued Dividends.
If the conversion of any share or shares of Preferred Stock results in a fractional share of Common Stock issuable after application
of the immediately preceding sentence, the Corporation shall pay a cash amount in lieu of issuing such fractional share in an amount
equal to the value of such fractional interest multiplied by the 10-Day VWAP of a share of Common Stock determined on the Conversion
Date.
(iv) Reservation of Shares. The Corporation
will at all times reserve and keep available out of its authorized and unissued Common Stock, solely for the purpose of effecting conversions
of the Preferred Stock into shares of Common Stock, a number of shares of Common Stock equal to 100% of the number of shares of Common
Stock then issuable upon conversion of all then outstanding shares of Preferred Stock. The Corporation shall take all action permitted
by applicable law, including calling meetings of stockholders of the Corporation and soliciting proxies for any necessary vote of the
stockholders of the Corporation, to amend the Certificate of Incorporation to increase the number of authorized and unissued shares of
Common Stock, if at any time there shall be insufficient authorized and unissued shares of Common Stock to permit such reservation or
to permit the conversion of all outstanding shares of Preferred Stock. The Corporation covenants that the Preferred Stock and all Common
Stock that may be issued upon conversion of Preferred Stock shall upon issuance be duly authorized, fully paid and non-assessable and
will not be subject to preemptive rights or subscription rights of any other stockholder of the Corporation. The Corporation further
covenants that the Corporation shall, if permitted by the rules of the NASDAQ, at its sole expense, cause to be authorized for listing
or quotation on the NASDAQ, all Common Stock issuable upon conversion of the Preferred Stock, subject to official notice of issuance.
The Corporation will use its reasonable best efforts to ensure that such Common Stock may be issued without violation of any applicable
law or regulation.
(b) Mechanics of Conversion.
(i) The Conversion Right of a Holder of Preferred
Stock shall be exercised by the Holder by delivering written notice to the Corporation, substantially in the form attached hereto as
Annex A, that the Holder elects to convert all or a portion of the shares of Preferred Stock held by such Holder (a “Conversion
Notice”) and specifying the name or names (with address or addresses) in which shares of Common Stock are to be issued and
(if so required by the Corporation or the Corporation’s Transfer Agent) by a written instrument or instruments of transfer in form
reasonably satisfactory to the Corporation or the Transfer Agent, duly executed by the Holder or its legal representative.
(ii) As promptly as practicable after the
receipt of the Conversion Notice, and the payment of required taxes or duties pursuant to Section 10(a), if applicable, and in no
event later than three (3) Trading Days thereafter (the “Share Delivery Date”), the Corporation shall instruct
the Transfer Agent to update the Register to reflect the shares of Common Stock held by such Holder as a result of such conversion and
shall issue and shall deliver or cause to be issued and delivered to such Holder, or to such other Person on such Holder’s written
order (A) evidence of such issuance reasonably satisfactory to such Holder, and (B) cash for any fractional interest in respect
of a share of Common Stock arising upon such conversion settled as provided in Section 6(a)(iii).
(iii) The conversion of any share of Preferred
Stock shall be deemed to have been made in connection with any exercise of the Conversion Right at the Close of Business on the date
of giving the Conversion Notice (the “Conversion Date”). Until the Conversion Date with respect to any share of Preferred
Stock has occurred, such share of Preferred Stock will remain outstanding and will be entitled to all of the powers, designations, preferences
and other rights provided herein, including that such share shall (A) accrue and accumulate Annual Dividends and participate in
Participating Dividends pursuant to Section 4 and (B) entitle the Holder thereof to the voting rights provided in Section 10.
(iv) Corporation’s Obligations to
Issue Common Stock. Subject to Section 6(c), the Corporation’s obligations to issue and deliver shares of Common Stock
upon conversion of shares of Preferred Stock in accordance with the terms hereof are absolute and unconditional, irrespective of any
action or inaction by any Holder to enforce the same, any waiver or consent with respect to any provision hereof, the recovery of any
judgment against any Person or any action to enforce the same, or any setoff, counterclaim, recoupment, limitation or termination, or
any breach or alleged breach by any Holder or any other Person of any obligation to the Corporation or any violation or alleged violation
of law by any Holder or any other Person, and irrespective of any other circumstance which might otherwise limit such obligation of the
Corporation to any Holder in connection with the issuance of such shares of Common Stock.
(v) Failure to Deliver Shares of Common
Stock upon Conversion of Shares of Preferred Stock. If, in the case of any Conversion Notice, the Conversion Shares to be issued
in connection with the Conversion Right are not delivered to the applicable Holder by the Share Delivery Date, in addition to any other
rights herein, the Holder shall be entitled to elect by written notice to the Transfer Agent, on behalf of the Corporation, at any time
on or before its receipt of such Conversion Shares, to rescind such Conversion Notice, in which event the Corporation shall promptly
return to the Holder any certificated Preferred Stock delivered to the Corporation and the Holder shall promptly return to the Corporation
any Conversion Shares issued to such Holder pursuant to the rescinded Conversion Notice.
(vi) Compensation for Buy-In on Failure
to Timely Deliver Conversion Shares Upon Conversion. In addition to any other rights available to the Holder, if the Corporation
fails for any reason to deliver to a Holder the applicable Conversion Shares by the Share Delivery Date pursuant to Section 6(b)(ii) (other
than a failure caused by incorrect or incomplete information provided by the Holder to the Corporation and which the Corporation promptly
provides written notice to the Holder of), and if after such Share Delivery Date such Holder is required by its brokerage firm to purchase
(in an open market transaction or otherwise), or the Holder’s brokerage firm otherwise purchases, shares of Common Stock to deliver
in satisfaction of a sale by such Holder of the Conversion Shares which such Holder was entitled to receive upon the conversion relating
to such Share Delivery Date (a “Buy-In”), then the Corporation shall (A) pay in cash to such Holder (in addition
to any other remedies available to or elected by such Holder) the amount, if any, by which (x) such Holder’s total purchase
price (including any brokerage commissions) for the Common Stock so purchased exceeds (y) the product of (1) the aggregate
number of shares of Common Stock that such Holder was entitled to receive from the conversion at issue multiplied by (2) the actual
sale price at which the sell order giving rise to such purchase obligation was executed (including any brokerage commissions) and (B) at
the option of such Holder, either reissue (if surrendered) the shares of Preferred Stock equal to the number of shares of Preferred Stock
submitted for conversion (in which case, such conversion shall be deemed rescinded) or deliver to such Holder the number of shares of
Common Stock that would have been issued if the Corporation had timely complied with its delivery requirements under Section 6(b)(ii).
For example, if a Holder purchases shares of Common Stock having a total purchase price of $11,000 to cover a Buy-In with respect to
an attempted conversion of shares of Preferred Stock with respect to which the actual sale price of the Conversion Shares (including
any brokerage commissions) giving rise to such purchase obligation was a total of $10,000, under clause (A) of the immediately preceding
sentence, the Corporation shall be required to pay such Holder $1,000. The Holder shall provide the Corporation written notice indicating
the amounts payable to such Holder in respect of the Buy-In and, upon request of the Corporation, evidence of the amount of such loss.
Nothing herein shall limit a Holder’s right to pursue any other remedies available to it hereunder, at law or in equity including,
without limitation, a decree of specific performance and/or injunctive relief with respect to the Corporation’s failure to timely
deliver the Conversion Shares upon conversion of the shares of Preferred Stock as required pursuant to the terms hereof.
(c) NASDAQ Conversion Limits; Solicitation of Stockholder
Approval. Notwithstanding Section 6(a) of this Certificate of Designations, the Corporation shall not be required
to issue any shares of Common Stock to a given Holder upon conversion by such Holder (or its assigns) of any shares of Preferred Stock
to the extent (and only to the extent) that such conversion would result in a given Holder (including its predecessors-in-interest) beneficially
owning a number of shares of Common Stock in excess of the applicable Threshold Amount that has not been approved by the Corporation’s
stockholders (including at any special meeting of the Corporation’s stockholders) in accordance with the stockholder approval requirements
of NASDAQ Marketplace Rule 5635 (or any equivalent rule or requirement of the applicable exchange or automated quotation system
on which the Common Stock is then listed or quoted). In the event that any proposed conversion would be restricted by the foregoing limitation,
the Corporation shall use reasonable best efforts to take any and all actions which may be necessary, including obtaining regulatory,
NASDAQ (or such exchange or automated quotation system on which the Common Stock is then listed) or stockholder approvals, in order that
the Corporation may thereafter validly and legally issue such shares of Common Stock to the given Holder or Holder(s) in compliance
with the applicable listing standards of NASDAQ (or such exchange or automated quotation system on which the Common Stock is then listed).
Section 7.
Adjustments to Conversion Price.
(a) Adjustments to Conversion Price. Except as provided
in Section 7(d), the Conversion Price shall be subject to the following adjustments:
(i) Stock Dividends and Distributions.
If the Corporation declares a dividend or makes a distribution on the Common Stock payable in shares of Common Stock, then the Conversion
Price in effect at the opening of business on the Ex-Date for such dividend or distribution shall be adjusted to the price determined
by multiplying the Conversion Price at the opening of business on such Ex-Date by the following fraction:
OS0
OS1
Where,
OS0 = the number of shares of Common Stock outstanding at the Close
of Business on the Business Day immediately preceding the Ex-Date for such dividend or distribution.
OS1 = the sum of the number of shares of Common Stock outstanding
at the Close of Business on the Business Day immediately preceding the Ex-Date for such dividend or distribution plus the total number
of shares of Common Stock constituting such dividend or distribution.
If any dividend or distribution described in this Section 7(a)(i) is
declared but not so paid or made, the Conversion Price shall be readjusted, effective as of the date and time the Board of Directors
determines not to make such dividend or distribution, to such Conversion Price that would be in effect if such dividend or distribution
had not been declared.
(ii) Subdivisions, Splits and Combination
of the Common Stock. If the Corporation subdivides, splits or combines the shares of Common Stock, then the Conversion Price in effect
immediately prior to the effective date of such share subdivision, split or combination shall be adjusted to the price determined by
multiplying the Conversion Price in effect immediately prior to the effective date of such share subdivision, split or combination by
the following fraction:
OS0
OS1
Where,
OS0 = the number of shares of Common Stock outstanding immediately
prior to the effective date of such share subdivision, split or combination.
OS1 = the number of shares of Common Stock outstanding immediately
after the opening of business on the effective date of such share subdivision, split or combination.
If any subdivision, split or combination described in this Section 7(a)(ii) is
announced but the outstanding shares of Common Stock are not subdivided, split or combined, the Conversion Price shall be readjusted,
effective as of the date the Board of Directors determines not to subdivide, split or combine the outstanding shares of Common Stock,
to such Conversion Price that would be in effect if such subdivision, split or combination had not been announced.
(iii) Other Distributions. If the
Corporation distributes to all holders of shares of Common Stock, any Convertible Securities or Options or any other assets for which
there is no corresponding distribution in respect of the Preferred Stock pursuant to Section 4(a)(i) (which excludes,
for the avoidance of doubt, any distribution of cash or non-cash property for which there is a corresponding distribution in respect
of the Preferred Stock pursuant to Section 4(a)(i)), then the Conversion Price in effect immediately prior to the Ex-Date
for such distribution shall be adjusted to the price determined by multiplying the Conversion Price in effect immediately prior to the
Ex-Date for such distribution by the following fraction:
SP0 – FMV
SP0
Where,
SP0 = the 10-Day VWAP of a share of Common Stock determined on the
Ex-Date for such distribution.
FMV = the fair market value of the portion of the distribution applicable
to one share of Common Stock on the Ex-Date for such distribution, in the case of a non-cash distribution or with respect to the non-cash
portion of a distribution, if any, as determined (i) by the good faith determination of the Board of Directors or (ii) if,
within five (5) Business Days following notice from the Corporation of the value determined by the Board of Directors pursuant to
clause (i), the Holders of a majority of the outstanding shares of Preferred Stock object in good faith to such determination,
then the fair market value will be determined by a nationally recognized independent investment banking firm that has for this purpose
(x) been selected by the Board of Directors, and (y) is reasonably acceptable to Holders of a majority of the
outstanding shares of Preferred Stock; provided, that such value, whether determined pursuant to the foregoing clause (i) or
(ii), shall not for the purposes hereof in any event be equal to or greater than the 10-Day VWAP of a share of Common Stock determined
on such date.
In a “spin-off,” where the Corporation makes a distribution
to all holders of shares of Common Stock consisting of capital stock of any class or series, or similar equity interests of, or relating
to, a Subsidiary of the Corporation or other business unit, the Conversion Price will be adjusted on the fifteenth (15th)
Trading Day after the effective date of the distribution by multiplying such Conversion Price in effect immediately prior to such fifteenth
(15th) Trading Day by the following fraction:
MP0
MP0 + MPs
Where,
MP0 = (i) if the Common Stock is listed or quoted on a
principal U.S. national or regional securities exchange or traded on an over-the-counter market, the 10-Day VWAP of a share of Common
Stock determined on the eleventh (11th) Trading Day following the effective date of such distribution, or (ii) if
the Common Stock is not listed or quoted on a principal U.S. national or regional securities exchange or traded on an over-the-counter
market, the 10-Day VWAP of a share of Common Stock on the effective date of such distribution.
MPs = (i) if the capital stock or equity interests distributed
to the holders of shares of Common Stock are listed or quoted on a principal U.S. national or regional securities exchange or traded
on an over-the-counter market, an amount equal to the product of (x) the number of shares of such capital stock or equity
interests representing the portion of the distribution applicable to one share of Common Stock and (y) the 10-Day VWAP of
such capital stock or equity interests on the eleventh (11th) Trading Day following the effective date of such distribution,
or (ii) if such capital stock or equity interests are not listed or quoted on a principal U.S. national or regional securities
exchange or traded on an over-the-counter market, the 10-Day VWAP of the capital stock or equity interests representing the portion of
the distribution applicable to one share of Common Stock on the effective date of such distribution (after giving effect to such distribution).
In the event that such distribution described in this Section 7(a)(iii) is
not so paid or made, the Conversion Price shall be readjusted, effective as of the date the Board of Directors publicly announces its
decision not to pay or make such distribution, to the Conversion Price that would then be in effect if such distribution had not been
declared.
(iv) Automatic Adjustment Upon Reset Dates.
The Conversion Price will automatically reset upon each of the eighteen (18) month and forty-seven (47) month anniversaries of the Original
Issuance Date to be equal to the lower of (x) the then-current Conversion Price and (y) the higher of (A) the Floor Price
or (B) the 10-Day VWAP of the Common Stock determined as of the date of such reset. Notwithstanding the foregoing, there shall be
no automatic resets of the Conversion Price pursuant to this Section 7(a)(iv) following a Fundamental Transaction Date.
(b) Other Adjustments.
(i) The Corporation may make decreases in
the Conversion Price, in addition to any other decreases required by this Section 7, if the Board of Directors deems it advisable
to avoid or diminish any income tax to holders of the Common Stock resulting from any dividend or distribution of shares of Common Stock
(or issuance of Options for Common Stock) or from any event treated as such for income tax purposes.
(ii) If the Corporation takes any action
affecting the Common Stock, other than an action described in Section 7(a), which upon a determination by the Board of Directors,
in its good faith discretion (such determination intended to be a “fact” for purposes of Section 151(a) of the
DGCL), would materially adversely affect the conversion rights of the Holders of shares of Preferred Stock, the Conversion Price shall
be adjusted, to the extent permitted by applicable law, in such manner, if any, and at such time, as the Board of Directors determines
in good faith to be equitable in the circumstances.
(c) Successive Adjustments. Successive adjustments in
the Conversion Price shall be made, without duplication, whenever any event specified in Section 7(a) or Section 7(b) shall
occur.
(d) Rounding of Calculations; Minimum Adjustments. All
adjustments to the Conversion Price shall be calculated to the nearest one-tenth (1/10th) of a cent. No adjustment in the Conversion
Price shall be required if such adjustment would be less than $0.01; provided, that any adjustments which by reason of this Section 7(d) are
not required to be made shall be carried forward and taken into account in any subsequent adjustment; provided, further
that on any Conversion Date adjustments to the Conversion Price will be made with respect to any such adjustment carried forward and
which has not been taken into account before such date.
(e) Statement Regarding Adjustments; Notices. Whenever
the Conversion Price is to be adjusted in accordance with one or more of Section 7(a) or Section 7(b), the
Corporation shall: (i) compute the Conversion Price in accordance with Section 7(a) or Section 7(b),
taking into account the one cent threshold set forth in Section 7(d); (ii) (x) in the event that
the Corporation shall give notice or make a public announcement to the holders of Common Stock of any action of the type described in
Section 7(a) (but only if the action of the type described in Section 7(a) would result in an adjustment
to the Conversion Price), or Section 7(g) (but only if the action of the type described in Section 7(g) would
result in a change in the type of securities or property to be delivered upon conversion of the Preferred Stock), the Corporation shall,
at the time of such notice or announcement, and in the case of any action which would require the fixing of a record date, at least ten
(10) days prior to such record date, give notice to each Holder by mail, first class postage prepaid, at the address appearing in
the Register, which notice shall specify the record date, if any, with respect to any such action, the approximate date on which such
action is to take place and the facts with respect to such action as shall be reasonably necessary to indicate the effect on the Conversion
Price and the number, kind or class of shares or other securities or property which shall be deliverable upon conversion of the Preferred
Stock or (y) in the event that the Corporation does not give notice or make a public announcement as set forth in subclause
(x) of this clause (ii), the Corporation shall, as soon as practicable following the occurrence of an event that requires an adjustment
to the Conversion Price pursuant to one or more of Section 7(a) or Section 7(b), taking into account the
one cent threshold set forth in Section 7(d) (or if the Corporation is not aware of such occurrence, as soon as practicable
after becoming so aware), provide, or cause to be provided, a written notice to the Holders of the occurrence of such event, in the same
manner and with the same detail as the notice set forth in subclause (x) of this clause (ii); and (iii) whenever the
Conversion Price shall be adjusted pursuant to one or more of Section 7(a) or Section 7(b), the Corporation
shall, as soon as practicable following the determination of the revised Conversion Price, (x) file at the principal office
of the Corporation, a statement showing in reasonable detail the facts requiring such adjustment, the Conversion Price that shall be
in effect after such adjustment and the method by which the adjustment to the Conversion Price was determined and (y) cause
a copy of such statement to be sent in the manner set forth in subclause (x) of clause (ii) to each Holder.
(f) Certain Adjustment Rules. If an adjustment in the
Conversion Price made pursuant to Section 7(a)(iv) would reduce the Conversion Price to an amount below the Floor Price,
then such adjustment in Conversion Price shall only reduce the Conversion Price to the Floor Price. As a condition precedent to the taking
of any action which would require an adjustment pursuant to this Section 7, the Corporation shall use its reasonable best
efforts to take any and all actions which may be necessary, including obtaining regulatory, NASDAQ (or such exchange or automated quotation
system on which the Common Stock is then listed) or stockholder approvals or exemptions, in order that the Corporation may thereafter
validly and legally issue as fully paid and nonassessable all shares of Common Stock issuable upon conversion of the Preferred Stock
in compliance with the applicable listing standards of NASDAQ (or such exchange or automated quotation system on which the Common Stock
is then listed).
(g) Fundamental Transactions.
(i) Subject to applicable
law and the last sentence of this Section 7(g)(i), upon the occurrence of any Fundamental Transaction (the date of such occurrence,
a “Fundamental Transaction Date”), then, upon any subsequent conversion of the Preferred Stock, the Holder shall have
the right to receive, for each share of Common Stock that would have been issuable upon such conversion immediately prior to the occurrence
of such Fundamental Transaction, (i) the number of shares of Common Stock of the Corporation (if it is the surviving entity), or
(ii) common stock of the successor or acquiring corporation (if it is the surviving entity), as well as any additional consideration
(the “Alternate Consideration”) receivable as a result of such Fundamental Transaction by a holder of the number of
shares of Common Stock (including, for avoidance of doubt, the number of shares of Common Stock in respect of any Accrued Dividends to
the extent unpaid as of the Fundamental Transaction Date, calculated as the quotient of (A) such Accrued Dividends divided by (B) the
Conversion Price in effect immediately prior to such Fundamental Transaction, the “Accrued Dividend Fundamental Transaction
Shares”) for which the Preferred Stock is convertible immediately prior to such Fundamental Transaction. For purposes of any
such conversion, if holders of Common Stock are given any choice as to the securities, cash or property to be received in a Fundamental
Transaction, then the Holder shall be given the same choice as to the securities, cash or property it receives upon any conversion of
the Preferred Stock following such Fundamental Transaction. Notwithstanding the foregoing and for the avoidance of doubt, for any transaction
that constitutes a Fundamental Transaction under clauses (iii) or (v) of the definition of Fundamental Transaction where the
Corporation is the surviving entity, upon any conversion of the Preferred Stock subsequent to such Fundamental Transaction, the Holder
shall be entitled to receive only (y) the number of shares of Common Stock of the Corporation for which the Preferred Stock is convertible
immediately prior to such Fundamental Transaction, plus (z) the Accrued Dividend Fundamental Transaction Shares.
(ii) if the Corporation is not the
surviving company in any Fundamental Transaction or will be dissolved in connection with a Fundamental Transaction, the Corporation shall
cause, as a condition to the closing of such transaction, any successor entity in a Fundamental Transaction in which the Corporation
is not the survivor (the “Successor Entity”) to assume in writing all of the obligations of the Corporation under
this Certificate of Designations in accordance with the provisions of this Section 7(g) prior to the consummation of
such Fundamental Transaction and shall deliver to the Holders in exchange for the Preferred Stock a security of the Successor Entity
evidenced by a written instrument substantially similar in form and substance to the Preferred Stock which is convertible for a corresponding
number of shares of capital stock of such Successor Entity (or its parent entity) and any Alternate Consideration equivalent to the shares
of Common Stock (including any Accrued Dividend Fundamental Transaction Shares) receivable upon conversion of the Preferred Stock (without
regard to any limitations on the conversion of the Preferred Stock) prior to the consummation of such Fundamental Transaction, and with
a conversion price which applies the Conversion Price hereunder to such shares of capital stock and any Alternate Consideration (but
taking into account the relative value of the shares of Common Stock pursuant to such Fundamental Transaction and the value of such shares
of capital stock and any Alternate Consideration, such conversion price being for the purpose of protecting the economic value of the
Preferred Stock immediately prior to the consummation of such Fundamental Transaction). Upon the occurrence of any such Fundamental Transaction,
to the extent necessary to effectuate the foregoing provisions, the Successor Entity shall file a new Certificate of Designations with
the same terms and conditions or, if applicable, the Successor Entity shall succeed to, and be substituted for (so that from and after
the date of such Fundamental Transaction, the provisions of this Certificate of Designations referring to the “Corporation”
shall refer instead to the Successor Entity), and may exercise every right and power of the Corporation and shall assume all of the obligations
of the Corporation under this Certificate of Designations with the same effect as if such Successor Entity had been named as the Corporation
herein.
Section 8.
Voting Rights.
(a) General. The Holders of shares of Preferred Stock
shall be entitled to vote with the holders of the Common Stock on all matters submitted to a vote of stockholders of the Corporation,
except as otherwise provided herein or as required by applicable law, voting together with the holders of Common Stock as a single class.
For such purposes, each Holder, for each share of Preferred Stock held by such Holder as of the record date for the determination of
stockholders entitled to vote on such matters, shall be entitled to a number of votes equal to the quotient of (i) $10.00 divided
by (ii) [the Minimum Price of the Common Stock as of the Original Issuance Date (as determined by reference to the Nasdaq Official
Closing Price)]3, or, if no such record date is established, each Holder, for each share of Preferred Stock held by such
Holder as of the date such vote is taken or any written consent of stockholders is solicited, shall be entitled to a number of votes
equal to the quotient of (i) $10.00 divided by (ii) [the Minimum Price of the Common Stock as of the Original Issuance
Date (as determined by reference to the Nasdaq Official Closing Price)]. The Holders of shares of Preferred Stock shall be entitled to
notice of any stockholders’ meeting in accordance with the Certificate of Incorporation and the By-laws as if they were holders
of record of Common Stock for such meeting.
3 NTD: Actual amount to be inserted into Certificate
of Designation filed with Delaware, with such amount determined based on the Minimum Price (as defined in Nasdaq Listing Rule 5635(d))
of MTAC’s Class A Common Stock.
(b) Class Voting Rights. So long as any shares of
Preferred Stock are outstanding, in addition to any other vote required by applicable law, the Corporation may not take any of the following
actions (including by means of merger, consolidation, reorganization, recapitalization or otherwise) without the prior affirmative vote
or written consent of the Holders representing at least a majority of the then-issued and outstanding shares of Preferred Stock, voting
as a separate class:
(i) amend, alter, repeal or otherwise modify
any provision of the Certificate of Incorporation or this Certificate of Designations in a manner that would alter or change the terms
or the powers, preferences, rights or privileges of the Preferred Stock as to affect them adversely;
(ii) authorize, create, increase the authorized
amount of, or issue any class or series of Senior Securities;
(iii) increase the authorized number of shares
of Preferred Stock; or
(iv) enter into any agreement with respect
to the foregoing.
(c) The consent or votes required in Section 8(b) shall
be in addition to any approval of stockholders of the Corporation which may be required by law or pursuant to any provision of the Certificate
of Incorporation or the By-laws. Each Holder of shares of Preferred Stock will have one vote per share on any matter on which Holders
of shares of Preferred Stock are entitled to vote separately as a class, whether at a meeting or by written consent.
Section 9.
Transfer Agent.
The Corporation shall appoint a Transfer Agent and remove its Transfer
Agent in accordance with the agreement between the Corporation and such Transfer Agent; provided that the Corporation shall appoint
a successor transfer agent of recognized standing who shall accept such appointment prior to the effectiveness of such removal. Upon
any such removal or appointment, the Corporation shall send notice thereof by first-class mail, postage prepaid, to the Holders. When
a Holder requests to register the transfer of shares of Preferred Stock, the Corporation or the Transfer Agent, as applicable, shall
register the transfer as requested if its reasonable requirements for such transaction are met.
Section 10.
Miscellaneous.
(a) Taxes. The issuance or delivery of shares of Preferred
Stock, shares of Common Stock or other securities issued on account of Preferred Stock pursuant hereto, or certificates representing
such shares or securities, shall be made without charge to the Holder for such shares or certificates or for any tax in respect of the
issuance or delivery of such certificates or the securities represented thereby, including any share transfer, documentary, stamp or
similar tax; provided, however, that the Corporation shall not be required to pay any tax that may be payable in respect
of any transfer involved in the issuance or delivery of shares of Preferred Stock, shares of Common Stock or other securities in a name
other than that in which the shares of Preferred Stock with respect to which such shares or other securities were issued or delivered
are registered, or in respect of any payment to any Person other than a payment to the Holder thereof, and the transferee or payee, as
the case may be, shall pay or bear the cost of any such tax, and the Corporation shall not be required to make any such issuance, delivery
or payment unless and until the Person otherwise entitled to such issuance, delivery or payment has paid to the Corporation the amount
of any such tax or has established, to the satisfaction of the Corporation, that such tax has been paid or is not payable.
(b) Good Faith. The Corporation shall not, by amendment
of the Certificate of Incorporation or through reorganization, consolidation, merger, dissolution, sale of assets, or otherwise, avoid
or seek to avoid the observance or performance of any of the terms of this Certificate of Designations, but will at all times in good
faith assist in the carrying out of all such terms and in the taking of all such action as may be necessary or appropriate in order to
protect the rights of the Holders of Preferred Stock against impairment as set forth in this Certificate of Designations.
(c) Status of Shares. Shares of Preferred Stock which
have been converted, redeemed, repurchased or otherwise cancelled shall be retired and, following the filing of any certificate required
by the DGCL, have the status of authorized and unissued shares of Preferred Stock, without designation as to series until such shares
are once more, subject to and in accordance with the provisions of Section 8, designated as part of a particular series of
Preferred Stock by the Board of Directors.
(d) Notices. All notices referred to herein shall be in
writing, and, unless otherwise specified herein, all notices hereunder shall be deemed to have been given upon the earlier of receipt
thereof or three (3) Business Days after the mailing thereof if sent by registered or certified mail (or by first class mail if
the same shall be specifically permitted for such notice under the terms of this Certificate of Designations) with postage prepaid, addressed:
(i) if to the Corporation, to its office at 6272 W. 91st Avenue, Westminster, CO 80031, Attention: Chief Financial Officer,
or to any transfer or other agent of the Corporation designated to receive such notice as permitted by this Certificate of Designations,
or (ii) if to any Holder, to such Holder at the address of such Holder as listed in the Register or (iii) to
such other address as the Corporation or any such Holder, as the case may be, shall have designated by written notice similarly given.
(e) Severability. If any right, preference or limitation
of the Preferred Stock set forth in this Certificate of Designations (as amended from time to time) is invalid, unlawful or incapable
of being enforced by reason of any rule of law or public policy, all other rights, preferences and limitations set forth in this
Certificate of Designations (as so amended) which can be given effect without the invalid, unlawful or unenforceable right, preference
or limitation shall, nevertheless, remain in full force and effect, and no right, preference or limitation herein set forth shall be
deemed dependent upon any other such right, preference or limitation unless so expressed herein.
(f) Other Rights. Except as expressly provided in any
agreement between a Holder and the Corporation, the shares of Preferred Stock shall not have any voting powers, preferences or relative,
participating, optional or other special rights, or qualifications, limitations or restrictions thereof, other than as set forth herein
or in the Certificate of Incorporation or as provided by applicable law.
(g) Headings. The headings of the various subdivisions
hereof are for convenience of reference only and shall not affect the interpretation of any of the provisions hereof.
(h) Effectiveness. This Certificate of Designations shall
become effective upon the filing thereof with the Secretary of State of the State of Delaware.
[Remainder of this page intentionally
left blank]
IN WITNESS WHEREOF, the Corporation has caused this Certificate of
Designations to be duly executed and acknowledged by its undersigned duly authorized officer this [ ] day of [ ], 2023.
|
TRISALUS
LIFE SCIENCES, INC. |
|
|
|
|
By: |
|
|
Name: |
|
|
Title: |
|
[Signature Page to the Certificate of
Designations]
ANNEX A
CONVERSION NOTICE
(TO BE EXECUTED BY THE REGISTERED HOLDER IN ORDER
TO
CONVERT SHARES OF SERIES A PREFERRED STOCK)
The
undersigned hereby elects to convert the number of shares of Series A Preferred Stock indicated below into shares of common stock,
$0.0001 par value per share (the “Common Stock”), of TRISALUS LIFE SCIENCES, INC., a Delaware corporation,
according to the conditions hereof, as of the date written below.
Conversion calculations:
Date to Effect Conversion: |
|
Number of shares of Series A Preferred Stock
owned prior to Conversion: |
|
Number of shares of Series A Preferred Stock
to be Converted: |
|
Number of shares of Common Stock to be Issued: |
|
Applicable Conversion Price: | |
Number of shares of Series A Preferred Stock
subsequent to Conversion: |
|
|
[Holder] |
|
|
|
|
By: |
|
|
Name: |
|
|
Title: |
|
Exhibit B
Accredited Investor Questionnaire
Capitalized terms used and not defined in this Exhibit A
shall have the meanings given in the Subscription Agreement to which this Exhibit A is attached.
¨ The
undersigned represents and warrants that the undersigned is an “Institutional Account” as such term is defined in FINRA
Rule 4512(c).
The undersigned represents and warrants that the undersigned is an
“accredited investor” as such term is defined in Rule 501(a) of Regulation D under the U.S. Securities Act of 1933,
as amended (the “Securities Act”), for one or more of the reasons specified below (please check all
boxes that apply):
¨ | (i) | A bank as defined in Section 3(a)(2) of the Securities
Act, or any savings and loan association or other institution as defined in Section 3(a)(5)(A) of the Securities Act, whether
acting in its individual or fiduciary capacity; |
¨ | (ii) | A broker or dealer registered pursuant to Section 15 of
the Securities Exchange Act of 1934, as amended (the “Exchange Act”); |
¨ | (iii) | An investment adviser registered pursuant to section 203 of
the Investment Advisers Act of 1940 (the “Investment Advisers Act”) or registered pursuant to the laws of a state,
or an investment adviser relying on the exemption from registering with the Commission under the section 203(l) or (m) of the
Investment Advisers Act; |
¨ | (iv) | An insurance company as defined in section 2(13) of the Exchange
Act; |
¨ | (v) | An investment company registered under the Investment Company
Act or a business development company as defined in Section 2(a)(48) of that Act; |
¨ | (vi) | A Small Business Investment Company licensed by the U.S. Small
Business Administration under Section 301(c) or (d) of the Small Business Investment Act of 1958; |
¨ | (vii) | A plan established and maintained by a state, its political
subdivisions, or any agency or instrumentality of a state, or its political subdivisions for the benefit of its employees, if such plan
has total assets in excess of $5,000,000; |
¨ | (viii) | An employee benefit plan within the meaning of the Employee
Retirement Income Security Act of 1974, if the investment decision is made by a plan fiduciary, as defined in Section 3(21) of such
act, which is either a bank, savings and loan association, insurance company, or registered investment adviser, or if the employee benefit
plan has total assets in excess of $5,000,000 or, if a self-directed plan, with investment decisions made solely by persons that are
accredited investors; |
¨ | (ix) | A private business development company as defined in Section 202(a)(22)
of the Investment Advisers Act of 1940; |
¨ | (x) | An organization described in Section 501(c)(3) of
the Internal Revenue Code, or a corporation, business trust, partnership, or limited liability company, or any other entity not formed
for the specific purpose of acquiring the Shares, with total assets in excess of $5,000,000; and/or |
¨ | (xi) | A trust, with total assets in excess of $5,000,000, not formed
for the specific purpose of acquiring the Securities, whose purchase is directed by a sophisticated person who has such knowledge and
experience in financial and business matters that such person is capable of evaluating the merits and risks of investing in the Company. |
¨ | (xii) | A “family office,” as defined in Rule 202(a)(11)(G)-1
under the Advisers Act: (i) with assets under management in excess of $5,000,000, (ii) that is not formed for the specific
purpose of acquiring the Shares, and (iii) whose prospective investment is directed by a person who has such knowledge and experience
in financial and business matters that such family office is capable of evaluating the merits and risks of the prospective investment. |
¨ | (xiii) | A “family client,” as defined in Rule 202(a)(11)(G)-1
under the Advisers Act, of a family office meeting the requirements of the category immediately above and whose prospective investment
in the Company is directed by such family office pursuant to clause (iii) in the category immediately above. |
¨ | (xiv) | An individual whose individual net worth, or whose joint net
worth with such individual’s spouse or spousal equivalent, is in excess of $1,000,000. |
¨ | (xv) | An individual whose individual net income (exclusive of any
income attributable to such individual’s spouse or spousal equivalent) is more than $200,000 in each of the past two years, or
whose joint income with such individual’s spouse or spousal equivalent is more than $300,000 in each of those years, and such individual
reasonably expect to reach the same income level in the current year. |
¨ | (xvi) | An individual who holds in good standing one or more of the
following professional certifications and designations administered by the Financial Industry Regulatory Authority: Licensed General
Securities Representative (Series 7), Licensed Investment Adviser Representative (Series 65), and Licensed Private Securities
Offerings Representative (Series 82). |
¨ | (xvii) | The Subscriber does not qualify under any of the investor categories
set forth in (i) through (xvi) above. |
| 2.1 | Type of the Subscriber. Indicate the form of entity of the Subscriber: |
¨ |
Limited Partnership |
¨ |
General Partnership |
|
¨ |
Corporation |
¨ |
Limited Liability Company |
|
¨ |
Individual |
¨ |
Revocable Trust |
|
¨ |
Other
Type of Trust (indicate type): |
|
|
¨ |
Other
(indicate form of organization): |
|
|
|
Subscriber: | |
|
| |
|
Subscriber Name: | |
|
|
By: |
|
|
|
Signatory Name: |
|
|
Signatory Title: |
Exhibit 10.3
July 4, 2023
MedTech Acquisition Corporation
48 Maple Avenue
Greenwich, CT 06830
Re: Termination of Backstop Letter Agreement
Ladies and Gentlemen:
In accordance with that certain Backstop Letter Agreement,
dated June 7, 2023 (the “Backstop Letter Agreement”), this letter (this “Termination Letter”) hereby
serves as confirmation and agreement by each of MedTech Acquisition Corporation, a Delaware corporation (“MTAC”) and
MedTech Acquisition Sponsor LLC, a Delaware limited liability company (the “Sponsor”), that Individual Sponsor Investors
(as such term is defined in the Backstop Letter Agreement) have collectively executed and delivered Subscription Agreements (as such term
is defined in the Backstop Letter Agreement) to MTAC providing for an aggregate investment by such Individual Sponsor Investors equal
to or greater than Two Million Dollars ($2,000,000), and that as such, the Backstop Letter Agreement is hereby terminated, effective immediately,
pursuant to Section 3 of the Backstop Letter Agreement.
Upon execution of this Termination Letter by the
respective parties hereto, there shall be no continuing obligation or liability of either party pursuant to the Backstop Letter Agreement.
This Termination Letter may be executed and delivered (including by facsimile or portable document format (.pdf transmission) in one or
more counterparts, and by the different parties in separate counterparts, each of which when executed shall be deemed to be an original
but all of which taken together shall constitute one and the same agreement.
[Signature Page Follows]
IN WITNESS WHEREOF, this Termination Letter Agreement
has been executed as of July 4, 2023.
|
MTAC: |
|
|
|
MEDTECH ACQUISITION CORPORATION |
|
|
|
By: |
/s/ Christopher Dewey |
|
|
Name: |
Christopher Dewey |
|
|
Title: |
Chief Executive Officer |
|
|
|
|
|
SPONSOR: |
|
|
|
MEDTECH ACQUISITION SPONSOR LLC |
|
|
|
By: |
/s/ Christopher Dewey |
|
|
Name: |
Christopher Dewey |
|
|
Title: |
Managing Member |
[Signature Page to Termination
Letter]
MedTech Acquisition (NASDAQ:MTACU)
Historical Stock Chart
From May 2024 to Jun 2024
MedTech Acquisition (NASDAQ:MTACU)
Historical Stock Chart
From Jun 2023 to Jun 2024